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To be, or not to be: that is the question: 
Whether ‘tis nobler in the mind to suffer 
The slings and arrows of outrageous fortune, 
Or to take arms against a sea of troubles, 
And by opposing end them? To die: to sleep; 
No more; and by a sleep to say we end 
The heart-ache and the thousand natural shocks 
That flesh is heir to, ‘tis a consummation 
Devoutly to be wish’d. To die, to sleep; 
To sleep: perchance to dream: ay, there’s the rub; 
For in that sleep of death what dreams may come 
When we have shuffled off this mortal coil, 
Must give us pause. 
                                                                             Hamlet Act III Scene I ;William Shakespeare 
 
कर्मणे्यवाधिकारसे्त र्ा फलेषु कदाचन। र्ा कर्मफलहेतुर्भमर्ाम ते सङ्गोऽस्त्वकर्मधि॥ 
 
Bhagavad Gita 
 
“Yesterday I was clever, so I wanted to change the world. Today I am wise, so I am changing 
myself.” 
Rumi 
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1.1 INTRODUCTION 
The ability to control and understand the functioning of organisms using synthetic 
biomolecules and networks is a long-envisioned goal among scientists. The convergence of 
this traditional bioengineering approach with principles of engineering gave birth to the 
discipline that is referred to as synthetic biology. One definition of synthetic biology is :- the 
design and construction of new biological parts, devices, and systems, and the re-design of 
existing, natural biological systems for useful purposes. Since the start of the 21st century, this 
field has witnessed an exponential growth as it has facilitated the engineering of a variety of 
genetic networks which display complex behaviours. In the past decade, a subset of this field 
called cell-free synthetic biology has developed which offers a simplified prototyping 
environment to implement genetic circuits without the interference from and burdening the 
cellular host. In conjugation with microfluidics, long-lived cell-free platforms have been 
developed which have been used to rapidly forward engineer new network topologies and 
increase the complexity of synthetic genetic networks. In this chapter I will provide some 
examples from literature to highlight the progress made in these fields. I will start with the 
engineering of different synthetic circuits in E.coli which exhibit complex behaviours such as 
oscillations and bistability. These networks paved the way for other genetic circuits which can 
control cellular behaviour, often times for real-world applications. I will go on to briefly discuss 
some of the limitations with in vivo synthetic biology and how cell-free transcription translation 
or cell-free protein synthesis (TX-TL or CFPS) helps in alleviating some of these limitations. 
I will discuss the benefits of cell-free systems and their usefulness as a platform to rapidly 
prototype synthetic genetic networks such as oscillators. Finally, I shall highlight the role 
played by cell-free systems as a tool for bottom-up synthetic biology. 
 
1.2 IN VIVO SYNTHETIC GENETIC NETWORKS 
At the start of the new millennium, two seminal pieces of work were published which defined 
synthetic biology -  the genetic oscillator and the genetic toggle switch. They relied on using 
existing genetic elements to rationally design exhibiting desired dynamical behaviours. These 
works served as a proof-of-principle for the engineering of genetic networks and paved the way 
for numerous and diverse subsequent works involving more complex and diverse synthetic 
genetic networks. 
The first synthetic oscillator was engineered by Elowitz and Leibler1 and comprised of three 
repressors (lacI, CI and tetR) with each repressor inhibiting the production of the other in a 
cyclical manner (hence the name repressilator) (Figure 1.1 a and b) along with a gfp gene under 
the control of the tetR repressor to report on the state of the system. Furthermore, each repressor 
was tagged for targeted degradation by the endogenous ClpXP protease present in the cells. 
When transformed in E. coli cells, the repressilator oscillated with a period of approximately 
150 mins and oscillations were observed over a few cell generations after which they died out. 
Since the system suffered from high variability, measurement of oscillatory characteristics such 
as period of oscillation was performed at single-cell level. The behaviour of the network was 
also found to be coupled to cell growth as the oscillations halted when the cells reached 
stationary state of their growth. Purcell et al attributed this effect to the increase in 
concentration of σ38 which could outcompete σ70 for the RNA polymerase and hence alter the 
network dynamics2. Furthermore, the authors proposed designing a repressilator whose 
promoters are controlled by σ38 and σ70 as a potential solution to propagate the oscillations into 
stationary phase of the cells. Tsai et al. demonstrated that the addition of a positive feedback 
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loop further increased the robustness of the repressilator and allowed the independent tuning 
of the frequency and amplitude of oscillators.3 
The first synthetic genetic toggle switch was built by Gardner et al.4. It is a network capable of 
switching between two exclusive states and remains in a particular state until it is switched 
(Figure 1.1 c and d). Gardner et al. used two repressor molecules under the control of two 
constitutive promoters with each promoter being inhibited by the repressor controlled by the 
other promoter. The system was able to switch between two states – either promoter 1 active 
or promoter 2 active- by the addition of inducers which inhibit the repressors. Two versions of 
the toggle switch were implemented. One version had lacI and tetR as the repressors, and IPTG 
and aTc were the inducers respectively and the other version used  C1 instead of tetR which is 
heat-sensitive and hence IPTG and change in temperature were used to switch the system. A 
reporter molecule (GFP) was incorporated which provided real-time output of the state of the 
system.   
         
Figure 1.1 First synthetic networks exhibiting complex behaviour. (a) Biological realisation of the repressilator 
with the three repressors – lacI, tetR and λ C1 – inhibiting the production of each other cyclically. A reporter 
protein under the control of lacI is incorporated as readout. (b) Fluorescence signal from the repressilator at the 
single-cell level over time. Figures taken from Elowitz et al.1 (c) General scheme of the toggle switch consisting 
of two promoters controlling two repressor which inhibit protein production from the other promoter. (d) 
Biological realization of the toggle switch – the plasmid contains the lacI gene and R1 represents the location of 
either one of the other two repressors – tetR or λ C1. (e) When transformed in cells, bistable behaviour was 
observed upon changing the concentration of the inducer- IPTG. The red curves show the stable steady-state of 
the toggle switch and the yellow curve the unstable steady-state of the system. The blue curve shows the sigmoidal 
response of GFP from a control plasmid upon IPTG induction i.e. no bistability. Figures were taken from Gardner 
et al.4 
The bistable switch and the repressilator were fundamental for the progress of synthetic biology 
for two reasons. Firstly, these examples demonstrated the ability to use a rationally designed 
genetic network to engineer new complex behaviours in cells. Secondly, mathematical 
modelling and quantitative analysis were used to characterize and map out the behaviour of the 
respective systems. Every biological process such as rates of mRNA and protein synthesis, 
repressor-DNA binding, protein degradation were aligned with a mathematical profile to 
describe the system behaviour and predict the impact of modifications on system behaviour. 
For example, a weaker promoter regulating the production of the lacI gene disrupted the 
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balance of rates essential to observe bistable behaviour in the system. The model predictions 
matched the results as this version of the toggle switch did not show bistable behaviour thereby 
underlining the importance and value of a good model in designing synthetic networks.  
Stricker et al. engineered a robust synthetic oscillator by a combination of topology design, 
strain selection and mathematical analysis5. The system consisted of dual feedbacks – a 
negative feedback implemented by the lacI repressor and a positive feedback implemented by 
araC in the presence of arabinose (Figure 1.2a) along with a modified version of GFP as the 
reporter. Each promoter controlling the genes was activated by araC (which upon dimerization 
displayed a high affinity for the RNA polymerase) and was repressed by lacI. In order to negate 
the influence of cellular metabolism, a strain of E. coli was engineered which does not produce 
any endogenous lacI. In contrast to previous work, the authors implemented a microfluidic 
system providing laminar flow of medium which prevented the cells from reaching stationary 
phase thereby allowing the transmission of the state of the oscillators through several 
generations of E. coli cells. The period of oscillations were tuned (13-60 mins) by altering 
inducer levels (IPTG and arabinose), temperature and the medium in which the cells were being 
grown (Figure 1.2b). The detailed mathematical analysis of Stricker et al., which took into 
account biological processes such as dimerization and multimerization of the regulatory 
proteins, predicted the existence of an oscillator with an alternative topology. Hence, the 
oscillator topology was minimized by removing the positive feedback, and the new design had 
lacI repressing its own expression and the expression of GFP. This oscillator, also termed the 
Goodwin oscillator6, was found to be less robust as compared to the dual-feedback oscillator, 
with the system never reaching a complete OFF state and it was not as susceptible to different 
IPTG concentration i.e. oscillator properties were not as tuneable as the dual-feedback 
oscillator. These individual oscillators were further used to demonstrate higher order 
phenomena –  such as synchronization and entrainment –  among a population of cells. Prindle 
et al. designed an array of coupled genetic ‘biopixels’7. Each ‘biopixel’ is a centimetre long 
compartment containing E. coli cells engineered with a synthetic oscillator. The oscillator is 
similar to the dual-feedback design of their previous work except that it has an additional 
coupling module – a NADH dehydrogenase II (ndh) gene which produces H2O2. H2O2 vapours 
diffuse across the device and synchronizes the colonies across the biopixels (Figure 1.2c). The 
presence of AHL (N-acyl homoserine lactone, a signalling molecule) helps in the 
synchronization of colonies within a ‘biopixel’. The AHL cannot help in inter-biopixel 
synchronization because it is continuously flushed out by the flow of medium in the device. 
The ‘biopixel’ array exhibited synchronized oscillations (Figure 1.2d) and in the presence of 
35 mM thiourea- which is a radical quencher – the synchronization decayed. Mondragon-
Palomino et al. further explored the phenomenon of entrainment among these oscillators8. 
Entrainment is a common feature of natural oscillators such as circadian clocks where 
biological clocks adjust their phase to daily environmental stimuli. In order to mirror the 
influence of external variations displaying a fixed period, such as sunlight, the authors used 
sinusoidal variations of arabinose or IPTG concentrations to affect the behaviour of the Hasty 
oscillator. Using mathematical modelling, they found parameter regimes for concentrations of 
arabinose and IPTG in which they can entrain oscillations from the Hasty oscillator.  
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Figure 1.2 (a) Topology of the Dual Feedback Genetic Oscillator with araC activating the genes and lacI 
repressing the production of genes. (b) Fluorescence signal from the cells transformed with the oscillator. The 
trace on the top represents the signal obtained from the red curve.  Figures were taken from Stricker et al.5. (c) 
Schematic of the genetic array of ‘biopixels’ as designed by Prindle et al.13. H2O2 diffuses across the PDMS 
membranes allowing long-range communications (d) Fluorescence measurements show very high consistency 
and synchronicity of oscillations. 
In order to build a synthetic oscillator which can harness and integrate into the metabolism of 
the cell, Fung et al., designed a metabolic oscillator (metabolator)9. It is a synthetic circuit that 
exhibits oscillatory behaviour by harnessing the glycolytic flux via acetyl phosphate. 
Essentially, the system consisted of two metabolite pools - M1 (acetyl coenzyme A) and M2 
(acetyl phosphate, acetate and protonated acetate) – with two enzymes – E1 (phosphate 
acetyltransferase) and E2 (acetyl-CoA synthetase) – catalysing their interconversion. When the 
level of M2 is low, E1 is expressed and E2 is not. A high metabolic influx switches the system 
from M1 to M2. As the level of M2 increases, it represses E1 and upregulates E2. When the 
outflux from M2 increases and level of M1 increases, E1 is expressed and E2 is degraded 
bringing the system back to its original state. Acetyl Phosphatase from M2 activates the glnAP2 
promoter which produces the lacI gene which in turn regulates GFP production. The 
metabolator oscillates with a period of approximately 45 mins, and its behaviour was tuned by 
changing the carbon source of the growth medium. Glucose, fructose and mannose which have 
high glycolytic rates supported oscillatory behaviour but glycerol which has low glycolytic 
rates did not support oscillations.  
The forward engineering of genetic oscillators can now be based on a set of rational design 
principles as described by Novak and Tyson10 :  
1. A negative feedback with sufficient time delay – this can be implemented in a number 
of ways such as a protein inhibiting the production of its own mRNA.  In eukaryotic 
systems the time delay can be extended if the mRNA has to be exported out of the 
nucleus to be translated and the protein has to re-enter the nucleus to inhibit its mRNA. 
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2. Sufficient non-linearity in rates :- the sources of non-linearity can arise from 
oligomerization of a ligand, cooperativity in enzymes, or multi-site phosphorylation by 
kinases to activate an enzyme. 
3. Proper balance of rates – this is ensured either by controlling the copy number of 
plasmid containing the genes or by tuning the in vivo concentrations of mRNA and 
proteins using degradation tags. 
4. A positive feedback loop to increase the robustness of oscillations. 
In addition to oscillators, a variety of complex genetic circuits have been reported, some of 
which found real-world applications. Shao et al. implemented a light-controlled synthetic 
genetic circuit which helps in controlling glucose metabolism in diabetic mice which can be 
operated via a smart phone11. Auslander et al. developed one of the most complex logic gates 
called the full adder using a genetic network12. Full adder circuits process three input signals 
to generate two outputs-a sum and a carry. Significantly this circuit was distributed  among 
nine different cell types to establish a genetic logic gate across a tissue. Sedlmayer et al. 
engineered designer mammalian cells which contain a synthetic genetic circuit that can sense 
the presence of microbial peptides and release a toxin AI-2 in response to bacteria and yeast13. 
This network senses the levels of the bacterial peptide and releases corresponding levels of AI-
2 in response. The Benenson group developed circuits which can process several microRNA 
(miRNA) inputs to make logical decisions via an RNA interference pathway and thereby 
regulate gene expression in cells14,15. Post-transcriptional regulatory elements such as 
riboregulators were developed to provide alternative means of gene regulation. One class of 
riboregulators relied on the binding of a ligand to an RNA sequences which induces a 
conformational change in the riboregulator16. The second class of riboregulators was based on 
the ability of an mRNA to prevent its own translation. A small sequence at the 5’-untranslated 
region of an mRNA, complementary to the RBS, hybridizes with the RBS and represses 
expression of the gene. This is termed cis-regulation. A second RNA called transactivator can 
bind to this mRNA at the cis-repressor sequence to inhibit its binding to the RBS and thereby 
activate production of the gene17. Ro et al. reported the production of arteminisic acid, which 
is a precursor of the antimalarial drug artemisin, from an engineered strain of S.cerevisiae18. 
Riglar et al. engineered bacteria that can stay in the mouse gut for up to six months and detect 
tetrathionate, a marker for inflammation19. Keasling and co-workers engineered a strain of 
E.coli which can synthesize isoprenoids, which serve as precursors for the synthesis of steroids 
which are important components of medicines20.  
As the diversity of genetic networks increased, so did the mathematical analyses of these 
networks because they provide scientists with the opportunity to test mathematical theories of 
gene regulation21. Tigges et al. designed a mammalian oscillator using a sense-antisense 
expression unit encoding the tetracycline dependent transactivator22. Using a deterministic 
model, the authors found reporter stability and dosage of one of the plasmids (pMT35 which 
codes for the transactivator) in their system to be key variables to optimize the oscillatory 
network. On replacing their reporter with a GFP variant with reduced half-life and using 
different amounts of pMT35 plasmid they found the transformed cells indeed showed 
oscillations proving the utility of model driven analyses. Since in vivo oscillators are subjected 
to intracellular noise arising from fluctuating levels of biomolecules, Zhu et al. developed a 
stochastic treatment of gene expression23. Since the cellular environment is inherently 
stochastic, genetic circuits transformed in isogenic cells can display phenotypic variability. 
Hence, the authors designed a stochastic framework and applied it to the level of single-gene 
expression and gradually increased the complexity to apply the model to the bistable switch 
and repressilator to find hitherto unknown network requirements to exhibit bistability or 
oscillations. For example, stochastic analysis revealed that strong repression can enable 
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bistability in the toggle switch without the need for cooperativity which was in disagreement 
with the deterministic model of Gardner et al. There have also been several mathematical 
analyses on accounting for or reducing noise in genetic networks24,25. 
1.3 SYNTHETIC BIOLOGY : OVERBURDENED AND OVERSTRESSED 
The drawback of implementing synthetic networks in vivo is that they can have unforeseen 
effects on the cellular chassis as well as the functioning of the synthetic circuit26 (Figure 1.3). 
Some of these drawbacks include competition for and reallocation of cellular resources 
otherwise dedicated to transcription27, translation28 or protein degradation29 which can lead to 
cellular stress. Excess of heterologous proteins can cause an abnormal increase in cell size as 
the host seeks to decrease the activity of heterologous proteins30. Sleight et al. observed the 
emergence of loss-of-function mutations in synthetic networks occurring as a consequence of 
the burden placed by synthetic networks on the viability of cells. These mutations eventually 
lead to the generation of escape mutants – cells in which the synthetic circuit had been 
inactivated after a few generations31. 
                                                                      
Figure 1.3 Resource burden in hosts transformed with synthetic networks. (a) The synthetic network shares 
resources of the cells which places a burden on the host. (b) Since protein degradation tags are used by synthetic 
circuits to tune in vivo protein concentrations, they rely on the native ClpXP protease. This could lead to saturation 
of the degradation machinery. (c) In order to compensate for the increase in heterologous proteins the cell has to 
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increase in volume leading to decrease in concentration of biomolecules such as DNA, RNA and protein 
machinery of the cell. Figures taken from Borkowski et al.26 
There have been efforts to circumvent the issue of cellular burden. For example, Ceroni et al. 
developed a ‘capacity monitor’ to track the burden of expressing synthetic networks on a host32. 
The authors identified an endogenous promoter (htpG1) which was sensitive to cellular burden 
and designed an effector (sgRNA along with dCas9) which is expressed on increased cellular 
burden and represses expression from the synthetic construct. Other alternatives include the 
use of orthologous degradation machinery, such as Lon protease33, so that the synthetic 
networks do not have to rely on the endogenous degradation machinery, or stress-responsive 
promoters which can act as toxic-metabolite detectors34.  
Another strategy includes characterizing genetic modules cell-free gene expression system. 
Such systems have the potential to serve as a molecular breadboard for the rapid prototyping 
of individual genetic regulatory elements and networks. 
1.4 CELL-FREE SYSTEMS 
Cell-free protein synthesis or Cell-free transcription-translation systems (abbreviated as CFPS 
or TX-TL ) recapitulates the cellular environment  by performing one of the most important 
cellular processes – that of information conversion or gene expression. Cell-free systems have 
been used since the 1960s, first by Matthei and Niremberg for their work in deciphering the 
genetic code by using mRNA of known sequence as an input for CFPS systems35,36.  Later, 
cell-free systems used DNA as the starting material introducing the concept of coupled 
transcription and translation37,38.  
The pioneering work in integrating cell-free systems into the framework of synthetic biology 
was reported by Noireaux and co-workers. Initially, Noireaux et al. developed single-template 
cell-free gene expression system where the viral T7 RNA Polymerase (RNAP) controls the 
transcription of the DNA and the bacterial translational machinery converts the mRNA to 
protein39. In 2010, Shin and Noireaux developed an all E.coli TX-TL system40. This system 
used the endogenous E.coli polymerase to carry out transcription instead of a viral T7 
polymerase. Bacterial RNAP is a multi-subunit enzyme which controls transcription in 
bacteria. It is assisted by its family of sigma factors which help the RNAP in transcription 
initiation. Different sigma factors control different promoters responsible for different 
functions in the bacteria such as flagellar control, stress response etc. Shin et al. used  σ70 , the 
housekeeping sigma factor, along with its promoter (P70) to produce nearly micromolar level 
of protein as compared to their previous work where they managed to produce only a few 
nanomolars of protein. 
Shin and Noireaux’s TX-TL system consists of broadly three components41,42 :- 
1. E. coli lysate – this is the component of the TX-TL system which contains all the 
necessary machinery to perform transcription and translation such as RNAP, σ70, 
ribosomes, elongation factors etc and is typically prepared from the BL21 Ros2 strain. 
2. Energy Mixture –  a combination of different resources such as NTPs ( to produce 
mRNA), amino acids (to produce proteins), and 3-PGA, in intermediate of the 
glycolysis pathway, which helps in ATP regeneration. 
3. DNA and other supplements- the necessary DNA to start the gene expression along 
with necessary supplements such as PEG, magnesium gluatamate, postassium 
glutamate etc. 
Caschera et al. optimized the system to improve protein yields by using additives like maltose 
which recycles inorganic phosphate (a by-product of TX-TL reactions) and couples to 3-
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phoshoglyceric acid (3-PGA) to improve ATP regeneration43. In order to better understand the 
kinetics of the different biomolecules a coarse grained model was developed to understand 
gene expression44,45 and to monitor resource usage in TX-TL systems46. 
TX-TL systems have been used for the detailed investigation of the gene expression process. 
Iskakova et al. used the RTS 100 E. coli cell-free kit to analyse and optimise for several 
bottlenecks, such as stability of mRNAs, sub-optimal usage of NTPs and amino acids in protein 
production47. Lentini et al. used the PURE system to identify some practical rules for the 
construction of genetic circuits in cell-free systems48. The authors studied the influence of 
different start codons, spacer length and spacer composition between RBS and start of the gene 
and the influence of restriction sites on gene expression. Hansen et al. engineered cell-like 
environments by using hydrogels to localize DNA and gene expression. The authors found that 
such environments greatly enhanced transcription and translation rates indicating that the role 
of diffusion in fundamental processes such as gene expression should not be discounted49. The 
usefulness of E. coli TX-TL systems propelled the design and development of alternative cell-
free systems such as B. subtilis cell-free system and V. natriegens cell-free system 50,51. 
Garamella et al. improved on the E. coli TX-TL genetic toolbox by increasing the number of 
regulatory genetic elements52. The authors expanded the number of transcriptional units 
(promoters and corresponding sigma factors), fluorescent reporter proteins (deCFP, deYFP, 
mCherry, RFP) and implemented transcriptional repression using the lambda C1 protein which 
binds to P70 promoter. This cell-free toolbox was used to construct cascades – linear circuits 
where protein from one DNA template activates/represses protein from the downstream DNA. 
The complexity of cascades was also increased from two-gene to five-gene which harnessed 
all the sigma factors of E. coli (Figure 1.4 a and b). Additionally, the TX-TL system was 
optimized to produce the metabolite violacein from a five-gene operon taken from the organism 
Chromobacterium violaceum. The two co-factors necessary for the production of violacein – 
Nicotinamide Adenine Dinucleotide (NADH) and Flavin Adenine Dinucleotide (FAD) –  were 
added to the TX-TL reaction along with the DNA, and the production of the purple coloured 
metabolite was observed (Figure 1.4 c and d). Shin et al. expanded the TX-TL toolbox of 
genetic elements available by implementing several mechanisms to tune protein and mRNA 
degradation53. This involved expressing native E. coli proteases like ClpXP which can bind to 
different amino-acid tags with different affinities and degrade proteins or nucleases such as 
mazF and its anti-toxin mazE to tune mRNA degradation. More recently, Marshall et al. 
expressed multiple Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-
Cas nucleases  and short guide RNAs (sgRNAs) for targeted repression of protein production 
from DNA templates in TX-TL systems 54. The authors also developed several anti-CRISPR 
proteins to help tune the activity of Cas nucleases. Maxwell et al. developed a TX-TL-based in 
vitro assay to rapidly elucidate several Protospacer Adjacent Motifs (PAMs) which are 
recognized by Cas nucleases. Their method allows the necessary proteins to be co-expressed 
in a TX-TL environment thereby obviating  the need for complex cloning and protein 
purification55. TX-TL systems have also been used synthesise T4, T7, фX174 and MS2 phages 
from their respective genomes56,57. 
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Figure 1.4 The all E. coli cell-free toolbox 2.0. (a) Genetic elements such as bacterial sigma factors and their 
respective promoters were combined to build genetic circuits comprising of upto six DNA templates. (b) 
Expression of reporter protein – deGFP – from the cascade with and without one of the intermediate DNA 
templates  – P28-T7RNAP. The absence of this construct breaks the circuit and there is no deGFP production. (c) 
Implementation of the five-gene vioABCDE operon coding for the enzymes to produce the metabolite violacein 
from its precursor molecules. (d) Photos of E. coli cells expressing  violacein (left), TX-TL reaction without the 
plasmid coding for the vioABCDE genes (middle) and TX-TL reaction with the precursor molecules  material and 
the vioABCDE plasmid indicating the production of violacein (right). Figures taken from Garamella et al.58 
Most of the research pertaining to cell-free systems thus far has relied on 
fluorescent/luminescent proteins as the reporter. Niederholtmayer et al. implemented a method 
to quantify mRNAs in real-time in PURE TX-TL systems by using binary probes, which 
consist of a Cy3 and Cy5 FRET pair, and fluoresce when bound to a specific region of the 
mRNA59. In order to investigate the effect of promoter strength on gene expression in an 
operon, Chizzolini et al. quantified mRNA levels from different promoters in TX-TL systems 
using an aptamer, which is a mRNA structure which binds to a specific molecule and upon 
binding of said molecule can change its spectral properties60. The authors used a GFP-mimic 
called Spinach which binds to DFHBI (3,5-difluoro-4-hydroxybenzylidene imidazolinone) 
upon which it fluoresces in the green region of the spectrum (λmax excitation = 447 nm and λmax 
emission = 501 nm).  
The Jewett group use TX-TL systems to develop an orthogonal central dogma for molecular 
biology using cell-free platforms by expressing and designing the necessary molecular 
machinery to execute genetic programs without cellular interference61. To this end Fritz et al. 
synthesised functional ribosome RNA subunits 5S, 16S and 23S de novo in a cell-free system 
which is devoid of endogenous ribosomes. This integrated synthesis, assembly and translation 
(iSAT) platform however needed to be supplemented with other ribosomal proteins to be fully 
functional62 (Figure 1.5a). Protein synthesis from iSAT was found to be sensitive to 
macromolecular crowding effects with a combination of 6% w/v Ficoll 400 and 2 mM DTBA 
(dithiobutylamine) – a reducing agent – resulting in a five-fold increase in protein yields63. In 
a subsequent work Li et al. also generated 50 of the 54 E.coli ribosomal proteins by co-
expression from DNA templates in cell-free systems64. Instead of traditional batch systems, 
semi-batch conditions were used to improve the yield of the proteins. Such conditions were 
implemented using a device which separates the reaction chamber from a feeding chamber with 
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a dialysis membrane (Figure 1.5b). The feeding chamber houses fresh reagents such as NTPs 
and amino acids, which can diffuse through the membrane into the reaction chamber and waste 
products diffuse away from the reaction chamber in the opposite direction thus improving the 
yield of TX-TL reactions. Karim et al. also established a framework to enrich cell-free systems 
by overexpressing enzymes and prototyping biosynthetic pathways by mixing and matching 
these overexpressed lysates as cell-free metabolic cocktails65.  
                      
Figure 1.5 (a) Schematic highlighting the plasmids involved in production of the 16S and the 23S rRNA. When 
supplemented with the necessary ribosomal proteins, they form the functional iSAT ribosome which can translate 
the mRNA produced by a reporter plasmid. Figures taken from Fritz et al.62 (b) Schematic of the dialysis devices 
used by Li et al.64 to generate the ribosomal protein in TX-TL systems. The dialysis membrane allows the diffusion 
of fresh nutrients and used reagents from and to the reaction chamber. 
Prototyping genetic elements in cell-free systems have  significant advantages compared to in 
vivo synthetic biology. In the latter case a lot of effort goes into plasmid design to control their 
copy number, incorporating protein degradation tags to tune in vivo protein concentrations etc. 
This requires multiple cycles building and testing different plasmids and constructs. Sun et al. 
established a method to bypass such tedious molecular biology by allowing TX-TL reactions 
to be carried out with linear DNA fragments which can be obtained by a simple PCR reaction. 
An exonuclease inhibitor – GamS – was used to counter the exonucleases in the lysate which 
could otherwise degrade linear DNA66. Using GamS, the authors demonstrated the prototyping 
of bistable genetic circuits in the TX-TL platforms using linear DNA. Marshall et al also 
exploited the preferential binding of the exonuclease to chi sites (5’– GCTGGTGG-3’) by 
adding dsDNA encoding these sequences to TX-TL reactions and observed increased protein 
yields from genes encoded by linear DNA and the effects were similar to using GamS67. 
In vivo synthetic biology is also limited to laboratory applications due to safety regulations. 
Cell-free systems offers a unique platform for synthetic biology for applications outside the 
laboratory because they are abiotic hence most regulations concerning genetic modified 
organisms (GMOs) do not apply to the cell-free studies. This increases the utility of TX-TL 
 22 
systems as they can also be soaked and freeze-dried on paper thereby allowing the long-term 
storage of TX-TL systems which can be reactivated by the addition of water. Pardee et al. used 
this ability to prototype TX-TL based diagnostic assays for the detection of two different Ebola 
virus species68 and the detection and discrimination of two forms of Zika virus69.  
Thus the progress made in developing and optimising TX-TL systems makes them useful 
platforms to prototype a wide range of genetic elements serving diverse purposes. 
1.5 CELL-FREE SYSTEMS : PROTOTYPING GENETIC NETWORKS  
All living organisms operate in out-of-equilibrium conditions i.e. there is a constant inflow of 
nutrients and used molecules are ejected from the system periodically thereby preventing key 
cellular process from reaching a state of equilibrium which causes death. A drawback with 
most cell-free systems is that they operate in batch conditions i.e. the quantity of nutrients is 
fixed and hence the lifetime of reactions is limited. While sufficient to implement simple 
circuits such as cascades, batch conditions alone are not ideal to prototype complex genetic 
networks. To implement synthetic genetic networks, cell-free systems have to operate in ‘open’ 
systems where important resources such as NTPs, amino acids, RNAP etc. need to periodically 
replenished and harmful by-products such as ADP needs to be periodically removed such that 
transcription and translation rates are kept at a steady-state and the system remains out-of-
equilibrium. Niederholtmayer et al. were the first to implement an oscillator in cell-free 
systems under steady-state conditions70 (Figure 1.6 a and b). Their network was implemented 
in a flow-based, microfluidic chip which has eight, 33 nL reactors which can carry out 
independent TX-TL reactions in steady-state. Fresh TX-TL reagents are periodically flown in 
which simultaneously removes used TX-TL reagents and waste products from the reactor 
which is ejected from the device. The multiplexer present in the device addresses each reactor 
independently and controls the sequential inflow of reagents from the inlet into the reactors.  
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Figure 1.6 (a) Topology of the oscillator used by Niederholtmayer et al.70 consisting of a variety of transcriptional 
and post-transcriptional regulatory elements. The network is driven by the T3 RNAP produced supD and the tetR 
genes. When the concentration of the former is sufficiently high, it produces the tetR gene which represses the 
production of the T3 RNAP. (b) Qualitative behaviour of the oscillator from (a) when the concentrations of the 
different DNA templates are varied showing sustained oscillations, damped oscillations and a single-peak 
behaviour. (c) Schematic for the rapid prototyping of cell-free ring oscillators. Using a combination of cell-free 
systems, microfluidics and  mathematical modelling Niederholtmayer et al.71 prototyped ring oscillators and 
compared their behaviour in TX-TL and in vivo conditions.  
Having established a platform to carry out long-term TX-TL, Niederholtmayer et al. prototyped 
the first cell-free genetic oscillator70 (Figure 1.6 a and b). The oscillator had multiple regulators 
operating on a transcriptional, and post-translational level. The T3 RNAP induces its own 
expression and transcribes the supD and tetR genes. These produce the amber suppressor tRNA 
and tetR mRNA which can only be translated when the suppressor tRNA concentration is 
sufficiently high enough. TetR represses transcription of the t3rnap gene thereby stopping its 
own synthesis. The authors demonstrated that they could use their microfluidic platform to 
characterize every regulatory element and find regimes where the network oscillated. The 
period of the oscillator could be tuned to between 5.4 hours to 9.5 hours. Niederholtmayer et 
al. further used their microfluidic platform to prototype and test multiple ring oscillators 
topologies71. The authors used a combination of mathematical modelling and iterative testing 
to evolve a series of oscillator topologies based on the repressilator which could yield the most 
robust oscillatory behaviour(Figure 1.6c) and subsequently implemented these designs in 
bacteria to compare the behaviour of the oscillators in vivo and in vitro. Remarkably, the 
oscillators behaved the same in the cell-free system and in vivo conditions. The significance of 
this work is twofold. First, the usefulness of cell-free systems to forward engineer complex 
synthetic networks was demonstrated. Secondly, it was shown that cell-free systems can 
reproduce the complex environment present within the cell. In another work, Maddalena et al, 
used the microfluidic TX-TL platform to characterize a set of E. coli promoters in the presence 
of transcriptional chaperones such as GreA and GreB in the PURE system72. 
The Bar-Zhiv group have performed some excellent research in this area as well. Bracha et al. 
designed DNA nano-brushes in 2-D compartments to localize the source of gene expression 
and thereby emulate the dense cellular environment73. Analysis of the mRNA expression 
pattern revealed that the density of the brushes entropically excludes biomolecules thereby 
reducing concentration of molecules such as RNAP within these brushes. The concentration of 
genes in these brushes could be varied (denoted as gene ratio i.e. brushes with gene/total density 
of brushes) thereby allowing the implementation of protein cascades in these compartments. 
These DNA compartments were further used to build an ‘open’ system where resources can be 
exchanged constantly. The design involved flowing the TX-TL reagents via a central flow 
channel (Figure 1.7a). The TX-TL components reached the DNA compartments via diffusion 
through a thin capillary channel. Having patterned different circuits in the DNA compartments, 
including an oscillator, Karzbrun et al. were able to modify network behaviour by varying the 
length of the capillary which affects the diffusion of TX-TL components and subsequently the 
residence times of biomolecules inside the compartments74 (Figure 1.7b). Tayar et al. further 
used this device to design a 1-D array with coupled DNA compartments using forked channels. 
Each compartment was programmed with a bistable circuit consisting of an activator and its 
inhibitor75. A model was developed to describe the behaviour of this circuit and to find the 
combination of parameters necessary for it to operate in two regimes – monostable and bistable. 
Arrays were designed with each microcompartment housing the bistable circuit with suitable 
gene ratios such that it operates in either one of the two regimes or close to transition between 
the two regimes. In the monostable regime, all compartments showed uniform levels of reporter 
(eGFP). Close to the transition, the compartments showed a transient propagating front which 
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was replaced by uniform protein levels over time and in the bistable regime, the array of 
microcompartments exhibited front propagation. Tayar et al. also programmed oscillators into 
their array of interconnected compartments76. The authors used an activator-repressor motif 
along with active protein degradation methods and an inhibitor to sequester the activator. Each 
compartment of the array was programmed with different gene ratios of activator and repressor 
so as to generate a ‘population’ of oscillators. Upon physically coupling these compartments 
higher-order collective behaviour such as synchronization and entrainment were observed 
(Figure 1.7 c and d). Oscillators with lower periodicity were found to entrain the other 
oscillators. Furthermore, the synchronization amongst oscillators was broken by the addition 
of  an external ‘morphogen’ gradient to observe pattern formation across the array of coupled 
reactors. 
The combination of cell-free systems with microfluidic platforms which increase the lifetime 
of TX-TL reactions can serve as platforms to prototype complex genetic networks such as 
oscillators and have the potential to engineer higher-order phenomena in vitro. 
                
 
Figure 1.7 (a) DNA brushes used by Karzbrun et al.74 to implement synthetic networks in ‘open’ conditions. 
DNA is compartmentalized in nanobrushes and TX-TL mixture flows through a central flow line and 
biomolecules reach the DNA-microcompartments through a thin capillary via diffusion. (b) Topology of activator-
repressor motif implemented in the nanobrushes. The property of oscillations were controlled by varying the 
length of the capillary channel. The colours represent different channel lengths. Implementation of an array of 
microcompartments with the activator-repressor motif exhibiting oscillations by Tayar et al.76. When the 
compartments are (c) uncoupled each compartment exhibits different oscillations and when coupled (d) the 
behaviour of the different oscillators are synchronized. 
 
1.6 CELL-FREE SYSTEMS : BOTTOM-UP CONSTRUCTION OF ARTIFICIAL 
CELLS 
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Figure 1.8 The three pieces of the puzzle needed to design an artificial cells as postulated by Caschera et al77 – 
Information module, Metabolism Module and Self-organization module.  
One of the great scientific challenges of the 21st century is the construction of an artificial cell. 
Apart from understanding the fundamental questions concerning the origin of life such an 
endeavour can address key biomedical and biochemical challenges of the future. There are 
broadly two approaches to construct an artificial cell :- top-down and bottom-up approach. The 
former approach involves starting with a complex organism and reducing its complexity until 
a minimal system is reached. The best example of this approach is the work conducted by the 
Venter group. Using molecular biology techniques, scientists have chemically synthesised 
genomes of murine mitochondria and bacteria such as M. genitalium. The synthetic M. 
genitalium genome (JVCI syn-1.0) was further transformed into ‘empty’ M. capricolum cells, 
to obtain viable ‘synthetic cells’78–80. This genome was further minimized - JVCI syn-3.0 - 
which is 531 kilobasepairs (kbp) as compared to the 1079 kbp JVCI syn-1.0, which when 
transformed also gave rise to viable cells81. JVCI syn-3.0 cells have a doubling time of 180 min 
as compared to the 63 mins of JVCI syn-1.0 cells and both of these growth rates are much 
quicker than the 16-hour doubling time of M. genitalium.  
In contrast, the aim of bottom up synthetic biology is to start from non-living biomolecules and 
increase the complexity by assembling them together in order to eventually construct an 
artificial cell and understand the mechanisms which govern life. All the biomolecules required 
to construct artificial life can broadly be categorised into three modules :- information module 
(DNA program), metabolism module (energy production) and self-organisation module 
(biomolecules which form the physical boundary) (Figure 1.8). Since cell-free systems harbour 
important machinery that can carry out transcription and translation they can be encapsulated 
in droplets or vesicles to carry out compartmentalized gene expression. Apart from aiding the 
bottom-up construction of synthetic cells, such systems help in engineering of programmable 
vesicles/droplets and the study of the effect of fundamental physicochemical forces on gene 
expression. 
Garamella et al. extended the lifetime of  TX-TL reactions by encapsulating TX-TL reactions 
in lipid vesicles along with the alpha-hemolysin nanopore which facilitates the exchange of 
small molecules by simple diffusion. Caschera et al. encapsulated the iSAT system of Fritz et 
al62 inside liposomes to assemble an artificial system which could synthesize its own ribosomes 
for protein synthesis82. The Ces group developed multi-compartment liposomes and have 
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demonstrated the execution of multi-step enzymatic reactions and independent TX-TL 
reactions in the compartments of such liposomes83,84. Adamala et al. engineered a set of 
liposomes which they term ‘synells’. The Synells contained TX-TL reactions with different 
plasmids and a set of permeable activators (Arabinose and Theophylline) and non-permeable 
activators (doxycycline and IPTG) which enter the synells using nanopores. Using such genetic 
elements, Adamala et al. engineered a population of synells to carry out simple independent 
reactions such as expression of fLuc or rLuc (different variants of luciferase) in linear circuits 
– where IPTG released from a population of vesicles which have DNA templates coding for 
alpha-hemolysin enter a second population of vesicles to inhibit lacI thereby activating 
expression of reporter. Fusogenic peptides called SNAREs were used to fuse synells containing 
complementary versions of the SNAREs (Figure 1.9 a and b). This mechanism was used to 
deliver the T7 RNAP present in vesicle A to vesicle B to activate fLuc production which is 
under the control of the T7 promoter85. Maeda et al. demonstrated the programmed 
reconstitution of the cytoskeleton in synthetic liposomes by encapsulating TX-TL mix along 
with a DNA template that codes for MreB and MreC proteins.86. MreB formed small clusters 
when expressed alone and finely organized bundle structures are formed when MreB and MreC 
are co-expressed together. Lentini et al. engineered vesicles to interact directly with bacterial 
cells and used them to effect a two way communication between bacterial cells in response to 
quorum sensing molecules87,88. Van Nies et al. demonstrated the replication of the ф29 viral 
genome in an encapsulated TX-TL system. Replication was initiated by expressing the DNA 
polymerase and associated proteins from DNA fragments. Upon replication, the genome was 
able to synthesise all the necessary proteins on its own thereby representing an autocatalytic 
DNA replication loop 89 . 
    
 
Figure 1.9 (a) Fusion of vesicles containing using SNAREs by Adamala et al.85. The population of vesicles 
contains two different DNA templates – P70-T7RNAP (Population A/Red) and PT7-Luc (Population B/Blue). (b) 
To express Luc protein Population B needs T7RNAP produced from Population A. The signal is high only when 
vesicles with complementary SNAREs combine.  
Encapsulation of cell-free systems in confined environments can also serve as platforms to 
investigate biophysical phenomena occurring in the cell. Hansen et al., encapsulated TX-TL in 
water droplets to study the effect of  noise on gene-expression arising from copy number 
variation and macromolecular crowding. The authors found that molecular crowding leads to 
formation of heterogenous environments of mRNA production due to limited diffusion. It 
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contributes to the stochasticity of the system as it causes the TX-TL machinery to aggregate at 
the microenvironments90. Sokolova et al. also observed enhanced transcription rates in 
coacervates formed by cell-lysate in droplets further highlighting the ability of TX-TL systems 
to mimic the cell in so far as organizing gene expression into membrane-free compartments91. 
These examples highlight the importance and utility of TX-TL systems in bottom-up synthetic 
biology. 
1.7 AIM OF THE THESIS 
To summarize, cell-free systems have been used as molecular breadboards for rapidly 
prototyping synthetic networks and are an important tool in bottom-up synthetic biology. 
However it is a far from perfect system as there are several bottlenecks that can hamper the 
process of gene expression. It is important to analyse such bottlenecks in order to make the 
process of gene expression efficient and predictable which aids the prototyping of synthetic 
networks. Additionally, despite the presence of microfluidic tools which increase the lifetime 
of TX-TL reactions, we have not fully explored the functionality of key cell-free regulatory 
elements – such as bacterial sigma factors – in complex networks such as oscillators, which 
limits the expansion of the cell-free toolbox. Finally, the full potential of cell-free systems as a 
tool in bottom up synthetic biology has not been realised and there has not been a concerted 
effort to integrate the information, metabolism and compartmentalization module in order to 
partially reconstitute an E. coli cell. 
In the second chapter, we present our analysis on one of the crucial bottlenecks in cell-free 
systems – sequence dependent mRNA secondary structures – and its role in inhibiting the 
protein yield from cell-free transcription and translation. We analyse the use of  DMSO, which 
is able to remove secondary structures, to improve the protein yield  in coupled and uncoupled 
cell-free systems. Finally, we investigate the role of DMSO in promoting protein synthesis 
from genetic operons – genetic devices with multiple genes present on a single mRNA. 
In the third chapter, we present the bottom up construction of a synthetic genetic oscillator with 
an activator-repressor motif using elements from the E. coli toolbox 2.0. We used a 
mathematical model to quantified every element of the oscillator, characterized the behaviour 
of the network in microfluidic flow reactors.  
In the fourth chapter, we demonstrate the tuning of systems-level properties of the oscillator 
by changing the sigma factor/activator in the oscillator and the ability of our model to quantify 
the kinetics of all the genes in our system. Furthermore, we couple multiple oscillators driven 
by different sigma factors in the same reaction to observe the effect of passive transcriptional 
control between sigma factors in modulating network behaviour.  
In the fifth chapter , we present a microfluidic approach to construct monodisperse liposomes. 
We use this technique to encapsulate TX-TL reactions and visualize protein and mRNA 
production. Finally we attempt to reconstitute an E. coli cell by designing degfp gene-
containing nucleoids using CRISPR to try to express proteins from nucleoids in encapsulated 
TX-TL systems. 
In the sixth chapter, we summarize the major findings of the thesis and present a perspective 
on the future possibilities. 
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2.1 INTRODUCTION 
Transcription and translation in prokaryotic cells are synchronized in time and space. In E. coli, 
as soon as an mRNA (messenger RNA) is transcribed by the bacterial RNA polymerase 
(RNAP), ribosomes bind to the nascent mRNA to initiate translation1 (Figure 2.1). Multiple 
ribosomes can initiate translation on the same mRNA transcript leading to the formation of 
structures called polysomes. A recent study has shown that the alpha-subunit of the bacterial 
RNAP interacts with the ribosome via the αCTD domain (Carboxy Terminal Domain of α 
subunit of RNAP), thereby actively coupling transcription and translation by forming a 
complex structure labelled the ‘expressome’2. The bacterial RNAP is also known to pause 
during transcription thereby allowing the translational machinery to catch up with the 
transcription process3. The bacterial cell has evolved these mechanisms to prevent backtracking 
of RNAP, retain genomic integrity, minimize exposure of naked mRNA, and prevent depletion 
of resources4. Desynchronization of these two processes can lead to bottlenecks in the synthesis 
of protein synthesis. For example, premature transcription termination can cause uncoupling 
of transcription and translation leading to the formation of R loops. The R loop is a structure 
in which the mRNA is hetero-duplexed with one strand of the DNA and can impair 
transcriptional elongation by acting as roadblocks to the RNAP5. 
                                
Figure 2.1 Schematic of coupled transcription and translation in prokaryotic organisms. Translation is initiated 
almost immediately after transcription leading to the formation of structures called polysomes – where multiple 
ribosomes are attached to a single mRNA. 
A particular bottleneck in gene expression is the formation of secondary structures in mRNA. 
Analysis of the structural propensity of the E. coli mRNA reveals the role of secondary 
structures in regulating several processes – from translation initiation and termination to 
mRNA abundance and degradation6. However, mRNA secondary structures can also have 
detrimental effects – particularly those around the RBS (Ribosome Binding Site) and start 
codon region – as they can occlude the RBS from the ribosomes resulting in mRNA 
inactivation7. While IVTx (In vitro transcription : in vitro production of mRNA from DNA) is 
a widely used and studied platform8–10, IVTl (In vitro translation : in vitro production of 
 37 
proteins from mRNA) is difficult to control because of the formation of secondary structures 
which leads to poor efficiency of protein production as only a small fraction of mRNA 
transcripts is actively translated11–13. Strategies have been developed to improve in vivo protein 
production based on reducing secondary structures resulting in increased binding and re-
initiation of ribosomes14. Computational tools have been developed over the years to predict 
and quantify the folding energy of these structures to aid in optimal mRNA design15. In vitro 
studies have revealed translation initiation in ‘naked’ mRNAs is three-fold lower when 
compared to mRNAs ‘protected’ by polysomes which prevents misfolding of mRNA 
transcripts16. In the same research it was found that addition of elongation factors helps to 
improve translation rates thereby highlighting the formation of mRNA structures as a 
bottleneck in protein synthesis.  
Over the past decade cell-free protein synthesis systems (TX-TL) have established themselves 
as a molecular breadboard to test genetic elements and networks before their implementation 
in vivo17–19. Successful implementation of genetic networks relies on the efficient transfer of 
information from DNA to mRNA to proteins. This means that all processes involved in protein 
synthesis – in particular, transcription and translation - must be properly synchronized. 
Bottlenecks arising from desynchronization such as sequence-dependent secondary structure 
could lead to mRNA inactivation, resulting in lower efficiency of protein synthesis, loss of 
predictability and wastage of resources. The use of T7-based transcription in TX-TL reactions 
adds to this problem because although T7 RNAP is a single subunit enzyme with a high 
specificity for its promoter20 and allows for simple and robust transcription, usage of T7 RNAP 
along with bacterial translation machinery breaks the coupling between the transcription and 
translation process, since T7 RNAP is five to eight times faster than the bacterial RNAP21. In 
vivo, such desynchronization results in reduced stability of mRNA and inefficient protein 
synthesis. For example, Iost and Dreyfus found that the expression of lacZ mRNA in E. coli 
via the T7 RNA Polymerase (RNAP) renders the mRNA more vulnerable to degradation by 
RNases when compared to bacterial RNAP. Since transcription and translation are more tightly 
coupled in the latter case, the simultaneity of the synthesis and translation of mRNA plays an 
important role in its stability22. Desynchronization of transcription and translation could also 
result in overproduction of mRNA transcripts of which only a small fraction is actively 
translated because the remaining are inactivated due to the formation of sequence-dependent 
secondary structures. In fact, recent research incorporated this effect explicitly in their models 
so as to obtain a better fit of their model to the experimental data23,24. 
Since  TX-TL systems are used to rapidly prototype genetic elements and networks, it is crucial 
that there are no bottlenecks, such as mRNA inactivation, in the flow of information from DNA 
to proteins. Current strategies to reduce mRNA inactivation involves optimization of the 
DNA/mRNA sequence to reduce sequence-dependent secondary structures. However, as the 
complexity, number and organization of genes involved increases, it might not be always be 
feasible to optimize all the sequences. The need is for a simple chemical tool which can remove 
secondary structures from mRNA and/or DNA transcripts thereby preventing their 
inactivation.. DMSO (Dimethyl Sulfoxide) is known to be able to denature RNA by disrupting 
its structure25,26. Lee et al. discovered that DMSO plays a significant role in the ‘local melting’ 
of the stem-loop structure in the HIV TAR 1 RNA27. The authors highlight the role of DMSO 
in forming hydrogen bonds with the nucleobases, thereby disrupting the original bonds and 
consequently affecting its structure. Nwokeoji et al. showed the effective denaturation of 
dsRNA and dsDNA by DMSO caused by the destabilisation of inter-base interactions in 
nucleic acids28. Bonner et al. demonstrated the inability of synthetic and natural DNA 
fragments to maintain their double helical structure in solvents such as DMSO, highlighting 
the role of solvophobic interactions in the denaturation of DNA29. DMSO is also used as an 
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additive in PCR (Polymerase Chain Reaction) reactions to linearize DNA oligos and thus 
improve primer binding and overall PCR-yield30. Therefore, since DMSO is a potent 
denaturant of nucleic acid structure, we tested the potential of DMSO to remove secondary 
structures in mRNA transcripts and improve protein yield from IVTl and TX-TL reactions. 
Having explored the potential of DMSO to remove a major bottleneck in protein synthesis we 
test its utility to gain insight into the role of secondary structures in protein synthesis from 
genetic devices such as operons.  
2.2 RESULTS AND DISCUSSION 
2.2.1 Effect of DMSO on In Vitro Translation reaction 
To test the potential of DMSO to remove secondary structures in mRNA transcripts, we 
performed IVTl with four different mRNA templates – wtGFP (wild type Green Fluorescent 
Protein) , CFP/YFP (Cyan/Yellow Fluorescent Protein), and deGFP (enhanced GFP) (Figure 
2.2) in the presence and absence of 10% DMSO (v/v) (Fig 2.2). Apart from coding for different 
fluorescent proteins, these mRNA templates have different number of bases around the RBS 
and the start codon involved in the formation of secondary structures. We used mFold to predict 
possible secondary structures for a 50 nucleotide mRNA sequence window, for all four 
sequences, with the RBS in the center of the window. The number of bases from the RBS and 
start codon (AUG) involved in the structure with the lowest predicted energy were determined. 
Since CFP and YFP mRNA templates have identical sequences surrounding the RBS, both 
have the same number of bases from the RBS and start codon (AUG) involved in the lowest 
energy fold, namely 4 (Figure 2.2b). deGFP mRNA template has 8 bases involved in the lowest 
energy fold, and wtGFP mRNA template has only 2 (Figure 2.2 a and c). In the absence of 
DMSO, we observed that the yield from IVTl reactions from all four mRNA templates is 
almost negligible and upon addition of DMSO , we observed protein expression in all cases. 
For wtGFP and deGFP mRNA templates the yield with DMSO was 100 times that of without 
DMSO (Figure 2.2 d and g) while in the case of YFP and CFP templates it the fold change in 
protein yield was ten times and three times respectively (Figure 2.2 e and f). We would expect 
the fold change in yield to follow a trend inverse to the number of stable secondary structures 
present in the RBS region i.e. wtGFP > CFP/YFP  > deGFP . However, since we used different 
fluorescent proteins each with different folding and maturation rates, it is hard to draw definite 
conclusions.  
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Figure 2.2 :- mFold analysis of mRNA sequences of (a) wtGFP, (b) CFP/YFP and (c) eGFP, the top triangle 
depict bases involved in  pairing in all possible folds, the bottom triangle depicts paired bases in the lowest energy 
fold. Bases from the RBS involved in secondary structures are marked in red, and bases from the start codon 
(AUG) are marked in blue (in collaboration with Maike Hansen). End-point fluorescent yields reported for IVTl 
reactions with different mRNAs – (e) wtGFP (f) CFP (g) YFP (h) deGFP- performed with and without 10% 
DMSO (v/v). All reactions were performed with 500 nM of mRNA template and end-point fluorescence were 
reported after three hours of IVTl reaction. Error bars are the standard error from three independent measurement. 
Since the mRNA is a single stranded nucleic acid, it is prone to rapid degradation from 
nucleases. In order to analyse the role of degradation in preventing protein synthesis, we 
performed IVTl reactions with the deGFP mRNA template in the presence and absence of 
RNase-inhibitor (Figure 2.3a). We found that the addition of RNase-inhibitor alone did not 
rescue protein expression. As an additional control, we investigated if DMSO has an effect in 
enhancing the fluorescence levels of the proteins by measuring the fluorescence of different 
concentrations of purified deGFP protein with and without DMSO (Figure 2.3b) to find that 
the fluorescence did not show any difference under the two conditions. These results indicate 
that the major bottleneck for protein synthesis from IVTl is the formation of secondary 
structures in mRNA templates and DMSO is able to rescue protein production by preventing 
mRNA inactivation. 
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Figure 2.3 (a) IVTl with deGFP mRNA template in the presence and absence of RNase Inhibitor. SUPERase 
inhibitor was used at a concentration of 1U/uL to prevent degradation of mRNA from RNases to find that using 
RNase inhibitors alone did not rescue protein synthesis from IVTl reactions. (b) Fluorescence of different 
concentrations of deGFP was measured with and without DMSO and no difference in fluorescence levels were 
observed indicating that DMSO has no effect on fluorescence of protein alone. 
To determine if there is a correlation between the number of secondary structures in mRNA 
transcripts and the concentration of DMSO needed to rescue protein production, we performed 
IVTl reactions with mRNA templates containing the most and least number of stable secondary 
structures – deGFP (8) and wtGFP (2) – with a range of DMSO concentrations (Figure 2.4). 
We found that for both mRNA templates, the protein yield increases with increasing DMSO 
with the maximum at 10% DMSO (v/v). In the case of wtGFP template, 7.5% DMSO (v/v) 
yielded approximately 60% of the maximum protein yield (Figure 2.4a) but in the case of 
deGFP template, using 7.5% DMSO yields only 20% of the maximal protein yield (Figure 
2.4b). This result indicates that for mRNA templates with a smaller number of stable secondary 
structures, a lower concentration of DMSO is required to rescue protein production in IVTl. 
               
Figure 2.4  End-point fluorescent yields reported for IVTl reactions for a range of DMSO concentrations (v/v) 
with (a) wtGFP mRNA and (b) deGFP mRNA. The yields are reported as a percentage of the yield from the 10% 
DMSO reaction. All reactions were carried out with 500 nM of mRNA template and end-point fluorescence were 
reported after three hours of reaction. mRNA templates were obtained by performing IVTx with respective DNA 
templates and subsequent purification.  
2.2.2 Effect of DMSO on TX-TL reactions 
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Using T7 RNAP with bacterial translation machinery causes desynchronization in the 
transcription and translation process resulting in  mRNA inactivation  which can have 
deleterious effects in cells22. Hence, we investigated the extent of mRNA inactivation in 
bacterial TX-TL systems due to the formation of sequence-dependent secondary structures 
when using T7 RNAP. Since DMSO is able to remove secondary structures in IVTl, we aimed 
to use DMSO as an indirect tool to obtain a qualitative idea of the level of inactivation of 
mRNA in TX-TL systems. In contrast to IVTl, the starting material for TX-TL reactions is 
DNA rather than mRNA. We used a plasmid DNA which has a degfp gene present downstream 
of a PT7 promoter, which is under the transcriptional control of the T7 RNAP. We observed 
that addition of increasing concentrations of DMSO in the TX-TL reactions lead to an increase 
in protein yields with the maximum at 10% DMSO concentration mirroring the IVTl results 
(Figure 2.5a). The yield however decreases upon addition of 12.5% DMSO hinting at possible 
toxicity effect of DMSO on TX-TL components. For example, DMSO is also known to 
destabilise the stacking interactions between the nucleic acid bases in the A site RNA of 
ribosomes27, hence a possible side-effect of high concentration of DMSO is that it can 
negatively affect ribosome structure and functionality. 
Mg2+ ions play an important role in stabilising secondary structures in mRNAs31. Additionally, 
they are important for the functioning of T7 RNAP32,33 and the assembly and functioning of 
the ribosome34. Since Mg2+ ions play an important role in different steps of TX-TL reactions, 
we sought to optimize the Mg2+ concentration in the DMSO regime to maximize protein yield. 
We found the optimal Mg2+ concentration to be 0 mM (Figure 2.5b) i.e. at no added Mg2+ in 
the TX-TL reaction. The cell lysate is dialyzed in a buffer containing magnesium glutamate, 
which brings a residual level of Mg2+ into the TX-TL mixture (approx. 5 mM). Next, we 
optimized the Mg2+ concentration in TX-TL reactions for non-DMSO regimes (Figure 2.5c). 
On comparing the protein yields in the DMSO and Salt Optimized (S.O) regimes, we found 
that yield from the latter was marginally higher. In TX-TL reactions, it is clear that the there is 
an optimal magnesium concentration at which protein yield is maximum (Figure 2.5 d). This 
varies between batches of cell lysate depending on the concentration of residual Mg2+ from the 
dialysis buffer. In the S.O regime, this optimal Mg2+ concentration was 10 mM. For the DMSO 
regime, we observed a shift toward lower Mg2+ concentrations corresponding to higher protein 
yields (Figure 2.5d). However, it is unclear if we have reached the optimal Mg2+ concentration 
in the DMSO regime for our cell lysate or if it is simply experimentally inaccessible. 
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Figure 2.5 (a) Effect of DMSO on TX-TL reactions. Increasing protein yields were observed with increasing 
DMSO concentrations in TX-TL reactions until 10% DMSO (b) Time trace of deGFP expression  under different 
Mg2+ concentration at 10% DMSO (v/v) concentration. (c) Time trace of deGFP expression under different Mg2+ 
without DMSO. (d) Comparison of protein yield vs Mg2+ concentrations in TX-TL systems in DMSO and Salt 
Optimized (S.O) regimes. All reactions were carried out with 1.5 nM of plasmid DNA expressing deGFP protein 
and end-point fluorescence were reported after five hours of reaction. 50 nM of T7 RNAP (T7i) was added to start 
the reaction. Error bars and bands are the standard error from three independent measurement. 
In order to test if we can improve protein yields in DMSO regime compared to S.O regime, we 
prepared different cell lysates which contain lower Mg2+ concentrations. We achieved this by 
dialysing the lysates in buffers with lower Mg2+ concentration. On testing two different lysates 
with lower residual Mg2+ we found that protein yields in DMSO regimes were nearly double 
that of S.O conditions (Figure 2.6). In these lysate systems the residual Mg2+ concentrations in 
Lysate 1 and 2 were 2.5 mM and 4 mM, respectively. The optimized Mg2+ concentration for 
Lysate 1 and Lysate 2 were 1.5 mM and 0 mM in the DMSO regime and 13 mM and 11.5 mM 
in the S.O regimes.  Despite the differences in absolute concentrations, we observed a clear 
trend in TX-TL performance in DMSO and S.O regimes: in regimes of reduced Mg2+ 
concentrations, DMSO can improve protein production in TX-TL systems.   
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Figure 2.6  Effect of DMSO on IVTT reactions in different batches of cell lysates. In cell lysates with lower 
residual Mg2+ concentrations, protein yields are nearly double in the DMSO regime (10% v/v) as compared to the 
S.O regime. All reactions were carried out with 1.5 nM of plasmid DNA expressing deGFP protein and end-point 
fluorescence was reported after five hours. Error bars are the standard error from three independent measurement. 
The exact role of Mg2+ is slightly more difficult to ascertain because it plays a crucial role in 
several processes. As mentioned before Mg2+ is known to stabilize secondary structures in 
nucleic acids31 however optimising  the Mg2+ concentration alone appears to have no influence 
on removing secondary structures and rescuing protein production in IVTl reactions (Figure 
2.7a). We further investigated the influence of DMSO and Mg2+ on transcriptional yield by 
performing IVTx reactions with T7 RNAP in the presence and absence of DMSO for different 
Mg2+ concentrations (Figure 2.7b). We found the yield of transcription increased with 
increasing Mg2+ concentrations but DMSO did not have any appreciable effect on transcription 
yield for both 5 mM and 10 mM Mg2+ concentrations. 
                   
Figure 2.7  (a) Effect of DMSO and Salt Optimization on IVTl. Since S.O regime yielded marginally more protein 
, IVTl reactions were performed in S.O regime and protein yields were compared to that of DMSO regime for 
500 nM of deGFP mRNA template. Optimization of salt concentrations alone was not enough to carry out protein 
synthesis in IVTl and DMSO is required to remove secondary structures. (b) Results of IVTx for different DMSO 
and Mg2+ concentrations. IVTx yield increased with increasing Mg2+ concentrations but DMSO appears to have 
no effect on mRNA production. A linear fragment of the PT7-deGFP-TT7 plasmid was used as substrate and results 
were checked by running the samples on a 1% (w/v) agarose gel with ethidium bromide stain.(+) indicates samples 
with 10% DMSO (v/v) and (-) without DMSO. Error bars are the standard error from three independent 
measurement. 
Based on our results, we posit Mg2+ and DMSO as agents to fine tune protein expression in 
TX-TL systems (Figure 2.8). The variation of Mg2+ and DMSO concentrations enable the 
operation of TX-TL reactions in two different regimes – S.O and DMSO regime. We 
hypothesize that in the S.O regime there is a temporal mismatch between the viral T7 
transcription and the bacterial translational machinery which causes a fraction of mRNA 
transcripts produced to get locked into secondary structures which leads to occlusion of the 
RBS and subsequent inactivation (Figure 2.8). Addition of DMSO weakens the stacking 
interactions between the bases in secondary structure of mRNAs, thereby preventing the 
occlusion of the RBS and making them accessible to ribosomes resulting in improved protein 
yields in TX-TL reactions. (Figure 2.8). However the DMSO regime is accessible only in 
certain Mg2+ concentrations. This is likely because Mg2+ is known to chelate to RNA thereby 
and has a stabilising effect on RNA structures31. Our results indicate that lower concentrations 
of Mg2+ is necessary to destabilise these structures which is further denatured by DMSO 
thereby preventing mRNA inactivation and improving protein yields. 
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Figure 2.8 Schematic outlining the influence of Mg2+ and DMSO on TX-TL reactions. In S.O regime some mRNA 
transcripts get inactivated by the formation of sequence-dependent mRNA secondary structures. On addition of 
DMSO, the number of inactivated mRNA transcripts are reduced because DMSO is able to remove secondary 
structures preventing the occlusion of the RBS and increasing the protein yield. 
2.2.3 Effect of DMSO on protein production from synthetic operons 
Having established DMSO as a tool to remove a major bottleneck in protein synthesis, we 
investigated its potential to improve protein production in genetic devices such as operons. The 
genetic material of bacteria is a single piece of DNA and the genes are packed in a highly 
organized manner35. One such example of genomic arrangement is the operon. It refers to an 
arrangement in which several genes are present under the transcriptional control of a single 
promoter i.e. the different genes are encoded on the same mRNA. The most famous and well-
studied example is that of the lac operon in which the different genes involved in lactose 
metabolism are regulated by the lac promoter36. Operons are useful genetic devices as they 
have been shown to improve the efficiency of assembly of protein subunits to form their 
respective complex compared to when the subunits are expressed on separate mRNAs37. The 
Mansy group has carried out detailed research on the factors that influence protein expression 
from genes in an operon in TX-TL systems38,39. Having controlled for different factors such as 
promoter strength and length of the transcript, gene position was found to be the crucial factor 
for determining protein yield with the level of protein expression of genes in an operon 
decreasing as it moves distally (farther from the promoter) within an operon. Secondary 
structures in the mRNA transcripts are one of the potential reasons for this behaviour, because 
as the size of the operon increases, so does the corresponding mRNA transcript thereby 
increasing the likelihood of formation of mRNA secondary structures which could occlude the 
RBS and inactivate the distal genes of the operon. Since DMSO is efficient in removing 
secondary structures, we investigated if it could rescue protein expression of distal genes in a 
synthetic operon. 
We constructed two and three-gene synthetic operons which are regulated by the PT7 promoter. 
We used deGFP as a reporter and placed it as the most distal gene in both constructs. The 
bacterial sigma factors (σ28 and σ19) served the proximal genes as they associate with only with 
the bacterial RNAP and hence will not interfere with the T7 transcription40. We compared the 
deGFP yield from the operons to the standard single gene construct in DMSO and S.O 
conditions (Figure 2.9).  
We found that each construct showed an optimal protein yield for the distal gene at different 
DNA template concentrations. Protein yield for the standard construct increased until a DNA 
concentration of 15 nM (Figure 2.9a) whereas protein production from operons saturated at 
around 5 nM of DNA template concentrations (Figure 2.9 b and c). Since the operons express 
additional genes which consume resources for their expression the yield from distal genes in 
an operon saturate at lower DNA concentrations compared to the standard construct. 
 In order to investigate the extent of secondary-structure dependent mRNA inactivation, we 
performed TX-TL with the three constructs in S.O and DMSO regimes (Figure 2.9). In both 
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regimes, we observed that the expression of the degfp gene decreases by approximately 10-
fold as it moves distally within an operon. Addition of DMSO helped in increasing the gene 
expression with each construct showing a nearly two-fold increase in protein yield for nearly 
all DNA concentrations. However, the absolute deGFP yield for each operon was still very low 
and also showed a 10-fold drop as the degfp gene moved distally in the operon. This leads us 
to conclude that while mRNA secondary structures do play a role in reduced gene expression 
in distal genes of an operon, it is clearly not the prominent force that causes this effect.  
          
 
Figure 2.9 DMSO improves protein production in distal genes of synthetic operons for a range of DNA 
concentrations. (a) Standard one gene-one promoter organization (b) Two gene operon and (c) Three gene operon 
with deGFP as the most distal gene from the promoter. All experiments were carried out with linear DNA along 
with 3 uM of GamS protein and end-point fluorescence was reported after five hours. Error bars are the standard 
error from three independent measurement. 
While DMSO helps marginally improve protein production from distal genes in an operon, our 
results along with those of Chizzolini et al.38 are in contrast to Lim et al.41 who observe 
increasing expression with increasing transcript length in an operon in vivo. Lim et al. relied 
on the bacterial RNAP, as opposed to T7 RNAP, to implement their synthetic operons. As the 
bacterial RNAP interacts with the ribosome2 we asked if the coupling of transcription and 
translation can improve the expression from distal genes in an operon. To this end we expressed 
degfp as the proximal and distal gene from a two-gene synthetic operon regulated by the P70 
promoter  (Figure 2.10).  While using bacterial RNAP to transcribe synthetic operons does not 
correspond to the in vivo results of Lim et al, the extent of decrease in expression of the distal 
gene in the operon was less (two-fold) as compared to using T7 RNAP (nearly ten-fold). These 
results indicate that the coupling of transcription and translation, facilitated by bacterial RNAP, 
could potentially play an important role in gene expression by preventing mRNA inactivation, 
particularly in synthetic operons and in general complex synthetic networks.  
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Figure 2.10 End-point expression of deGFP as the proximal and distal gene in a synthetic operon controlled by 
P70 promoter for different concentrations of the DNA template. This promoter is activated by the bacterial RNAP 
in the presence of σ70 with σ28 being the other gene. The expression of deGFP decreases as it moves farther from 
the promoter however only by approximately two-fold as compared to ten-fold when regulated by T7 RNAP.  
Since, the other gene is the bacterial sigma factor σ28, competition with σ70 for RNAP also contributes in decreasing 
the production of deGFP (this will be discussed in detail in the next chapters)17. 
2.3 CONCLUSION 
In this Chapter we have shown that DMSO can  improve yields in protein synthesis in IVTl in 
the appropriate Mg2+ regimes compared to regular salt optimized TX-TL regime. The most 
likely reason for this improvement is the denaturation of mRNA secondary structures, which 
result in the occlusion of the RBS. However, increasing DMSO concentration to 12.5% showed 
detrimental effects of DMSO on protein yields, as did increasing Mg2+ concentration in the 
DMSO regime indicating possible toxicity effects of DMSO, possibly on ribosome function. 
As mentioned previously, Mg2+ plays an important role in multiple processes in TX-TL 
reactions. For example, recently Yamagami et al. found that Mg2+ ions that are weakly chelated 
to amino acids help in stabilising and promoting the activity of functional RNA molecules such 
as ribozymes42. In order to optimize and understand TX-TL systems completely, further 
research is essential in the role of Mg2+ and its interaction with different components of a TX-
TL reaction.  
In terms of genome design, synthetic operons represent a promising method to express a large 
number of genes in from a single DNA fragment. However their functionality is limited by the 
unequal gene expression within the genes involved. Usage of bacterial RNAP resulted in better 
expression from distal genes in a synthetic operon, as compared to T7 RNAP indicating that 
the endogenous bacterial RNAP is a better choice to express genes from an operon in in vitro 
systems. Further research is required on identifying the causes for the drop in expression in 
operons, with particular focus on mRNA stability, until which it is prudent to optimise gene 
position in an operon in accordance with their activity and level of expression required. Finally, 
the strong decoupling between transcription and translation in T7 transcriptional systems 
indicates that it is a sub-optimal choice for building complex synthetic genetic networks in 
bacterial lysates. Hence, in the next chapters, we switch to endogenous bacterial RNAP for 
controlling transcription and building synthetic genetic networks.  
2.4 ACKNOWLEDGEMENTS 
I would like to thank Maike Hansen for including me in the project, David Foschepoth for 
providing me with the necessary plasmids , Frank Nelissen for the T7 RNA polymerase and 
Emilien Dubuc and Hans Heus for their suggestions and guidance. 
 47 
2.5 METHODS 
DNA constructs: The following plasmids were prepared. The pET plasmids with CFP and 
YFP sequence at the multiple clone sites were a kind gift from R.Y. Tsien. The sequences for 
CFP and YFP production in the pET plasmids were inserted into pRSET vectors (Life 
Technologies) with Nco-I at the 5’end of the coding sequence (CDS) and a Xho-I restriction 
site at the 3’end of the CDS. The plasmids were purified and purity was analysed using gel 
electrophoresis and sequencing analysis (GATC Biotech, Germany). Concentration of 
plasmids was determined using a Nanodrop N1000 spectrophotometer. The plasmids 
containing degfp and wtgfp genes were a kind gift from David Foschepoth. The pRSET vector 
has T7 RNAP promoter and terminator regions. The synthetic operons and the PT7-Sp2-TT7 
template were ordered from IDT and PCRs were carried out using Phusion Polymerase using 
manufacturer’s protocol. DNA sequences are shown in the appendix. 
In vitro Transcription (IVTx): In a reaction tube a reaction mixture of  40 mM Hepes (pH 
8.0); 3.7 mM DTT; 1 mM spermidine; 25 mM magnesium chloride; 4 mM each of GTP, ATP, 
CTP and UTP; 5 mM GMP; 400 nM T7 RNA polymerase; 3 nM DNA was prepared. In order 
to extract mRNA, this reaction mixture was incubated for 3 hours at 37ºC and 20 U mL-1 
DNAse I (Sigma-Aldrich) was added to stop transcription, and the reaction was incubated for 
an additional 30 minutes at 37ºC. EDTA (100 mM) was added and mRNA was purified using 
a QIAGEN mRNA extraction kit. In order to track mRNA, 60 uM of DFHBI (Tocris) and 5 
nM of the PT7-Sp2-TT7 template were added to the reaction mixture and fluorescence was 
measured in a plate reader. 
Preparation of TX-TL reactions :- For transcription–translation systems, the reaction 
mixtures consisted of one-third cell lysate (prepared as described below ~ 33 mg ml-1) and two-
thirds reaction buffer. The final reaction mixture contained 50mM Hepes (pH 8.0), 3mM 
guanosine triphosphate, 1mM each of adenosine triphosphate, cytidine triphosphate and uridine 
triphosphate, 0.66 mM spermidine, 0.5 mM cyclic adenosine monophosphate, 0.22 mM 
nicotinamide adenine dinucleotide, 0.17 mM coenzyme A, 20 mM 3-phosphoglyceric acid, 
0.045 mM folinic acid, 0.13 mg ml−1 transfer ribonucleic acid, 0.5 mM of each amino acid, 
9.4mM magnesium glutamate, 11mM potassium glutamate, 2 µM of T7 RNAP and ~11 mg 
ml-1 cell lysate, contributing an additional 0 - 15mM magnesium glutamate (as required) and 
20mM potassium glutamate and fluorescence was measured in a plate reader. T7 polymerase 
was purified and 50 nM was added to start TX-TL reactions. GamS was prepared for TX-TL 
reactions with linear DNA according to previously established protocols43. For In vitro 
Translation (IVTl) reactions, instead of DNA and T7 RNAP, 500 nM of the respective 
mRNA template and was added to the reaction mixture. SUPERase inhibitor (1U/uL of 
reaction, TheroScientific) was added to reactions in Fig S12 a. 
Preparation of cell lysate (protocol for 1L of bacterial culture) : A starter culture of E.coli 
Rosetta2 was prepared in 2xYT broth (16 g tryptone, 10 g yeast extract, 5 g NaCl dissolved in 
850 mL water and autoclaved) and cultured at 37oC overnight.  To 850 mL of autoclaved 2YT 
broth, 50 mL of starter culture was added along with 100 mL of 10x 2YPTG salt (0.22 M 
NaH2PO4, 0.55 M Na2HPO4, titrated to pH 7.0, autoclaved) and 18.02 g glucose and incubated 
on a shaker (230-250 rpm) at 37oC. OD600 was checked regularly and the culture was harvested 
at OD600 = 1.8. The cells were collected by centrifugation at 5500 rpm for 10 mins at 4
oC in 
three JA-10 vials. The pellets were re-suspended in ice-cold lysis buffer (20% sucrose, 1 mM 
EDTA, 1 mg mL-1 egg white lysozyme, filter-sterilised, 16 mL/ JA-10 vial) and incubated for 
10 mins on ice. The dissolved pellets were pooled and 24 mL of ice-cold MQ water was added. 
They were incubated for 5 more minutes on ice and centrifuged at 7500 rpm for 10 mins at 
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4oC. The supernatant was drained and the pellet was weighed. The pellet was resuspended in 
ice-cold milliQ water (0.75x volume) carefully. The cells were lysed by 10 cycles of 10 seconds 
of sonication at 10uM amplitude with 30s breaks on ice between cycles. Once sonicated, the 
cells were centrifuged at 10000 rpm for 10 mins at 4oC. The supernatant was collected, 
incubated at 37oC for 30 minutes and centrifuged again at 15700 rpm at 4oC for 10 mins. The 
supernatant, now lysate, was dialysed against 50% dialysis buffer (5 mM Tris-Cl, 30mM 
potassium glutamate, 3.5-7 mM magnesium glutamate, 0.5 mM DTT, autoclaved) for 45 
minutes followed by 3x45 minutes dialysis against 100% dialysis buffer (10mM Tris-Cl, 60 
mM potassium glutamate, 7-14 mM magnesium glutamate, 1 mM DTT, autoclaved). The 
lysate was aliquoted and flash-frozen in liquid nitrogen and stored at -80°C. Protein 
concentration was determined using a Pierce™ BCA Protein Assay Kit. 
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Chapter 3 :-  Bottom-up engineering of a cell-
free genetic oscillator 
                                                 
 
 
 
 
 
 
Parts of this chapter have been published in :-  
Sigma factor-mediated tuning of bacterial cell-free genetic oscillators  
Maaruthy Yelleswarapu, Ardjan van der Linden, Bob van Sluijs, Pascal Pieters, Emilien 
Dubuc, Tom de Greef and Wilhelm Huck. 
ACS Synthetic Biology 2018,  DOI: 10.1021/acssynbio.8b00300 
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3.1 INTRODUCTION 
Synthetic biology employs synthetic genetic networks to re-engineer organisms for a range of 
applications. Synthetic genetic circuits have been designed to display higher-order temporal 
functions1–4, perform logic operations in cells5,6, and produce heterologous proteins in 
microorganisms7–10. A major difficulty faced by synthetic biology concerns the implementation 
of synthetic genetic networks in living organisms, which presents an unnatural load for the host 
organism and affects the cell growth, often leading to the poor performance of engineered 
circuits11. 
Cell-free protein synthesis (TX-TL) has the potential to serve as a biochemical breadboard that 
allows for the rapid prototyping of genetic networks without interference from cellular 
hosts12,13. Numerous works have focused on the optimization of protein expression from 
bacterial cell-free systems14–18 which has resulted in a well-characterised toolbox of genetic 
elements comprising a range of transcriptional and translational regulators19–21. This toolbox 
extends the variety of synthetic genetic networks that can be constructed by allowing the use 
of essential bacterial machinery which would be difficult to achieve in vivo (E.coli) as they are 
important to the native functionality of the cell. Synthetic cascades, which use transcriptional 
machinery such as the T7 RNA Polymerase (RNAP) and bacterial RNAP, have been 
engineered using this cell-free toolbox19,20,22. Since such circuits exhibit linear behaviour, they 
can be prototyped in batch TX-TL conditions, as their functioning does not depend on the 
balance of rates between the individual steps (Figure 3.1). To engineer networks that exhibit 
complex behaviour – such as oscillations – batch conditions are insufficient primarily because 
the resources available for the synthesis of mRNAs and proteins are finite and the utilization 
of these resources results in by-products which can inhibit critical TX-TL components20. To 
extend the lifetime of TX-TL reactions, microfluidic platforms have been designed wherein the 
TX-TL components can be replenished, thereby creating an open system wherein the 
transcription and translation rates are sustained in a steady-state.  
            
Figure 3.1 The all E.coli cell-free toolbox 2.0. Genetic elements such as sigma factors and their respective 
promoters were combined to build cascades with six DNA templates. deGFP output from the cascade with and 
without one of the intermediate DNA constructs – P28- T7RNAP. The absence of this construct breaks the 
circuit and there is no deGFP production. Figures from Garamella et al.23 
Niederholtmayer et al. utilised pneumatically-controlled microfluidic flow reactors to study 
numerous ring oscillators under steady-state TX-TL conditions, showing that the qualitative 
and quantitative performance of the oscillators in vitro reflect those in in vivo conditions24 
(figure 3.2 a and b). Karzbrun et al. studied oscillatory behaviour in continuous TX-TL 
reactions by immobilizing DNA networks within two-dimensional microfluidic compartments. 
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Separated from the central flow channel, their system relied on the diffusion of TX-TL reagents 
components through capillary channels to reach the DNA compartments, enabling the 
dynamics of a cell-free oscillator to be tuned by changing the dimensions thereof25 (Figure 3.2 
c and d).  
      
Figure 3.2 (a) Topology of the oscillator used by Niederholtmayer et al.26 consisting of a variety of transcriptional 
and post-transcriptional regulatory elements. The network is driven by the T3 RNAP produced supD and the tetR 
genes. When the concentration of the former is sufficiently high, it produces the tetR gene which represses the 
production of the T3 RNAP. (b) Qualitative behaviour of the oscillator from (a) when the concentrations of the 
different DNA templates are varied showing sustained oscillations, damped oscillations and a single-peak 
behaviour. (c) DNA brushed used by Karzbrun et al.25 to implement synthetic networks in open conditions. DNA 
is compartmentalized in nanobrushes. The TX-TL mixture flows through  a central flow line and biomolecules 
reach the microcompartment through a thin capillary via diffusion. (d) Topology of activator-repressor motif 
implemented in the microcompartments. The characteristics of the oscillations were controlled by varying the 
length of the capillary channel. The colours represent different channel lengths.  
Despite the availability of a well characterised cell-free toolbox and long-lived TX-TL 
platforms, the full repertoire of available elements has not been used to engineer higher-order 
genetic networks. In order to expand the toolbox, it is necessary to implement the toolbox 
elements to design complex genetic networks, such as oscillators, in open systems where key 
TX-TL resources are not limiting. Oscillatory networks are important as they control key 
aspects of life such as circadian rhythms, cell division, metabolism and cell signaling27. 
However, engineering oscillators is challenging because their design requires an optimal 
balance of rates of the various regulatory processes involved28. To aid the systematic 
engineering of oscillators, mathematical models can be used to provide a mechanistic 
understanding of the system and facilitate the design of higher-order network topologies24. In 
our research, we focused on engineering a synthetic genetic oscillator in an open TX-TL 
system, leveraging an important regulatory component of E.coli machinery; the endogenous 
RNAP and its associated sigma factors. Bacterial RNAP is a multi-subunit enzyme which uses 
sigma factors to help in transcription initiation29. Despite the regulatory role of sigma factors 
in vivo being well understood30–32, their potential in engineering complex genetic networks is 
only starting to be realised. Recently it has been shown that bacteria use sigma factors to alter 
the transcriptional landscape under stressed conditions by time-sharing the core RNAP, thereby 
modulating its function33. Bervoets et al. have recently engineered a sigma factor toolbox 
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belonging to B. subtilis as an orthogonal transcriptional control mechanism that can be used in 
other bacterial species such as E. coli34. Karzbrun et al. and Tayar et al. have implemented 
sigma-factor based oscillators in diffusion-limited TX-TL systems to demonstrate the 
emergence of collective behaviour such as entrainment and synchronization between coupled 
oscillators25,35. Since sigma factors allow convenient reprogramming of the transcriptional 
machinery and exhibit versatile properties with respect to binding to RNAP and DNA, using 
them as regulatory molecules in oscillators will improve our knowledge about the properties 
of key biomolecules inside the cell. Furthermore, the competition of sigma factors for the core 
RNAP, allows for the facile coupling of multiple networks driven by different sigma factors 
via the competition for core RNAP thereby opening a new avenue to increase complexity of 
synthetic genetic networks. 
Here, we present the  characterization of a two-component oscillator with an activator-repressor 
motif based on genetic elements from the E.coli cell-free Toolbox 2.020 in well-stirred 
conditions. Our initial network (Figure 3.3) is based on the sigma factor 28 (σ28) serving as the 
activator, the C1 protein serving as a repressor, and deGFP as a reporter. We have quantitatively 
characterised every genetic element as well as the behaviour of the network, by optimizing a 
mathematical model with experimental data using an evolutionary algorithm. This has enabled 
us to map the characteristics and behaviour of this oscillator. 
3.2 OSCILLATOR DESIGN AND MODEL 
The oscillator presented here is based on a delayed negative feedback topology (Figure 3.3a) 
as introduced by Stricker et al.4. The oscillatory network constitutes an activator-repressor 
motif, as also found in several natural systems36, and utilizes the σ28 as an activator and the C1 
protein as the repressor (Figure 3.3b). A key mechanism leveraged in this design is the 
asymmetric competition between sigma factors for core RNAP. This asymmetric competition 
determines the amount of holoenzyme of each sigma factor – the complex formed by the 
association of sigma factor and RNAP – available to transcribe genes from their respective 
promoters19,31. The oscillatory network comprises three DNA constructs: P70-σ28, P28-C1-ssra, 
and P70-deGFP (Figure 3.3b). The expression of σ28 is regulated by the P70 promoter. 
Transcription from this promoter is initiated when sigma factor 70 (σ70) binds to the core 
bacterial RNAP to form the RNAP-σ70 holoenzyme which can subsequently bind to the P70 
promoter. Once expressed, the σ28 protein binds competitively to the core RNAP to form the 
RNAP-σ28 holoenzyme and activates expression of genes under control of the P28 promoter. 
This promoter regulates the production of the λ phage protein C1, which binds exclusively at 
the P70 promoter, thereby inhibiting the transcription and the eventual production of σ28. 
Additionally, the C1 protein contains a C-terminal ssra tag for targeted protein degradation by 
ClpXP proteases. These proteases, along with the σ70, bacterial RNAP, and the necessary 
translational machinery (ribosomes, elongation factors etc.) are present in the E. coli cell 
lysate16. Finally a reporter protein, deGFP14,20 –  also under the control of P70 promoter – is 
incorporated as a fluorescent readout.   
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Figure 3.3 (a) The oscillator has an activator-repressor motif with the σ28 and C1 serving as activator and repressor 
respectively. Critical to the functioning of the oscillator is the competitive binding between the two sigma factors 
to the core RNAP to form their respective holoenzymes (b)Schematic representation of the σ28-oscillator. The 
network topology comprises three DNA constructs: P70-σ28, P28-C1-ssra, and P70-deGFP. The σ70 binds to the 
RNAP to form the RNAP-σ70 holoenzyme which binds to the P70 promoter and initiates the expression of σ28 and 
deGFP. σ28 competitively binds to RNAP to form the RNAP-σ28 holoenzyme which binds to the P28 promoter and 
initiates the expression of C1-ssra. C1-ssra exclusively binds to the P70 promoter and represses the production of 
σ28 and deGFP.  
Since designing oscillators is a challenging process and involves a fine balance of rates among 
regulatory components, we implemented an ordinary differential equation (ODE)-based 
mathematical model to quantify our system and inform our experiments. The corresponding 
ordinary differential equation (ODE) model uses Hill-type kinetics and can be found below. 
We explicitly model the binding of sigma-factors and RNA polymerase to account for 
competition and its effect on the network behaviour. The other components of the model 
include descriptions of transcription and translation of the activator gene construct P70-σ28 
(DNAActivator), repressor gene construct P28-C1-ssra (DNARepressor), and reporter gene construct 
P70-deGFP (DNAReporter). 
 
RNA Polymerase 
 
 
𝑅𝑁𝐴𝑃̇ =  −(deg𝑝𝑜𝑙 + 𝑑𝑖𝑙) ∗ 𝑅𝑁𝐴𝑃 + 𝑅𝑁𝐴𝑃0 ∗ 𝑑𝑖𝑙 − 𝑘𝑓𝑅𝑆70 ∗ 𝑅𝑁𝐴𝑃 ∗ 𝑆70 + 𝑘𝑟𝑆70 ∗ 𝑅𝑆70 − 𝑘𝑓𝑅𝑆28 ∗ 𝑆28 ∗ 𝑅𝑁𝐴𝑃 + 𝑘𝑟𝑅𝑆28 ∗ 𝑅𝑆28 3.1 
𝑅𝑆70̇ =  −(deg𝑝𝑜𝑙 + 𝑑𝑖𝑙) ∗ 𝑅𝑆70 + 𝑘𝑓𝑅𝑆70 ∗ 𝑅𝑁𝐴𝑃 ∗ 𝑆70 − 𝑘𝑟𝑆70 ∗ 𝑅𝑆70 3.2 
𝑅𝑆28̇ =  −(deg𝑝𝑜𝑙 + 𝑑𝑖𝑙) ∗ 𝑅𝑆28 + 𝑘𝑓𝑅𝑆28 ∗ 𝑅𝑁𝐴𝑃 ∗ 𝑆28 − 𝑘𝑟𝑆28 ∗ 𝑅𝑆28 3.3 
𝑆70̇ =  −(𝑑𝑒𝑔𝑆70 + 𝑑𝑖𝑙) ∗ 𝑆70 + 𝑆700 ∗ 𝑑𝑖𝑙 − 𝑘𝑓𝑅𝑆70 ∗ 𝑅𝑁𝐴𝑃 ∗ 𝑆70 + 𝑘𝑟𝑅𝑆70 ∗ 𝑅𝑆70 3.4 
P70-σ28  Construct  
𝑚𝑅𝑁𝐴𝑆28̇ =  −(𝑑𝑒𝑔𝑚𝑅𝑁𝐴 + 𝑑𝑖𝑙) ∗ 𝑚𝑅𝑁𝐴𝑆28 + 𝐷𝑁𝐴𝐴𝑐𝑡𝑖𝑣𝑎𝑡𝑜𝑟 ∗ 𝑣𝑚𝑎𝑥𝑅𝑆70 ∗
𝑅𝑆70
𝑘𝑑𝑅𝑆70
1 +
𝑅𝑆70
𝑘𝑑𝑅𝑆70
+ (
𝐶1
𝑘𝑑𝑐1
)
𝑁𝑐𝑖  
 
3.5 
𝑆28̇ =  −(𝑑𝑒𝑔𝑆28 + 𝑑𝑖𝑙) ∗ 𝑆28 + 𝑘𝑡𝑟𝑎𝑛𝑠𝑆28 ∗ 𝑚𝑅𝑁𝐴𝑆28 − 𝑘𝑓𝑅𝑆28 ∗ 𝑅𝑁𝐴𝑃 ∗ 𝑆28 + 𝑘𝑟𝑅𝑆28 ∗ 𝑅𝑆28 3.6 
P28-C1-ssra Construct  
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𝑚𝑅𝑁𝐴𝐶1̇ =  −(𝑑𝑒𝑔𝑚𝑅𝑁𝐴 + 𝑑𝑖𝑙) ∗ 𝑚𝑅𝑁𝐴𝐶1 + 𝐷𝑁𝐴𝑅𝑒𝑝𝑟𝑒𝑠𝑠𝑜𝑟 ∗ 𝑣𝑚𝑎𝑥𝑅𝑆28 ∗
(
𝑅𝑆28
𝑘𝑑𝑅𝑆28
)
𝑁28
1 + (
𝑅𝑆28
𝑘𝑑𝑅𝑆28
)
𝑁28  
3.7 
𝐶?̇? =  −(𝑑𝑒𝑔𝐶1 + 𝑑𝑖𝑙) ∗ 𝐶1 + 𝑘𝑡𝑟𝑎𝑛𝑠𝐶1 ∗ 𝑚𝑅𝑁𝐴𝐶1 3.8 
P70-deGFP Construct  
(𝑚𝑅𝑁𝐴𝑑𝑒𝐺𝐹𝑃)̇ =  −(𝑑𝑒𝑔𝑚𝑅𝑁𝐴 + 𝑑𝑖𝑙) ∗ 𝑚𝑅𝑁𝐴𝑑𝑒𝐺𝐹𝑃 + 𝐷𝑁𝐴𝑅𝑒𝑝𝑜𝑟𝑡𝑒𝑟 ∗ 𝑣𝑚𝑎𝑥𝑅𝑆70 ∗
𝑅𝑆70
𝑘𝑑𝑅𝑆70
1 +
𝑅𝑆70
𝑘𝑑𝑅𝑆70
+ (
𝐶1
𝑘𝑑𝑐1
)
𝑁𝑐𝑖  
 
3.9 
𝑒𝐺𝐹𝑃𝑑𝑎𝑟𝑘̇ =  −(𝑘𝑚𝑎𝑡 + 𝑑𝑒𝑔𝑑𝑒𝐺𝐹𝑃 + 𝑑𝑖𝑙) ∗ 𝑑𝑒𝐺𝐹𝑃𝑑𝑎𝑟𝑘 + 𝑘𝑡𝑟𝑎𝑛𝑠𝑑𝑒𝐺𝐹𝑃 ∗ 𝑚𝑅𝑁𝐴𝑑𝑒𝐺𝐹𝑃 3.10 
𝑒𝐺𝐹𝑃̇ =  −( 𝑑𝑒𝑔𝑑𝑒𝐺𝐹𝑃 + 𝑑𝑖𝑙) ∗ 𝑑𝑒𝐺𝐹𝑃 + 𝑘𝑚𝑎𝑡 ∗ 𝑑𝑒𝐺𝐹𝑃𝑑𝑎𝑟𝑘 3.11 
 
Equations 3.1 to 3.4 model the RNA polymerase, sigma factors and their respective 
holoenzymes, using general mass action kinetics where 𝑘𝑓 and 𝑘𝑟 are the respective forward 
and reverse binding rates32. The 𝑅𝑁𝐴𝑃0 and 𝑆700 are constants representing static 
concentrations flowing into the reactor scaled by the dilution rate (these are simultaneously the 
initial conditions of RNAP and σ70 in each simulation). Equations 3.5-3.6 model the 
transcription and translation of σ28 gene, using hill type kinetics for the regulation of the 
transcription37. Equations 3.7-3.8 model the C1 gene, and equations 3.9-3.11 the deGFP gene. 
We do not have a hill coefficient included for regulation of genes by σ70. The translation 
process is modelled with a mass action term. Finally, the parameters to describe the 
concentrations of the P70-σ28 template, P28-C1-ssra template, P70-deGFP template and the 
Refresh Rate (dil) are the experimentally controlled parameters and make up the control space.  
3.3 RESULTS AND DISCUSSION 
3.3.1 Key regulatory mechanisms of the σ28-oscillator 
In order to identify individual parameters in our model38, the key regulatory mechanisms of 
our network were implemented separately under batch TX-TL conditions (Figure 3.4).  Firstly, 
we added increasing concentrations of the P70-deGFP template to the TX-TL reaction mix 
(Figure 3.4a). We observed an increased expression of deGFP upon increasing template 
concentration confirming the presence of σ70 in the lysate. Next, we implemented a two-step 
cascade to test transcriptional activation by σ28 (Figure 3.4b) by adding increasing amounts of 
P70-σ28 template, to a fixed concentration of P28-deGFP template. No deGFP fluorescence was 
observed in the absence of the P70-σ28 template indicating the absence of σ28 in the lysate. We 
observed deGFP fluorescence upon addition of 0.5 nM of P70-σ28 template indicating the 
production of functional σ28, which activates protein production from the P28 promoter. The 
onset of deGFP expression and the final yield did not improve remarkably upon increasing the 
P70-σ28 template concentration from 0.5 to 5 nM, highlighting the potency of σ28 as a 
transcriptional activator. Since the design of the network involves two sigma factors competing 
for the RNAP, we quantified the extent of this competition by adding increasing amounts of 
P70-σ28 template to a fixed concentration of P70-deGFP template (Figure 3.4c). The 
sequestration of core RNAP by σ28 and the subsequent decrease in deGFP expression serves as 
an indirect measurement for sigma factor competition. We observed that the addition of 0.5 
nM of the P70-σ28 template is enough to produce sufficient σ28 to outcompete σ70 for the core 
RNAP, reducing the deGFP yield by approximately 50% when compared to the control 
(without any P70-σ28 template). The final regulatory mechanism tested is the transcriptional 
repression by C1 (Figure 3.4d). We fixed the concentration of P70-deGFP-ssra template at 5 
nM and P70-σ28 template at 0.1 nM, thus ensuring that any decrease in the expression yield of 
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deGFP is the result of inhibition via the C1 protein as opposed to competition from σ28, and 
added increasing concentrations of P28-C1-ssra template. We observed that the C1 protein 
inhibits protein production from the P70 promoter thereby decreasing the yields of deGFP for 
concentrations of P28-C1-ssra template as low as 0.4 nM. 
         
Figure 3.4 Time traces of deGFP production as readout for the key regulatory mechanisms of the σ28-oscillator 
under batch TX-TL conditions. (a) Linear DNA template (P70-deGFP) at different concentrations. (b) Two-step 
σ28-activation cascade. Increasing concentrations of P70-σ28 template were added to 5 nM of P28-deGFP template.  
Expression of σ28 from P70-σ28 activates deGFP production. (c) Expression from P70-deGFP under competition 
for core RNAP between sigma factors σ70 and σ28. Increasing concentrations of P70-σ28 template were added to 5 
nM of P70-deGFP. (d) Transcriptional repression by C1. The concentrations of P70-deGFP-ssra and P70-σ28 were 
fixed at 5 nM and 0.1 nM respectively to which increasing concentrations of P28-C1-ssra template were added. 
Shaded error bands are standard error of three separate measurements. 
Since the life-time of reactions in batch TX-TL conditions is limited, we used the initial 
expression kinetics to provide us with estimates of reaction rates and binding constants. We 
implemented an evolutionary algorithm (EA) adapted from Smith et al.39 to evolve model 
parameters to fit  the batch TX-TL data (Figure 3.5). The results of the fits can be found in 
Figure 3.5. Each batch TX-TL experiment was set up to identify different model parameters. 
We tested different concentration of the P70-deGFP template (Fig 3.5a) to get an estimate of 
the following system parameters: 𝑘𝑡𝑟𝑎𝑛𝑠𝑑𝑒𝐺𝐹𝑃 , 𝑣𝑚𝑎𝑥𝑅𝑆70, 𝑑𝑒𝑔𝑑𝑒𝐺𝐹𝑃. The σ28-activation 
cascade dataset (Figure 3.5b) was used to estimate parameters related to of transcription by σ28, 
including: 𝑣𝑚𝑎𝑥𝑅𝑆28, 𝑘𝑡𝑟𝑎𝑛𝑠𝑆28. The competition dataset (Figure 3.5c) was used to identify 
the binding rates for σ28  and σ70 sigma factors to the RNA polymerase, including:  𝑘𝑓𝑅𝑆70, 
 𝑘𝑟𝑅𝑆70 , 𝑘𝑓𝑅𝑆28 , 𝑘𝑟𝑅𝑆28, 𝑅𝑁𝐴𝑃0, 𝑆700. The repression by C1 dataset (Figure 3.6d) was used 
to estimate all the system parameters involving the repressor protein C1, including: 
𝑁𝑐𝑖, 𝑘𝑑𝑐1, 𝑣𝑚𝑎𝑥𝑅𝑆70, 𝑘𝑡𝑟𝑎𝑛𝑠𝐶1, 𝑑𝑒𝑔𝐶1, 𝑑𝑒𝑔𝑚𝑅𝑁𝐴.  
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Figure 3.5 An overview of the different parameter estimations by the EA. The batch TX-TL experiments were 
fitted separately (a) σ28-transcriptional activation cascade (b) P70-deGFP concentration range batch TX-TL (c) 
Expression from P70-deGFP under competition for core RNAP between sigma factors σ70 and σ28 (d) 
Transcriptional repression by C1. The green lines are the experimental data, the blue lines the fits. (In collaboration 
with Bob v Sluijs) 
 
Parameters  Fit Boundaries Batch TX-TL Steady-state 
TX-TL 
kf_RS28 (nM min-1) 0.01-100 2.83 0.55 
kf_RS70 (nM min-1) 0.01-100 0.085 0.88 
kr_RS28 (nM min-1) 0.01-100 2.42 0.012 
Kr_RS70 (nM min-1) 0.01-100 1.668 2.89 
kd_s28(nM) 0.1-500 3.58 208 
kd_S70 (nM) 0.1-500 4.308 18.89 
kd_ci (nM) 0.1-500 28.13* 1.12 
vmax_s70 (nM min-1) 0.4-3.5 0.99 N/A 
vmax_s28 (nM min-1) 0.4-3.5 0.53 0.77 
vmax_s70ci (nM min-1) 0.4-3.5 0.69 3.5 
k_trans_ci (nM min-1) 0.3-3.5 1.88 0.72 
k_trans_GFP(nM min-1) 0.3-3.5 0.43 0.771 
k_trans_s28 (nM min-1) 0.3-3.5 1.70 0.60 
N70 1-4. 1 1 
N28 1-12. 1.87 1.95 
Nci 1-12. 3.12 5.24 
deg_mRNA ( min-1) 0.06-0.2 0.063 0.16 
deg_s70 ( min-1) 0.005-0.01 0.0053 0.0088 
deg_GFP ( min-1) 0.005-0.01 0.0076 0.0061 
deg_ci (min-1) 0.01-0.02 0.053 0.023 
RNAP_0 (nM min-1) 50-200 146.97 94.8 
S70_0 (nM min-1) 35-200 78.66 139.88 
k_mat (min-1) N/A 0.044 0.044 
 
Table 3.1. Parameter table, the first column shows the parameter ID, the second column the boundaries that were 
maintained for the LHS analysis and the parameter estimation. The third column shows the parameters of the 
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initial estimation using batch data, these parameter were used to characterize the control space of the σ28-oscillator. 
The fourth column shows the re-estimation of these parameters using data from the TX-TL experiments (best fit). 
 
We used the system parameter set (Table 3.1) to explore the control parameter space described 
by the control parameters -  P70-σ28 template, P28-C1-ssra template, P70-deGFP template and 
the Refresh Rate. We fixed the concentration of the P70-deGFP reporter template at 8 nM and 
tested a combination of 25 uniformly spaced points for each of the other control parameters – 
a total of 15,625 points – to search for stable oscillations (i.e. presence of limit cycles). We 
estimated the subspace of this control parameter space for which the model predicts stable 
oscillations with an amplitude greater than 20 nM in deGFP expression. This cutoff is used to 
ensure we can observe oscillations experimentally. Figure 3.6a shows the region of the control 
space for which the model predicts stable oscillations. Figure 3.6b shows the density of the 
amplitudes and periodicities found within this oscillating regime, with relatively low amplitude 
oscillations dominating the space. We used this initial prediction as a basis to guide our initial 
experiments in steady-state TX-TL conditions. 
            
 
 
Figure 3.6 (a) The oscillating regime in the control parameter space for the σ28-oscillator initial parameter estimate 
obtained from the batch TX-TL data. This space is estimated by a combination of 25 uniformly sampled points 
for each control parameter. We used a convex hull algorithm to find the outer points of the scatter cloud and 
connected them using a Delauney algorithm (from the scipy and matplotlib library respectively). Colours on the 
plot correspond to the [P70-σ28] axis (b) The observed amplitudes and periodicities of oscillations found in the 
oscillating space are broken down in a probability density plot. (In collaboration with Bob v Sluijs) 
 
3.3.2 Microfluidic nanoreactors for steady-state TX-TL reactions 
Steady-state TX-TL experiments were conducted in a PDMS-based, pneumatically controlled, 
bi-layer microfluidic chip12. Each chip comprises eight independent, 11 nL reactors in which 
unique TX-TL reactions can be performed. Within the microfluidic device, the top layer (flow 
layer) houses the TX-TL reactions, whilst the water-filled bottom layer (control layer) regulates 
the flow of fluids in the flow layer (Figure 3.7a). Reaction reagents are injected into the flow 
layer device using constant pressure via nine inlets. To regulate the flow, each of the 23 control 
channels located within the control layer of the microfluidic device can be actuated; a process 
wherein the fluid within the control channel is pressurized causing the control channel to 
expand. Of the nine possible inflow reagents, only one solution is permitted to flow into the 
remainder of the microfluidic device at any one time, a process achieved by the incorporation 
of a multiplexer – a series of control channels operating in conjunction with each other to inhibit 
all but one inflow solution at any one point in time. Although the device design being based on 
previously reported microfluidic devices by Niederholtmeyer et al.12, our research makes use 
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of a flow layer with a uniform feature height, as opposed to the use of multiple channel heights 
within the same layer of the microfluidic device. Over the course of any TX-TL experiment, 
three distinct fluid operations are repeatedly called upon (Figure 3.7b).  Firstly, any reagent 
that needs to be added to the reaction solution currently residing in the reactor is flown into the 
device. This process is referred to as flushing since any residual reagents present in the flow 
channel are flushed out of the device. During the flushing process the inlets of the reactors 
remain closed. Subsequently, the desired reagent is loaded into the reactors, simultaneously 
displacing an equal volume of the reaction products from the reactor.  For each of the reaction 
reagents, the flushing and loading protocols are repeated. Finally, all the reagents in the reactors 
are mixed and fluorescence signal is measured. This cycle takes approximately 15 mins and is 
repeated for 10 hours. During an experiment, the microfluidic chip was placed within a 
temperature-controlled incubation chamber above an inverted microscope which allowed for 
the fluorescence imaging of the reactors at a constant temperature (30 °C). The TX-TL reaction 
mixture was loaded into a Peltier device which was maintained at 4 °C using a water-based 
cooling system. The Peltier device was mounted within the incubator as close as possible to 
the microfluidic device, minimizing the transfer distance of the TX-TL reaction solution upon 
exiting cooling unit and entering the microfluidic device. DNA templates and MQ water were 
stored in Tygon tubing (0.02” ID, 0.06” OD) which was placed within the incubator. The 
injection of all reaction solutions – cooled and uncooled – into the microfluidic device was 
achieved using constant pressure supplied by a  digital pressure control system (Fluigent, 
MFCS-EZ) (Figure 3.7c).  
        
Figure 3.7 (a) Top-view schematic of the pneumatically actuated bi-layer μCSTR microfluidic device used to 
conduct steady-state TX-TL experiments. The microfluidic devices comprise eight unique 11 nL reactors. The 
control layer (magenta) regulates the flow of fluids within the flow layer (blue) of the microfluidic device. (b) 
Schematic of the  flushing,  loading and mixing of reagents inside a reactor. The regions where the control channels 
intersect  the flow channels is indicated with red rectangles (filled rectangles – control channel is pressurized thus 
inhibiting flow, and unfilled rectangles – control channel is depressurized, thus allowing fluids to flow within the 
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flow channel) (Adapted from Niederholtmeyer et al12). (c) Schematic of the microfluidic set-up. The microfluidic 
chip is placed above an inverted microscope within an incubator. The TX-TL mix is injected via a Peltier element 
cooled at 4 °C and DNA templates and MQ are kept at 30 °C and  injected using constant pressure. (In collaboration 
with Ardjan v/d Linden) 
The periodicity of injections into the reactors, combined with the volume fraction of the reactor 
displaced during each injection, is represented by the Refresh Rate (min-1) (Table 3.2). We 
performed steady-state TX-TL experiment containing 8 nM P70-deGFP (along with 1 nM of 
P70-σ28 template) at a Refresh Rate of 0.019 min-1 and 0.026 min-1 to observe that at a higher 
Refresh Rate the system adopts a lower steady-state quicker. Therefore, by changing the 
Refresh Rate, it is possible to control the kinetics of the TX-TL reactions inside the reactors.  
(Figure 3.8). Our homemade TX-TL system was stable for 10 hours after which the efficiency 
of the reaction gradually decreases. 
Reactor volume replaced per 15 mins 
(%) 
Volume fraction replaced per 15 
mins 
Refresh Rate (min-1) 
20 0.2 0.013 
30 0.3 0.0195 
40 0.4 0.026 
Table 3.2  Refresh ratio calculations for various displacement volumes and frequency in the microfluidic chip. 
                                                             
Figure 3.8 Steady state experiment with 8 nM of P70-deGFP template and 1 nM of P70-σ28 template. Upon 
changing the Refresh Rate from 0.019 min-1 to 0.026 min-1  the system  adopts a lower steady state.  
3.3.3 Characterization of the σ28-oscillator 
Variation of the control parameters regulates the transition of the network through three 
qualitatively different outputs: sustained oscillations, damped oscillations, and single-peak 
behaviour under steady-state TX-TL conditions (Figure 3.9). Oscillations with the largest 
oscillation amplitude were observed at P70-σ28 and P28-C1-ssra concentrations of 0.6 nM and 
6.5 nM, with a Refresh Rate of 0.026 min-1 (Figure 3.9a). Lowering the Refresh Rate for 
comparable concentrations of P70-σ28 and P28-C1-ssra templates resulted in the dampening of 
oscillations (Figure 3.9b). Increasing the concentration of P28-C1-ssra template, for a fixed 
P70-σ28 concentration and Refresh Rate, increased the amplitude of damped oscillations 
(Figures 3.9 c and d). These results indicate that since σ28 is a transcriptionally strong sigma 
factor (Figure 3.4b) it produces C1 protein rapidly and the Refresh Rate needs to be 
sufficiently high to remove σ28 thereby generating the sufficient time delay for the negative 
feedback needed to observe oscillations. These results are in general agreement with previous 
work on similar systems35. Increasing the concentrations of the P70-σ28 and P28-C1-ssra 
templates to 3 nM and 10 nM respectively results in a loss of oscillations and leads to a single 
transient peak (Figures 3.9 e and f).  
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Figure 3.9 Experimentally obtained deGFP traces exemplifying the different behaviour of the σ28-oscillator (a) 
Sustained oscillations (b)-(d) damped oscillations and (e)-(f) single-peak behaviour of the σ28-oscillator under 
steady-state TX-TL conditions. P70-deGFP DNA template concentration was kept at 8 nM in all experiments. 
The concentrations of P70-σ28, P28-C1-ssra templates and the Refresh Rate values for each experiment are as 
indicated. 
Although our initial parameter estimates from batch TX-TL data aided in finding an oscillatory 
regime, they did not fully capture the dynamics of the oscillator completely. To improve the 
accuracy of our model parameters, we re-estimated them by fitting the model to the steady-
state TX-TL data using a datapoint within (Figure 3.10a) and outside (Figure 3.10b) the 
oscillating regime. During the estimation of parameters we did not obtain a unique parameter 
set but rather a distribution of parameter sets all of which equally capable of describing the data 
Figure 3.10c demonstrates the amplitudes for the conditions in Figure 3.10 a and b as predicted 
by the distribution of these parameter sets. Out of these parameter sets, we chose a best fit 
(Table 3.1) using which we re-characterised the oscillating regime of the σ28-oscillator with 
respect to its control parameters (Figure 3.10d) and the amplitudes and periods of oscillations 
within this regime as predicted by the model (Figure 3.10e). While the size of the oscillating 
regime did increase compared to Figure 3.6a, the model still predicts oscillations for a realtively 
narrow range of activator template concentration. 
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Figure 3.10 (a) and (b) Model-simulated and experimentally-obtained time traces for the parameter set showing 
the best fits. The traces are simulated from the parameters obtained by fitting the model to steady-state data as 
shown in Table 3.1. We chose a data point inside  and outside the oscillating regime to improve our parameter 
estimation. (c) Amplitudes as predicted by the distribution of parameter sets for the conditions in (a) and (b) (d) 
Model-predicted oscillating subset of the control parameter space of the σ28-oscillator after optimisation with 
steady-state TX-TL data. Colours on the plot correspond to the [P70-σ28] axis (e) Probability density plot of the 
amplitudes and periods of oscillations within this subset. (In collaboration with Bob v Sluijs) 
 
The oscillation amplitudes for the σ28-oscillator, as predicted by the model, were plotted against 
the P70-σ28 and P28-C1-ssra template concentrations for a fixed Refresh Rate (0.026 min-1) 
(Figure 3.11a). In order to test the predictive ability of the model, we compared the predicted 
and observed oscillation amplitudes for points sampled within this phase space. We found that 
the model predicts a decrease in amplitude of oscillations with increasing P70-σ28 template 
concentrations, for a constant P28-C1-ssra template concentration (Figure 3.11a). Upon 
decreasing the concentration of P70-σ28 template in the experiments from 2 nM to 1 nM (Figure 
3.11b (i) and (ii)), for a P28-C1-ssra concentration of 6.5 nM, we observed a decrease in the 
amplitude of oscillations (78 nM and 76 nM), although the extent of decrease was much less 
compared to the model prediction. Furthermore, the model predicts that increasing the P28-C1-
ssra template concentration, for a fixed concentration of P70-σ28 template, from 2 nM to 4.3 
nM should lead to an increase in oscillation amplitude and upon increasing the concentration 
further to 8 nM should marginally decrease the oscillation amplitudes. Upon experimental 
verification, we observed a similar trend (Figure 3.11b (iii), (iv), (v)) wherein the amplitude 
increases from 69.5 nM (P28-C1-ssra = 2 nM) to 99.25 nM (P28-C1-ssra = 4.3 nM) and then 
decreases marginally to 93 nM (P28-C1-ssra = 8 nM). Due to the reliance on a single output 
(deGFP) to quantify the system, our theoretical analysis was unable to find a single parameter 
set to describe all the data but rather a distribution of parameter set which can all describe the 
data equally well. We sought to mitigate this effect by setting boundaries to our parameters 
based on literature, estimating specific rates of the network from targeted batch TX-TL 
experiments and finally by fitting to steady-state TX-TL experiments. From this process, we 
use the parameter set with the best fit (Table 3.1) to describe our oscillating regime and for the 
further analysis. Hence, our theoretical approach captures trends of network behavior local to 
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the fit and is able to qualitatively guide network modifications which we will demonstrate in 
the next chapter. 
Figure 3.11 Characterization of the σ28-oscillator. (a) Contour plot showing the model-predicted amplitude of 
oscillations mapped on to [P70-σ28 , P28-C1-ssra] phase space for a given Refresh Rate (0.026 min-1). (b)(i)-(v) 
Experimentally obtained deGFP time courses for the σ28-oscillator exhibiting sustained oscillations under steady-
state TX-TL conditions for various values of  [P70-σ28 , P28-C1-ssra]. All points in b(i)-(v) have been mapped on 
to the contour plot in (a). P70-deGFP template concentration and Refresh Rate were fixed at 8 nM and 0.026 
min-1 respectively in all experiments.  
In order to minimise variability arising from the microfluidic set-up, experiments in a 
microfluidic chip were carried out in duplicates i.e. two independent reactors in the same chip 
with the same DNA template concentrations and Refresh Rate. Under such conditions we 
observed negligible variation among oscillations occurring across different reactors (Figure 
3.12a). In order to assess variability across microfluidic chips we compared an oscillation 
experiment performed across three different chips. We observed a marginal variation in 
oscillation amplitude (approximately 20 nM) upon repeating an experiment across multiple 
chips (Figure 3.12b) and hence grouped our model predictions of amplitude into intervals of 
atleast 20 nM to take this variation into account in the analysis. 
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Figure 3.12 Oscillation experiments (a) in two independent reactors in a single microfluidic chip with the σ28-
oscillator (gray lines are the individual reactors and green is the average) (b) across three different microfluidic 
chips with the σ19-oscillator (which will be explained in the next chapter) (gray lines are oscillations from 
individual chips and violet is the average). P70-deGFP template concentration was fixed at 8 nM in both cases. 
3.4 CONCLUSION 
In this chapter we have described the bottom-up engineering of a cell-free genetic oscillator 
leveraging sigma factors in well-stirred conditions. We have described our system using a 
mathematical model and used an modified evolutionary algorithm to estimate the system 
parameters and used this model to characterise the behaviour of this oscillator. We observed 
that the period of oscillations did not change remarkably upon variation of the control 
parameters but more variation in the amplitude of oscillations were observed. Periods can be 
tuned by expressing ClpXP proteins, which play a role in reducing in situ concentration of 
proteins, or anti-sigma factors which can sequester sigma factors and reduce their activity35. 
We also observed that due to the high transcriptional potency of σ28 the network exhibited 
oscillations over a relatively narrow range of Activator template concentration. Therefore, in 
the next chapter we focussed our efforts on using a different sigma factor, with different 
transcriptional and competitive strength, serving as activator to tune the systems-level 
properties of our cell-free genetic oscillator and engineer higher-order genetic networks.  
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3.6 METHODS 
Preparation of DNA templates: PCR for linear DNA templates was performed using Phusion 
High-Fidelity DNA Polymerase from ThermoFisher Scientific. PCR was carried out in a 
thermocycler according to the manufacturer’s protocol. DNA templates were purified using 
QIAGEN PCR purification kits and concentrations were measured using a Nanodrop. P19-C1-
ssra template was ordered from IDT as a gBlock fragment. All other DNA templates for this 
study were obtained from Arbor Biosciences. The sequences for the DNA constructs are shown 
in the appendix. 
Preparation of Cell Lysate: The energy mixture and cell lysate were prepared using protocols 
described previously by Sun et al.40 and Caschera et al.15. Briefly,  BL21 Rosetta2 cells were 
grown to an OD600 of 1.8 in LB medium supplemented with a phosphate buffer (0.22 M Sodium 
dihydrogen phosphate and 0.4 M Disodium hydrogen phosphate, pH 7) . The cells were washed 
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with S30A buffer (14 mM Magnesium glutamate, 60 mM Potassium glutamate, 2 mM DTT, 
titrated to pH 8.2 with Tris-base). The pellet was resuspended in S30A buffer in a volume equal 
to 0.8 times the cell pellet weight and passed through a cell press at 16000 lb. The extract was 
spun down from which the supernatant was collected, incubated at 37 °C, dialysed in S30B 
buffer (14 mM Magnesium glutamate, 150 mM Potassium glutamate, 1 mM DTT, titrated to 
pH 8.2 with Tris-base) and aliquoted. The density of the cell lysate was determined to be 40 
mg/mL using the Pierce BCA assay.  
TX-TL Reaction Set Up:- The Energy Mixture was added to the cell lysate along with 3 uM 
GamS, 3% w/v PEG-8000 , 6 mM Magnesium Glutamate and 80 mM Potassium Glutamate to 
obtain the TX-TL reaction mixture. The final concentrations were 11 mg/mL cell lysate, 50 
mM Hepes (pH 8.0), 0.9 mM cytidine triphosphate and uridine triphosphate, 1.5 mM each of 
adenosine triphosphate and guanosine triphosphate, 0.5 mM of each amino acid, 1 mM 
spermidine, 0.75 mM cyclic adenosine monophosphate, 0.33 mM nicotinamide adenine 
dinucleotide, 0.26 mM coenzyme A, 30mM 3-phosphoglyceric acid, 0.067 mM folinic acid, 
0.2 mg/ mL tRNAs. For batch TX-TL reactions the DNA templates and necessary volume of 
MQ H2O were added and mixed well. 10 μL of the final reaction solution was pipetted into a 
Nunclon 384 well plate and the deGFP fluorescence was measured using a Tecan M200 Infinite 
Plate-reader. GamS was prepared using protocols described previously by Sun et al13. 
During the steady-state TX-TL experiments, microfluidic devices were placed within an 
incubator set to 30°C. The TX-TL reaction mixture, was stored within a water-cooled Peltier 
element, maintained at 4°C. A short piece of tubing was used to connect the Peltier element to 
the microfluidic device allowing for the injection of the cooled TX-TL mix into the device. 
The remaining reaction components (i.e. MQ H2O and DNA solutions) were stored in Tygon 
tubing (0.02” ID, 0.06” OD) which was inserted directly into the microfluidic device. These 
solutions were maintained at 30°C for the entirety of the experiment. Over the course of the 
experiments, fluorescence images were periodically captured using an inverted microscope 
(Nikon Eclipse) to monitor the fluorescence within the microfluidic reactors. Fluorescence was 
determined from the obtained images using MATLAB software. Amplitude of sustained 
oscillations were determined by measuring the difference between the fluorescence maxima 
and minima of the final two oscillations in the steady-state TX-TL experiments. 
Fabrication and Design of Microfluidic device: The microfluidic devices used throughout 
this research were based on designs published by Niederholtmeyer et al12, and were 
manufactured according to previously described protocols.  
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Chapter 4 :-  Sigma factor mediated tuning of 
properties of a cell-free genetic oscillator 
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4.1 INTRODUCTION 
In the previous chapter we have demonstrated the bottom-up construction of a synthetic cell-
free genetic oscillator in well-stirred conditions using σ28 as the activator and C1 as the 
repressor. Within the parameter space in which the system shows oscillations, the 
characteristics of the oscillations, such as amplitude, can be tuned by changing DNA template 
concentrations. These changes influence the rate of reactions and subsequently the amount of 
proteins produced. However systems-level characteristics of oscillating systems – such as the 
size of its oscillating regime and robustness (likelihood of a system sustaining its oscillations 
upon external perturbation)– can be also be modified by the modification and/or incorporation 
of network elements1. Examples of such strategies in synthetic biology include: (i) modifying 
promoter composition – particularly the number and strength of operator sites – thereby altering 
the binding of a protein to its promoter and subsequently the strength of activation/repression2 
(ii) incorporation of excess DNA target sites to create a ‘molecular load’ for certain proteins 
due to which they take longer to perform the required function (retroactivity)3 (iii) tuning 
protein degradation using peptide tags to alter in situ protein concentrations4,5 (Figure 4.1). 
Properties of oscillators can also be modified by changing the topology of the network by 
addition of extra feedback loops6,7. 
               
Figure 4.1 Characteristics of oscillators can be tuned by different strategies such as varying promoter architecture, 
retroactivity, using proteolytic machinery and tags to tune protein degradation rates and modifying network 
properties.  
Tuning the characteristics of oscillators not only expands our current toolbox of genetic 
networks but also allows the construction of higher-order systems by the combination and 
coupling of individual oscillators. Higher-order system are complex genetic networks which 
exhibit population-level behaviours such as entrainment, synchrony and pattern formation. One 
such example involves synchronising oscillations across cells using bacterial quorum-sensing8. 
The first successful implementation of coupling oscillators via quorum sensing was reported 
by Danino et al.9 (Figure 4.2a). The authors assembled an oscillator consisting of the luxi gene 
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from V. fischeri and aiia gene from B. thuringiensis. luxI codes for a LuxI synthase which 
produces acyl-homoserine lactone (AHL). AHL associates with LuxR to activate the 
production of AiiA which degrades the AHL. This quorum-sensing oscillator (QS-oscillator) 
resembles the topology of the negative feedback oscillators (NFB-Oscillator) introduced by 
Hasty10. The autoinducer (AHL) helps in the synchronization of oscillations across a population 
of cells within a microfluidic compartment (Figure 4.2b). In subsequent work Prindle et al. 
added a H2O2 producing module to this design to couple and synchronize oscillators across 
multiple compartments due to the diffusion of H2O2 across the device
11. Mondragon-Palomino 
et al. demonstrated the entrainment of a population of oscillators to a periodic external signal 
(arabinose concentration)12. Signalling pathways, which rely on relatively fast phosphorylation 
and dephosphorylation reactions have also been proposed to combine multiple network 
modules13,14. In TX-TL systems, oscillators and bistable switches have been coupled physically 
in a diffusion-limited environments to generate a population of DNA micro-compartments15,16. 
These populations of ‘artificial cells’ demonstrate higher-order behaviour such as synchrony 
and entrainment when programmed with genetic oscillators and exhibit spatiotemporal patterns 
when they have a bistable switch encoded in them.  
 
Figure 4.2 (a) Schematic of the  QS-oscillator. The AHL produced synchronises the oscillations across the cells 
within a compartment. (b) Bacterial cells engineered with QS-oscillator exhibiting synchronised oscillations. (c) 
Proteolytic coupling of the QS-oscillator and the NFB-oscillator where all genes are tagged for degradation by 
the ClpXP protease. (d) Synchronised signals of the NFB and QS oscillator. Figures adapted from Danino et al9 
and Prindle et al17. 
A crucial phenomenon in complex networks is the effect of competition for critical resources 
i.e. where the saturation of an enzyme by one substrate will lead to a competitive situation 
which affects its interaction with the other substrates18. Rondelez has outlined the importance 
of taking into account the effect of saturation of the degradation machinery (such as ClpXP 
protease) and how competitive degradation can either promote or suppress the targeted 
behaviour of the network19. Proteolytic coupling or queueing – i.e. when multiple proteins in a 
network compete for being degraded by the same ClpXP protease – has been used to 
demonstrate the coupling of the QS-oscillator and the NFB-oscillator17  (Figure 4.2 c and d) 
and to entrain a population of oscillators to an external signal20. In general, competition for 
cellular resources (enzymes, binding sites etc) produce non-linear coupling effects which help 
in reducing noise and increasing sensitivity of cellular networks to metabolites21,22.  
In this context the interaction between bacterial sigma factors and the bacterial RNA 
Polymerase (RNAP) has been a relatively unexplored mechanism to couple oscillators as most 
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efforts focus on proteolytic coupling or quorum-sensing based modules to engineer higher 
order systems. Bacteria employ multiple sigma factors which bind to the core RNAP with 
different affinities to form their respective holoenzymes to regulate different cellular functions. 
This results in the portioning of the core RNAP amongst several sigma factors – a process 
termed molecular sharing (Figure 4.3). Recently it has been shown that bacteria can also use 
sigma factors to alter the transcriptional landscape under stressed conditions by time-sharing 
the core RNAP i.e. in which a single sigma factor binds to the core RNAP to form its 
holoenzyme for a give duration after which it deactivates leading to formation of another 
holoenzyme with a different sigma factor and so on (Figure 4.3). This time-sharing therefore 
enables the bacteria to activate all the genes regulated by a sigma factor for a sustained period 
of time in response to certain stressors23. Furthermore, since sigma factors exhibit versatile 
properties with respect to their binding affinities for core RNAP and transcriptional strength of 
their holoenzyme24, we aim to use them as regulatory molecules in oscillators in order to  
modulate systems-level behaviour of genetic networks. Therefore, in this chapter we 
demonstrate the tuning of the systems-level characteristic – in particular the size of the 
oscillating regime –  of our oscillator motif by replacing σ19 as the activator in the network 
instead of σ28. We also tested if our model could predict the amplitude of oscillations when the 
reporter gene is controlled by σ19/σ28 instead of σ70 so as to gain a better understanding of the 
kinetics of the all the proteins in our oscillator topology. Finally we couple our oscillators and 
investigated the influence of competition-driven passive transcriptional control between sigma 
factors on the behaviour of the coupled system. 
               
Figure 4.3 Sigma factors compete with different affinities to bind to the core RNAP to form their respective 
holoenzymes. Multiple sigma factors can share the RNAP by partioning i.e. each sigma factor utilising a constant 
fraction of the RNAP (molecular sharing) or the core RNAP can be shared over time i.e. each sigma factor 
occupying the RNAP for a certain period of time. Figure adapted from Park et al23. 
4.2 RESULTS AND DISCUSSION 
4.2.1 Tuning the characteristics of the σ28-oscillator 
In order to identify targets for network modification so as to effect changes on the systems-
level characteristics of our network , such as size of oscillating regime, we performed two sets 
of sensitivity analyses. Sensitivity analyses are used to assess the response of a network output, 
to variations in its model parameters. To this end, we fixed the control parameters at the center 
of the oscillating regime (Figure 3.10d, Activator = 1.16 nM, Repressor = 7.55 nM, Refresh 
Rate = 0.021 min-1) and varied each model parameter across six orders of magnitude to assess 
the qualitative change in the amplitude and period of the oscillatory network. The results 
(Figure 4.4) posits several modifications which can increase the amplitude of oscillations such 
as tuning the degradation rates (deg_mRNA, deg_S28), tuning the affinity for σ70 to core RNAP 
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(Kf_RS70) and decreasing the competitive strength of the activator sigma factor to the core 
RNAP (Kf_RS28) and decreasing the transcriptional potency of the activator (vmax_s28) of the 
activator. Since, E.coli has a variety of sigma factors – each with differing transcriptional and 
competitive strengths – switching σ28 for a weaker sigma factor is the most feasible and 
convenient option24.  
 
 
  
Figure 4.4 Sensitivity analysis of individual parameters, exploring the effect of parameter perturbations on the 
amplitude and period of deGFP oscillations. It shows that the amplitude of the deGFP oscillations can be increased 
by tuning the value of  rate constants associated with the activator (highlighted in green boxes). (In collaboration 
with Bob v Sluijs) 
We performed a second sensitivity analysis wherein the impact of varying a single system 
parameter on the overall size of the oscillating regime was assessed (Figure 4.5). We found  
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that tuning the competitive and transcriptional strength of the activator sigma factor can not 
only increase the amplitude of oscillations but also systems-level properties such as size of the 
oscillating regime.  
 
 
Figure 4.5 Sensitivity analysis of individual parameters exploring the effect of parameter perturbations. Seven 
values for each parameter were tested, the ranges were set manually based on the effect of parameter perturbations 
on oscillation amplitudes. The correlation between an increase in amplitude and the size of the oscillating region 
holds true for the decrease in competitive strength of the activating sigma factor. The volume (y-axis) corresponds 
to the size of the oscillating region across three dimensions shown in Figure 3.10d. The volume is a function of 
the concentration of the Activator (nM) and Repressor (nM) template concentration and Refresh Rate (min-1). 
The rate constants associated with the activator are highlighted in green boxes. (In collaboration with Bob v Sluijs) 
 
Among the variety of E. coli sigma factors, we chose σ19 as a replacement for σ28 as it reported 
to be a weaker competitor for core RNAP25, which we confirmed in batch TX-TL tests (Figure 
4.6). We quantified the extent of competition by adding increasing amounts of P70-σ19 template 
to a fixed concentration of P70-deGFP template (Figure 4.6a). The sequestration of core RNAP 
by σ19 and the subsequent decrease in deGFP expression serves as an indirect measurement for 
sigma factor competition. We observed that nearly 5 nM of the P70-σ19 template is required to 
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produce sufficient σ19 to outcompete σ70 for the core RNAP, reducing the deGFP yield by 
approximately 50% when compared to the control (without any P70-σ19 template). This result 
highlights that σ19 is a weaker competitor for RNAP as compared to σ28 for which 0.5 nM of 
P70-σ28 is sufficient to reduce protein production from P70-deGFP by approximately 50% 
(Figure 3.4c). Furthermore, we implemented a two-step cascade to test transcriptional 
activation by σ19 (Figure 4.6b) by adding increasing amounts of P70-σ19 template, to a fixed 
concentration of P19-deGFP template. No deGFP fluorescence was observed in the absence of 
the P70-σ19 template indicating the absence of σ19 in the lysate. We observed increasing deGFP 
production from P19-deGFP with increasing P70-σ19 template concentrations, however protein 
yield was lower when compared to the σ28-cascade and there was a marked difference in protein 
yield and onset of protein production between 0.5 nM and 5 nM of the P70-σ19 template, 
indicating that σ19 is also a transcriptionally less potent sigma factor as compared to σ28 (Figure 
3.4b). 
 
Figure 4.6 Time traces of deGFP production as readout for the key regulatory mechanisms of the σ19-oscillator 
under batch TX-TL conditions (a) End-point expression of deGFP from P70-deGFP under competition for core 
RNAP between sigma factors σ70 and σ19. Increasing concentrations of P70-σ19 template were added to 5 nM of 
P70-deGFP. (b) Two-step σ19-activation cascade. Increasing concentrations of P70-σ19 template were added to 5 
nM of P19-deGFP template.  
We estimated the oscillating regime for the σ19-oscillator in steady-state TX-TL conditions by 
setting Kf_S19 to be six times lower than Kf_S28 (based on batch experiments) and set Kf_S70 
to be four times higher (to account for increased activity in the new TX-TL mixture batch) and  
vmaxRS19 to half the value of vmaxRS28. Using these values we simulated a control parameter 
space consisting of 15,625 combinations of the control parameters (P70-σ19, P19-C1-ssra, 
Refresh Rate). We next estimated the subset of this control parameter space for which the 
model predicts stable oscillations in deGFP expression for the σ19-oscillator (Figure 4.7a). 
Herein, it was found that the model predicts a larger oscillatory subset, in particular a broader 
activator template concentration range, when using σ19 in the network. Within this subset the 
model also predicts oscillations across a larger range of amplitude for the σ19-oscillator when 
compared to the σ28-oscillator (Figure 4.7b and 3.10e).  
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Figure 4.7 (a) Model-predicted oscillating subset of the control parameter space of the σ19-oscillator. Colours 
correspond to the [P70-σ19] axis (b) Probability density plot of the amplitudes and periods of oscillations within 
the oscillating subspace. (In collaboration with Bob v Sluijs) 
 
4.2.2 Characterization of the σ19-oscillator 
The steady-state TX-TL behaviour of the σ19-oscillator was characterised within a phase 
described by the [P70-σ19, P19-C1-ssra] template concentrations for a fixed Refresh Rate 
(0.026 min-1) (Figure 4.8a). Upon experimentally sampling points within this space we found 
that the σ19-oscillator indeed exhibited oscillations for a higher range of P70-σ19 template 
concentrations (from 5 nM to 10 nM) compared to the σ28-oscillator (from 0.6 nM to 2 nM) 
(Figure 4.8b (i)-(ii) and Figure 3.9 and 3.11). However, the model fails to accurately capture 
the P70-σ19 template concentration range for which the network exhibits oscillations, as it also 
predicts oscillations for the conditions in Figure 4.8b (iii). Variation of the P19-C1-ssra 
template concentration, while fixing the P70-σ19 template concentration at 5 nM, yielded 
sustained oscillations for a concentration of 10 nM while at 3.3 nM and 15 nM the system does 
not display any oscillations despite model predictions indicating otherwise (Figure 4.8b (iv) - 
(vi)). Despite the lack of quantitative predictions, we found that the model can qualitatively 
describe the effect of changing network components on system-level properties of the 
oscillator.  
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Figure 4.8 Characterization of the σ19-oscillator (a) Contour plot showing the model-predicted oscillation 
amplitudes mapped on to the [P70-σ19 , P19-C1-ssra] phase space for a given Refresh Rate (0.026 min-1). (b)(i)-
(vi) Experimentally obtained deGFP time courses for the σ19-oscillator exhibiting oscillatory and non-oscillatory 
behaviour for various values of  [P70-σ19 , P19-C1-ssra]. All points have been mapped on to the contour plot (a). 
P70-deGFP template concentration and Refresh Rate were fixed at 8 nM and 0.026 min-1 respectively in all 
experiments.  
All the oscillators described thus far have had the reporter protein under the transcriptional 
control of the P70 promoter, thereby reporting on the behaviour of the proteins in the network 
regulated by σ70.  In order to gain a better understanding of the dynamics of the other protein in 
our network, we placed deGFP under the control of the P19 promoter. While this does not 
change the oscillating regime of the network, we can expect changes in amplitude and/or period 
of deGFP as it is now regulated by σ19 instead of σ70. We plotted the model-predicted oscillation 
amplitudes within a phase described by the [P70-σ19, P19-C1-ssra] template concentrations for 
a fixed Refresh Rate (0.026 min-1) (Figure 4.9a) and sampled points from this space for 
experimental verification. We observed the oscillation amplitude increased marginally upon 
increasing P19-C1-ssra for a P70-σ19 concentration of 5 nM (Figure 4.9b (i) and (ii)), however 
it decreased when increasing the repressor template concentration from 9.3 nM to 20 nM for a 
P70-σ19 template concentration of 10 nM (Figure 4.9b (iv)-(v)). While the model captures the 
trend in the former case, the decrease in oscillation amplitude in the latter case is not captured 
by the model as it predicts the oscillation amplitude should stay the same. Hence, we found 
that the model is able to satisfactorily capture the oscillating regime for the σ19-controlled 
reporter gene but yet again the analysis falls short of qualitative predictions. 
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Figure 4.9 Characterization of the σ19-oscillator using P19-deGFP as readout (a) Contour plot showing the 
model-predicted oscillation amplitudes mapped on to the [P70-σ19 , P19-C1-ssra] phase space for a given 
Refresh Rate (0.026 min-1). (b)(i)-(v) Experimentally obtained deGFP time courses for the σ19-oscillator 
exhibiting oscillatory and non-oscillatory behaviour for various values of  [P70-σ19 , P19-C1-ssra]. All points 
have been mapped on to the contour plot (a). P19-deGFP template concentration and Refresh Rate were fixed 
at 8 nM and 0.026 min-1 respectively in all experiments.  
4.2.3 Prediction breakdown due to parameter uncertainty 
We next proceeded to implement the σ28-oscillator with P28-deGFP as the readout (Figure 
4.10a) and used our model to predict the amplitude of oscillations in a phase space described 
by [P70-σ28, P28-C1-ssra] template concentrations for a fixed Refresh Rate (0.026 min-1) 
(Figure 4.10b). However, in this case we found that the model fails to even capture the 
oscillating regime as we did not observe any oscillations for different combinations of DNA 
template concentrations sampled from the phase space in steady-state TX-TL conditions 
(Figure 4.10 c and d).  
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Figure 4.10 (a) Schematic of the σ28-oscillator using P28-deGFP as readout (b) Contour plot showing the model-
predicted oscillation amplitudes mapped on to the [P70-σ28 , P28-C1-ssra] phase space for a given Refresh Rate 
(0.026 min-1). (c) and (d) Experimentally obtained deGFP time courses for the σ19-oscillator exhibiting non-
oscillatory behaviour for various values of  [P70-σ28 , P28-C1-ssra]. All points have been mapped on to the contour 
plot (b). P28-deGFP template concentration and Refresh Rate were fixed at 8 nM and 0.026 min-1 respectively 
in all experiments.  
We attribute such a significant discrepancy between model and experimental data to two issues. 
Firstly, the batch of TX-TL mix used to analyse the σ28-oscillator here is different from 
previous chapters. Variations in reaction rates and protein yields between different batches can 
affect overall network behaviour. Secondly, there is a certain level of inability to accurately 
estimate model parameters due to limitations in quality of data26. For example, we estimate 
important model parameters such as vmaxRS28 and kdRS28 – which describe the binding of the 
activator sigma factor to its promoter and the kinetics of its transcription – by implementing a 
cascade reaction wherein either σ28 or σ19 is produced from an activator template to produce 
reporter protein from either P28-deGFP or P19-deGFP respectively. However, since σ28 is a 
potent transcription factor, protein yields from the σ28-cascade are uniform despite variation of 
the activator template concentration by nearly two orders of magnitude (Figure 4.11a). This is 
in contrast to the σ19-cascade which produces a graded response for the same activator template 
range (Figure 4.11b). Therefore the uncertainty in parameter estimation from the σ19-cascade 
is much less as compared to σ28-cascade which is reflected in the poorer model predictions for 
the network using σ28 as the activator when compared to σ19 as the activator.  
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Figure 4.11 (a) σ28-activation cascade and (b) σ19-activation cascade for a range of Activator template 
concentrations. P28-deGFP and P19-deGFP template concentrations were fixed at 5 nM for the two cascades 
respectively. 
4.2.4 Effect of passive transcriptional control in coupled oscillators 
As mentioned previously, multiple sigma factors compete for the same pool of core RNAP, 
and thus an increase in activity of one sigma factor can exert an indirect repression on the 
binding of another sigma factor to the RNAP27,28. This mechanism is referred to as passive 
transcriptional regulation and bacteria harness this mechanism to change gene expression 
profiles in cells. Although present between σ28/σ19 and σ70 in the individual oscillators, this 
effect is difficult to investigate as the concentration of σ70 is fixed in the lysate. To investigate 
the extent of such competition-induced regulation amongst σ28 and σ19, we allowed the sigma 
factors  to directly compete for the core RNAP in batch TX-TL by adding different 
concentrations of P70-σ19 template to the σ29-cascade, as shown in Figure 4.12a. Comparing 
deGFP fluorescence in the absence or presence of 10 nM P70-σ19, we observed that with 0.85 
nM of P70-σ28 template, the σ19 only marginally decreases deGFP yield (Figure 4.12b). In 
contrast, decreasing the concentration of  P70-σ28  template from 0.85 nM to 0.4 nM resulted in 
a decrease of approximately 40% in yield of deGFP due to passive transcriptional repression 
on the σ28-activation cascade by σ19 (Figure 4.12c). 
 
Figure 4.12 (a) Schematic diagram showing the passive transcriptional regulation exerted by σ19 on the σ28 
activation cascade resulting in the decrease of the deGFP yield due to competition for RNAP by σ19. (b) and (c) 
End-point measurement of deGFP yields for the batch TX-TL reactions shown for two different concentrations 
of P70-σ28: 0.85 nM and 0.4 nM respectively. The concentration of P28-deGFP DNA template was fixed at 5 nM 
and the concentration of P70-σ19 was varied between 0 and 10 nM. 
As mentioned previously, competition for common catalytic resources has been shown to alter 
network dynamics in genetic networks.  Coupling the two oscillators within the same network, 
allows σ19 and σ28 to drive their respective networks whilst simultaneously competing for core 
RNAP. Both sigma factors produce C1 protein which represses the expression of σ19, σ28, and 
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deGFP from their respective templates (Figure 4.13a). Although multiple factors govern the 
behaviour of such a system, a crucial factor is the competition-induced transcriptional 
regulation between σ28 and σ19. Under steady-state TX-TL conditions, we observed that for a 
concentration of 0.85 nM of P70-σ28 the σ28-oscillator displayed a single-peak behaviour and at 
10 nM of P70-σ19 the σ19-oscillator showed sustained oscillations. Upon coupling the networks, 
we found that the system exhibited single-peak behaviour (Figure 4.13b). However, by 
decreasing the concentration of the P70-σ28 to 0.4 nM we found that the σ28-oscillator exhibited 
damped oscillations and the coupled system showed sustained oscillations (Figure 4.13c). This 
result indicates that decreasing the P70-σ28 concentration from 0.85 nM to 0.4 nM allows the 
system to enter a regime where σ19 can better compete for the core RNAP, thereby exerting 
greater passive transcriptional control over σ28, leading to the emergence of sustained 
oscillatory behaviour in the coupled system. To ensure that the preservation of oscillations in 
the coupled system results from the coupling of oscillators and is not a consequence of 
extraneous factors such as pressure fluctuations within the microfluidic setup, we coupled the 
oscillators under conditions for which the isolated σ28-oscillator exhibited no oscillations – 
sustained or damped – while the σ19-oscillator exhibited sustained oscillations (Figure 4.13d). 
The concentrations of the P70-σ28 and P70-σ19 templates were identical to those used in the 
experiments depicted in Figure 4.13c i.e. 0.4 nM and 10 nM respectively. We found that the 
coupled system exhibited sustained oscillations confirming that the behaviour of the coupled 
system is caused by the passive transcriptional control exerted by the weaker sigma factor – 
σ19 –  over the stronger sigma factor – σ28. 
  
 
Figure 4.13 (a) Schematic of the coupled oscillatory network. σ19 and σ28 regulate the expression of the C1 protein 
which inhibits the expression of both sigma factors and deGFP. (b), (c) and  (d) Experimentally obtained deGFP 
time traces of the σ28-oscillator, σ19-oscillator and the coupled system under steady-state TX-TL conditions. The 
concentration of P70-deGFP, P19-C1-ssra and P70-σ19 were kept fixed at 8 nM, 6.5 nM and 10 nM respectively. 
The respective concentrations of P70-σ28 and P28-C1-ssra were (b) 0.85 nM and 6.5 nM (c) 0.4 nM and 1.5 nM 
and (d) 0.4 nM and 0.9 nM . 
In order to gain better insight into the dynamics of the coupled system we repeated the 
experiment in Figure 4.13d using different fluorophores with deCFP and deYFP under the 
transcriptional control of σ19 and σ28 respectively (Figure 4.14a).  Under these conditions, we 
observed that individually, the σ19-oscillator exhibited oscillatory behaviour while the σ28-
oscillator showed non-oscillatory behaviour (Figure 4.14b). Upon coupling, however, both the 
oscillators showed oscillations indicating that the passive transcriptional control exerted by the 
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weaker σ19 drives the σ28-oscillator from non-oscillatory to oscillatory behaviour whilst 
sustaining the oscillations of the σ19-oscillator itself (Figure 4.14c). 
                
Figure 4.14 (a) Schematic of the coupled oscillatory network with different fluorophores controlled by σ19 and 
σ28. Experimentally obtained deCFP and deYFP time traces of the (b) σ19-oscillator, σ28-oscillator and (c) the 
coupled system under steady-state TX-TL conditions. The concentration of P28-deYFP, P19-deCFP, P19-C1-ssra, 
P70-σ19, P70-σ28 and P28-C1-ssra were 8 nM, 8 nM, 6.5 nM, 10 nM, 0.4 nM and 1 nM respectively. 
4.3 CONCLUSIONS 
In this chapter, we have outlined a strategy to tune systems-level properties of a cell-free 
genetic oscillator using the different E. coli sigma factors, which can influence network 
dynamics due to their different competitive and transcriptional strength. Since multiple sigma 
factor compete for the same pool of core RNAP, this also provides a facile means to couple 
and combine different oscillators and to tune the behaviour of a coupled system by passive 
transcriptional regulation between sigma factors. During the course of this chapter we 
encountered another source of variability – batch-to-batch differences in the TX-TL mixtures. 
This is an important source of variability as the rates of individual reactions, protein yields 
have been known to vary across different batches of TX-TL mixtures29. It is due to this 
variability that the oscillating regime for the σ28-oscillator do not match between the previous 
and current chapters. Hence, our mathematical analysis is valid for a given batch of TX-TL 
mixture and needs to be repeated in order to characterise networks for new TX-TL mix batches. 
We also found that our theoretical approach is able to qualitatively predict the dynamics of 
each gene of our network and effects of network modifications, however the lack of 
mechanistic detail hampers its predictive ability. Moving forward we envision to use aptamers 
to gain insight into the kinetics of mRNA30 production in such networks and take into account 
resource utilisation31 in TX-TL systems to improve our model and experiments such that we 
can make accurate quantitative predictions to engineer complex genetic networks. 
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4.5 METHODS 
Preparation of DNA templates: PCR for linear DNA templates was performed using Phusion 
High-Fidelity DNA Polymerase from ThermoFisher Scientific. PCR was carried out in a 
thermocycler according to the manufacturer’s protocol. DNA templates were purified using 
QIAGEN PCR purification kits and concentrations were measured using a Nanodrop. P19-C1-
ssra template was ordered from IDT as a gBlock fragment. All other DNA templates for this 
study were obtained from Arbor Biosciences. The sequences for the DNA constructs are shown 
in the appendix. 
Preparation of Cell Lysate: The energy mixture and cell lysate were prepared using protocols 
described previously by Sun et al.29 and Caschera et al.32. Briefly,  BL21 Rosetta2 cells were 
grown to an OD600 of 1.8 in LB medium supplemented with a phosphate buffer (0.22 M Sodium 
dihydrogen phosphate and 0.4 M Disodium hydrogen phosphate, pH 7) . The cells were washed 
with S30A buffer (14 mM Magnesium glutamate, 60 mM Potassium glutamate, 2 mM DTT, 
titrated to pH 8.2 with Tris-base). The pellet was resuspended in S30A buffer in a volume equal 
to 0.8 times the cell pellet weight and passed through a cell press at 16000 lb. The extract was 
spun down from which the supernatant was collected, incubated at 37 °C, dialysed in S30B 
buffer (14 mM Magnesium glutamate, 150 mM Potassium glutamate, 1 mM DTT, titrated to 
pH 8.2 with Tris-base) and aliquoted. The density of the cell lysate was determined to be 40 
mg/mL using the Pierce BCA assay.  
TX-TL Reaction Set Up:- The Energy Mixture was added to the cell lysate along with 3 uM 
GamS, 3% w/v PEG-8000 , 6 mM Magnesium Glutamate and 80 mM Potassium Glutamate to 
obtain the TX-TL reaction mixture. The final concentrations were 11 mg/mL cell lysate, 50 
mM Hepes (pH 8.0), 0.9 mM cytidine triphosphate and uridine triphosphate, 1.5 mM each of 
adenosine triphosphate and guanosine triphosphate, 0.5 mM of each amino acid, 1 mM 
spermidine, 0.75 mM cyclic adenosine monophosphate, 0.33 mM nicotinamide adenine 
dinucleotide, 0.26 mM coenzyme A, 30mM 3-phosphoglyceric acid, 0.067 mM folinic acid, 
0.2 mg/ mL tRNAs. For batch TX-TL reactions the DNA templates and necessary volume of 
MQ H2O were added and mixed well. 10 μL of the final reaction solution was pipetted into a 
Nunclon 384 well plate and the deGFP fluorescence was measured using a Tecan M200 Infinite 
Plate-reader. GamS was prepared using protocols described previously by Sun et al33. 
During the steady-state TX-TL experiments, microfluidic devices were placed within an 
incubator set to 30°C. The TX-TL reaction mixture, was stored within a water-cooled Peltier 
element, maintained at 4°C. A short piece of tubing was used to connect the Peltier element to 
the microfluidic device allowing for the injection of the cooled TX-TL mix into the device. 
The remaining reaction components (i.e. MQ H2O and DNA solutions) were stored in Tygon 
tubing (0.02” ID, 0.06” OD) which was inserted directly into the microfluidic device. These 
solutions were maintained at 30°C for the entirety of the experiment. Over the course of the 
experiments, fluorescence images were periodically captured using an inverted microscope 
(Nikon Eclipse) to monitor the fluorescence within the microfluidic reactors. Fluorescence was 
determined from the obtained images using MATLAB software. Amplitude of sustained 
oscillations were determined by measuring the difference between the fluorescence maxima 
and minima of the final two oscillations in the steady-state TX-TL experiments. 
Fabrication and Design of Microfluidic device: The microfluidic devices used throughout 
this research were based on designs published by Niederholtmayer et al34, and were 
manufactured according to previously described protocols.   
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Chapter 5 :- Bottom-up reconstitution of E. coli 
from its constituent components  
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5.1 INTRODUCTION 
A major scientific challenge of the 21st century is the construction of an artificial cell. It is an 
endeavour which straddles the philosophical and scientific world, because it can open avenues 
for numerous biomedical, chemical, biophysical applications and at the same time  answer vital 
questions on the origins of life. Broadly speaking, there are two scientific routes to achieve this 
goal – a top-down and a bottom-up route (Figure 5.1). The former approach consists in taking 
a living cell and reducing its complexity step by step until a minimal functional life-form is 
reached. The best example of this approach comes from the Venter group. Relying on powerful 
molecular biology techniques such as Gibson assembly1 and nuclear transplantation2, they 
engineered two synthetic genomes -  592 kbp M. genitalium genome3,4 and the 1079 kbp M. 
mycoides genome (JVCI-syn1.0)5, the latter of which was transplanted into an ‘empty’ M. 
capricolum cell to generate a viable minimal cell with a synthetic genome. JCVI-syn1.0 
genome was further minimized using a combination of transposon mutagenesis data6 and 
multiple cycles of designing, building and testing several candidates to obtain a 531 kbp 
minimal genome. The minimal genome (JCVI-syn3.0) consisted of 493 genes for different 
functions such as metabolism, cell division, transcription, translation etc. and when 
transformed in an empty chassis gave rise to viable cells7. While their efforts are great feats of 
genetic engineering, the drawback is that it does not greatly enhance our understanding of life 
or the role of its constituent components. Their approach lacks control over the different 
components what constitutes a living system and as a result while they have reached the goal 
of constructing a minimal system we are left with more questions than answers. For example, 
despite successfully minimising the genome, Hutchinson III et al. found that  in JVCI-syn3.0, 
79 out of 493 genes could not be assigned a functional category7.   
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Figure 5.1 Schematic showing the two approaches to constructing an artificial cell- top-down and bottom-up 
approaches. The former relies on reducing the complexity from a living organism and the latter relies on increasing 
complexity starting from basic biomolecules. Adapted from Sundmacher and Schwille.8 
In contrast, the bottom-up approach relies on the assembly of cellular components toward an 
increase in complexity until an out-of-equilibrium system is reached which is capable of self-
reproduction or at the very least the execution of a molecular ‘program’ encoded in a synthetic 
DNA9. While this approach has not met with as much success as the top-down approach, it 
offers a way to learn by building i.e. the step-wise assembly of each component sheds more 
light on the role and functioning of said component in the cell10,11. The cellular components 
needed to construct such an ‘artificial cell’ can be classified into :- container (the physical 
boundary that makes the container and other self-assembly processes), cytoplasm (crowded 
cellular environment) and information (DNA software to program the ‘artificial cell’) (Figure 
5.2). 
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Figure 5.2 (a) The three categories of biomolecules necessary to for the bottom up construction of an artificial 
cell – Cytoplasm, Container and Information. Figure adapted from Caschera et al.9  (b) Artistic impression of a 
cross-section of E. coli. The cell envelope is shown in green, the cytoplasm in purple and blue, and the nucleoid 
in yellow and orange. Illustration courtesy David S. Goodsell 
Cell-free protein synthesis (TX-TL) systems have been shown to emulate the cellular 
environment of E. coli and have been useful in carrying out protein synthesis, implementing 
genetic networks in vitro12–15. The group of Vincent Noireaux used TX-TL systems for the in 
vitro synthesis of viable, self-assembling viruses (MS2 (3.6 kbp, 4 genes), T7 (40 kbp , 57 
genes), T4 (170 kbp, 289 genes) and ФX174 (5.6 kbp , 11 genes)) in one-pot TX-TL 
reactions16–18. The group of Michael Jewett synthesised the necessary rRNA and almost all of 
the corresponding proteins to form a functional synthetic ribosome they term iSAT and 
investigated the influence of macromolecular crowders on its functionality19–21. TX-TL 
systems have also been used to demonstrate change in transcriptional profile caused by the 
localisation of gene expression in diffusion-limited environments due to the influence of 
crowders22,23. Hence, due to their versatility, TX-TL systems have become valuable platforms 
for synthetic biology and a primary choice to construct artificial cells.  
The use of liposomes – self assembled phospholipid vesicles – has seen a significant interest 
as an ideal container in the quest to construct artificial life24,25. Biological processes such as 
RNA replication, viral DNA replication,  protein synthesis from TX-TL and organization of 
cellular division machinery have all been demonstrated inside liposomal compartments thereby 
highlighting their usefulness and versatility17,26–32. However, all examples of programming 
liposomes with biological function relies on linear/plasmid DNA to encode information. In 
bacteria the genetic material of cells is tightly packed and organised as a region inside the 
cytoplasm called the nucleoid which consist of chromosomal DNA and nucleoid associated 
proteins (NAPs)33. Recently, Fujiwara et al. demonstrated the mRNA and protein production 
from the genome of T. thermophilus in an E. coli TX-TL system, thereby recapitulating the 
expression profile of rapidly dividing cells in a TX-TL system34. Furthermore, bacteria use the 
nucleoid not only as a template for protein synthesis but also to regulate gene expression 
through physicochemical effects such as nucleoid compaction35–37. 
To summarize, there has been plenty of work conducted on generating the necessary tools 
needed for the bottom up construction of artificial cells but there have been no concerted efforts 
in bringing these components together to integrate them into a single system in order to 
reconstitute, partially if not completely, an E. coli cell. To this end, we relied on transplanting 
an E. coli nucleoid – equipped with a construct to produce a heterologous gene – into an 
artificial system consisting of TX-TL reaction mixture encapsulated in liposomes. Nuclear 
transplantation is a technique used to program enucleated (nuclei-removed) cells by 
transferring nuclei from donor cells38 and has also been used by Venter and colleagues to 
introduce synthetic and natural genomes inside ‘empty’ bacterial cells in the works mentioned 
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previously. Therefore, our goal is to assemble a synthetic system which can integrate and boot 
up the three facets of an artificial cell – information, cytoplasm and container. As a first step, 
we would follow the production of a heterologous reporter protein from genomic DNA, thereby 
obtaining a proof-of-concept for the bottom-up construction of an artificial cell. To this end, 
we focussed our efforts on establishing a microfluidic platform which can produce 
monodisperse, multi-compartment liposomes compatible with TX-TL systems and tools to 
visualise mRNA and protein production, optimising a nucleoid extraction protocol from E. coli 
and engineered the nucleoid with a reporter gene to use it as a template for protein production 
in encapsulated TX-TL systems. Furthermore, the ability to control and modify the key 
components of an artificial cell will improve the understanding of the role played by different 
biomolecules of a cell and open avenues to research biophysical questions pertaining to 
chromosomal compaction, or transcription and translation in a densely crowded and 
membrane-restricted volume. 
5.2 RESULTS AND DISCUSSION 
5.2.1 Microfluidic platform for liposome production 
Since conventional methods to synthesise liposomes such as extrusion, electro-formation, 
reverse phase evaporation etc. result in low yields, polydisperse liposomes which show 
inefficient encapsulation we implemented a microfluidics-based method to produce stable, 
monodisperse liposomes39–43. We prepared liposomes from double emulsions using a 
surfactant-assisted microfluidic strategy. W/O/W double emulsion drops were prepared in a 
glass capillary microfluidic device (Figure 5.3a). The inner water phase (W1), middle oil phase 
(O) and outer water phase (W2) consisted of an aqueous solution with 8.0 % (w/v) polyethylene 
glycol (PEG) and 2.0 % (w/v) poly(vinyl alcohol) (PVA), a mixture of chloroform and hexane 
(40:60, v/v) containing 1.0-5.0 mg/mL L-α-phosphatidylcholine (egg PC), and a 10.0 wt % 
PVA and 0.1-5.0 wt % F-68 solution, respectively. PEG and PVA were used to improve 
emulsion preparation and stability. The key to the successful formation of monodisperse, stable 
and structured liposomes is control over the dewetting process. We used a triblock copolymer 
surfactant, Pluronic F-68, to adjust interfacial energies in the W/O/W emulsion system to 
ensure the complete dewetting and formation of oil-free liposomes. The oil shells gradually 
dewetted from the interior drops within 15 min at a concentration of 0.3 wt % F-68, ultimately 
forming completely separated liposomes and oil drops with excess lipids (Figure 5.3b). Once 
the oil is expelled from the shell the two lipid monolayers stick together forming a lipid bilayer 
membrane. The dewetting process and formation of liposomes were observed by adding 
fluorescein isothiocyanate-dextran (FITC-Dextran) in the inner phase (Figure 5.3c).   
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Figure 5.3 (a) Preparation of W/O/W double emulsions in a microcapillary-based device. Time-series of (b) 
bright-field and (c) fluorescenceconfocal images of the complete dewetting process with liposomes separating 
from residual oil droplets. W1, W2 and O stand for inner water phase, outer water phase and oil phase, 
respectively. Scale bars are 100 μm. Liposomes contain FITC-Dextran shown in green. (in collaboration with 
Nannan Deng). 
This surfactant-controlled strategy to form a large number of the oil-free monodisperse 
liposomes with high encapsulation efficiency provides an excellent platform to implement cell-
free transcription and translation (TX-TL) reactions. Prior to encapsulating TX-TL in 
liposomes we investigated the compatibility of our liposome-production technique with TX-
TL reactions. In particular, we tested the effect of residual solvents (mixture of chloroform and 
hexane (36:64, v/v)) on protein expression in TX-TL reactions. To this end, we performed 
batch TX-TL reactions , expressing deGFP from a plasmid, in the presence and absence of 
presence of residual solvents (Figure 5.4a). Despite the 25% drop in yield as compared to 
reactions without solvents, our results show that gene expression is feasible even at relatively 
high concentrations of organic solvents. We proceeded to encapsulate liposomes with TX-TL 
reaction mix along with the plasmid coding for deGFP serving as the inner water phase (Figure 
5.4b). The fluorescence intensity of deGFP in liposomes notably increased from 0 to 35 min 
and to 150 min. In the first hour, the fluorescence signal increased linearly and reached a 
plateau after three hours of expression due to the exhaustion of nutrients in the TX-TL mix. 
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Moreover, the fluorescence intensity increase is similar for all liposomes at the same incubation 
time (Figure 5.4 c, d and e).  
           
Figure 5.4 (a) TX-TL reaction showing effect of solvent (chloroform/hexane) on deGFP production from 2 nM 
of plasmid DNA. (b-e) Encapsulated TX-TL reactions in liposomes. Sequence images show expression of eGFP 
inside the liposomes. (in collaboration with Nannan Deng) 
The primary tool for visualisation of the TX-TL process is usually proteins – either fluorescent 
or luminescent. In order to expand our toolbox of genetic elements, we implemented a readout 
at the mRNA stage and verified the compatibility of such a tool with our liposome platform. 
Among the available methods to visualise mRNA production such as molecular beacons22,44, 
binary probes45 and aptamers – we chose the Spinach2 aptamer because of its ease of use and 
previous successful implementations of aptamers in in vivo conditions and TX-TL 
systems21,46,47. An aptamer is an mRNA structure which can bind a ligand. Upon binding of 
said ligand (in this case, 5-difluoro-4-hydroxybenzylidene imidazolinone (DFHBI)), its 
spectral properties are changed and it emits light in the green region (λmax excitation = 447 nm 
and λmax emission = 501 nm). We expressed the Spinach2 aptamer from a 532 basepair (bp) 
dsDNA (double stranded DNA) which is controlled by a PT7 promoter (under the control of T7 
RNA Polymerase (RNAP)) and a TT7 terminator. Embedded in the sequence is a tRNA scaffold 
to increase stability of the aptamer when expressed47. Before its implementation in liposomes 
we optimised the functioning of the Spinach2 aptamer in batch TX-TL conditions as a stand-
alone tool for mRNA detection and in conjugation with a fluorescent protein in order to detect 
mRNA and proteins simultaneously. We investigated the effect of solvents (chloroform and 
hexane) on the Spinach2 functioning prior to encapsulating in liposomes in In Vitro 
Transcription (IVTx) reactions (Figure 5.5a). Unlike the TX-TL reaction, chloroform/hexane 
did not have any effect on the yield or the functioning of Spinach2. This result, along with 
Figure 5.4a, indicate that the solvents interfere with cell-free protein synthesis presumably at 
the translation level and/or protein folding and maturation. In order to visualise mRNA and 
protein simultaneously, we cloned an mRFP gene upstream of the Spinach2 sequence (λmax 
excitation = 584 nm and λmax emission = 607 nm). Since Spinach2 emits light in the green 
region, we incorporated a protein that fluoresces in a non-green region. We found that this 
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construct was able to produce detectable levels of mRFP and Spinach2 in batch TX-TL 
reactions (Figure 5.5b). However, in contrast to IVTx reactions, the fluorescence of Spinach2 
reaches a maximum and decreases over time. We attribute this to the presence of nucleases in 
the lysate which affect the production and stability of the mRNA. 
      
 
Figure 5.5 (a) IVTx from Spinach2 with and without solvents (chloroform/hexane) (b) Batch TX-TL reactions 
with different concentrations of  PT7-mRFP-Spinach2-TT7 constructs showing expression of mRFP and Spinach2 
We proceeded to encapsulate the IVTx mix in single liposomes to demonstrate the 
compartmentalised synthesis of the Spinach2 mRNA (Figure 5.6a). As Figure 5.6a shows the 
fluorescence intensity of Spinach2-DFHBI in liposomes notably increased from 0 to 60 min 
and up to 120 min in the encapsulated IVTx. After two hours of expression, the fluorescence 
signal reached a plateau due to the depletion of nutrients. We proceeded to increase the 
complexity of the liposomes by embedding the single liposomes into larger liposomes thereby 
generating a cell-like architecture resembling the eukaryotic cell, with the inner liposome 
serving as the ‘nucleus’. Liposomes containing IVTx mix expressing Spinach2 aptamer were 
generated and fed into the larger droplets containing TX-TL mix along with the plasmid coding 
for monomeric red fluorescent protein (mRFP) (Figure 5.6b). mRNA was successfully 
expressed inside the ‘nucleus’ liposomes and mRFP in the ‘cytoplasm’ as shown in Figure 
5.6c. Furthermore, such liposome-in-liposome structures were found to be stable for more than 
eight hours. These results highlight the usefulness of the liposome platform and TX-TL 
components in the bottom up-construction of cellular architectures. 
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Figure 5.6 (a) Schematic showing in situ production of IVTx inside the liposomes. Sequence of images showing 
synthesis of Spinach2 mRNA in the liposomes detected using the ligand DFHBI. (b) Schematic of the microfluidic 
preparation of double emulsions with an inner liposome. (c) Independent encapsulation of IVTx mix into interior 
liposomes and TX-TL mix within the exterior liposomes. (in collaboration with Nannan Deng) 
5.2.2 Engineering E. coli nucleoid with heterologous reporter gene 
Having established a reliable platform to produce monodisperse liposomes which is compatible 
with TX-TL we next optimised the final component of our ‘artificial cell’ – the nucleoid. We 
decided to isolate the nucleoid from E. coli cells and add it to a compartmentalised TX-TL 
reaction mixture to verify if such a platform could stimulate protein synthesis from the 
nucleoid. In order to observe protein production, we incorporated a PT7-deGFP-TT7 construct 
into the nucleoid using CRISPR-Cas according to the protocol of Jiang et al.48. Briefly, the 
system works as follows :- a single guide RNA (sgRNA) guides the Cas9 endonuclease to a 
specific site on the genomic DNA, where it induces a double strand break (DSB). The sgRNA 
consists of a segment that associates with the Cas9 protein, called the scaffold, and a ‘feeler’ 
of 20 nucleotides which is complementary to the target DNA that is to be edited. This target 
sequence needs to be flanked by a Cas9-specific Protospacer Adjacent Motif (PAM) of 3 
nucleotides at the 5’ end (5’-NGG-3’ in the case of Cas9). When the Cas9 and the correct 
sgRNA are expressed, these automatically associate to form the complex that can induce a 
strand break at the site specified by the sgRNA. λ Red aids in the insertion of the heterologous 
gene using Homology Directed Repair (HDR). This mechanism is realised as a two plasmid 
system – pCas and pTargetF (pTF) (Figure 5.7). The former plasmid codes for the Cas9 protein 
and the λ Red proteins and the latter contains the sgRNA coding for the PAM which guides the 
location in the genome to be modified. The first round of transformation involves transforming 
the BL21 DE3 cells with pCas vector. Next, the pTargetF and the linear dsDNA coding for the 
insert sequence are electroporated into the cell. When induced with L-arabinose, the Cas9 and 
λ Red proteins are produced from pCas and along with the expressed sgRNA from the pTF 
inserts the desired sequence coded by the dsDNA into the genome. The pCas and pTF vectors 
can be kicked out of the cells by growing the culture at 370C and the linear dsDNA is degraded 
by the cells. 
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Figure 5.7 Schematic outlining the mechanism and the protocol of heterologous gene insertion into E.coli using 
CRISPR-Cas. Day 1: transforming pCas into chemically competent BL21(DE3). Day 2: co-electroporating pTF 
and donor dsDNA into electrocompetent BL21(DE3) pCas, which has been grown in the presence of L-arabinose 
to induce λ Red expression. pCas and pTF together express the CRISPR/Cas9 components that induce a DSB, 
after which the λ Red proteins assist in HDR with the degfp gene flanked by two homologous arms as the donor 
template. Day 3: curing of pCas and pTF by growing the bacteria in liquid medium at 37°C overnight which 
removes the plasmids from the cell. (in collaboration with Ludo Schoenmakers). 
Although CRISPR/Cas9 proteins can introduce the DSB in any location which is four base 
pairs (bp) removed from a PAM, it is unwise to introduce the construct between a functional 
gene or operon in the genome, lest it affects cellular function. Moreover, since E. coli has very 
little ‘junk’ DNA in its genome, there are a limited number of sites over 1 kilobasepair (kbp) 
in length where an exogenous genetic construct can be incorporated without affecting the rest 
of the bacterial chromosome. Our analysis revealed three potential target sites (TS) to 
incorporate the deGFP construct as shown in Table 5.1.  
 
EscherichiacoliBL21DE3Uid161947 
TS Coordinates 
(kbp) 
Length 
(kbp) 
Neighbouring genes Functions of neighbouring genes 
2 548 550 2.0 nohB ECB_0513 unknown prophage DNA 
packing protein 
7 1,545.5 1,548 2.5 ydeT yneL putative OMP unknown 
16 4,410 4,411.5 1.5 yjgW yjgZ phage-like 
element 
phage-like 
element 
 
 
       
Table 5.1 Table containing the introns between genes in E. coli BL21(DE3). Each row represents an intron, with 
the approximate coordinates, intron length, intron neighbouring genes and their functions provided in the different 
columns. The target sites that were eventually selected are indicated in green: TS2, TS7 and TS16. This table is 
based on the E. coli BL21 (DE3) reference genome EscherichiacoliBL21DE3Uid161947 obtained from the USCS 
genome browser, which downloads the genome from the NCBI assembly database.  Gene functions were searched 
in UniProt and EcoliWiki (in collaboration with Ludo Schoenmakers). 
Upon transformation, colonies were obtained for sites TS7 and TS16 while attempts to 
incorporate into site TS2 resulted in a poor efficiency and low number of transformed colonies. 
indicating that TS2 is present in a poorly accessible site of the bacterial chromosome. 
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Successful insertion of the construct was verified by colony PCR.  In order to test for function, 
cultures containing the construct at TS7 and TS16 were grown to stationary phase overnight, 
incubated with IPTG (400 μM), and a sample was taken every hour and observed under the SD 
microscope (Figure 5.8). IPTG was added to induce protein production because the genome of 
E.coli BL21 DE3 cells has a copy of the T7 polymerase gene under the regulatory control of 
IPTG. Upon induction, both strains exhibited fluorescence before IPTG has been added (T=0), 
and after adding IPTG, the intensity increased with each hour. 
           
 
Figure 5.8 Overnight culture of E. coli BL21(DE3) containing the PT7-deGFP-TT7 inserted at TS7 and TS16 
induced with 400 μM IPTG. Samples were taken every hour for three hours and were imaged under Sp8 
microscope (in collaboration with Ludo Schoenmakers).  
5.2.3 Nucleoid isolation and encapsulation  
Having engineered a nucleoid that can express a heterologous protein in vivo, we next 
optimised a protocol for the isolation and purification of E. coli nucleoids to test for 
heterologous protein production in vitro. We followed an osmotic shock-based procedure to 
isolate the nucleoids (Figure 5.9a). The three main steps in this method are : plasmolysis 
(shrinking of the cell cytoplasm due to a loss of water), breaking of the peptidoglycan layer 
with lysozyme (final concentration of 1 mg/mL) to form spheroblasts and hypotonic shock 
using 10 mM NaPi (refer Methods), which breaks the spheroblasts to release the nucleoids49,50. 
Once the nucleoids were isolated, they were purified to remove cellular debris using a 
continuous sucrose gradient51. Samples of one millilitre were taken from the sucrose gradient 
and stained with SYTOX orange to visualise the nucleoids. Millilitres eight though twelve of 
the sucrose gradient contain aggregates in the fluorescent images and debris visible in the bright 
field images. The third and seventh millilitres contain the most nucleoids without aggregates 
or debris. These samples were stored at -80°C where they were found to be stable up to a week 
(Figure 5.9b). 
T= 0 T= 1h T= 2h T= 3h 
TS7 
TS16 
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Figure 5.9 (a) Schematic representation of the three main steps in the nucleoid isolation process: plasmolysis, 
lysozyme-addition and liberation of the nucleoid by osmotic shock. Figure adapted from the master thesis of 
Elenora Bailoni. (b) Fluorescence and bright-field images of the 3rd till the 12th mL of an 18 mL sucrose gradient 
stained with SYTOX orange. Most nucleoids without debris can be found in millilitres 3 and 7, while the millilitres 
afterwards contain increasing amounts of debris and aggregates (in collaboration with Ludo Schoenmakers and 
Marta Delga). 
 
We next attempted to perform an TX-TL experiment using the nucleoids to check for deGFP 
expression (Figure 5.10). In order to evaluate our isolation and purification protocol, we 
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performed TX-TL reaction with a sample from each step of the process namely : live cells, 
Lysozyme treatment, and a 1:100 (v/v) NaPi dilution. Additionally, the experiment was 
performed by the addition of purified T7 polymerase (Figure 5.10a (i)-(iii)) or induction with 
IPTG (Figure 5.10b (i)-(iii)). Live cells showed fluorescence in the presence of IPTG but not 
with purified T7 polymerase because only IPTG can permeate the membrane of cells to induce 
protein production (Figure 5.10 a(i) and b(i)). Fluorescence signal was observed from 
Lysozyme-treated samples from both T7 RNA polymerase addition and IPTG induction as the 
breaking of the peptidoglycan layer permits the entry of T7 polymerase into the spheroblasts 
(Figure 5.10 a(ii) and b(ii)). The fluorescence signal disappeared in the samples obtained after 
NaPi dilution (Figure 5.10 a(iii) and b(iii)). This indicates that the fluorescence observed in 
Figures 5.10 a(i)-(ii) and b(i)-(ii) are from nucleoids present in cells and not from isolated and 
purified samples.  
    
Figure 5.10 Effect of (a) (i)-(iii) T7 RNA polymerase (100 nM) and (b) (i)-(iii) IPTG (400 µM) on samples from 
the different nucleoid isolation steps in TX-TL reactions: (i) the frozen pellet dissolved in LB medium (Bacteria); 
(ii) resuspension in sucrose buffer and incubation with lysozyme (Lysozyme); (iii) NaPi 1:100 dilution. 5 μl from 
each step was added to the complete TX-TL mixture. (inset in b(ii) shows the complete graph of protein 
expression) (in collaboration with Ludo Schoenmakers). 
 
Despite the lack of expression in batch TX-TL experiments from isolated nucleoids, we asked 
if compartmentalisation of TX-TL with nucleoids in liposomes could produce proteins due to 
an increase in local concentrations of the components44,52–54. Prior to encapsulating TX-TL mix 
with nucleoids, we tested the compatibility of our liposome platform with the nucleoids. We 
encapsulated the nucleoid solution alone in liposomes with 8% PEG and 2% PVA serving the 
inner phase, to observe  the formation of stable liposomes with nucleoids visible as bright red 
spots (Figure 5.11a). Having previously verified the compatibility of TX-TL mixtures and 
liposomes for gene expression (Figure 5.4), we proceeded to encapsulate both degfp-nucleoids 
in liposome with TX-TL mix as the inner phase in order to integrate the three major tenants of 
artificial cell. Upon encapsulating the system we observed multiple red spots inside the 
liposomes indicating the successful encapsulation of the TX-TL mixture and nucleoids. 
Although these structures were stable for nearly four hours (Figure 5.11b) we did not observe 
any deGFP production inside the liposomes (data not shown). In order to bring the size of our 
liposomes to cell-sized dimensions, we proceeded to reduce the size of the liposome by 
applying a hypertonic shock using 2M sucrose which also increases local concentrations of 
important biomolecules involved in transcription and translation process which could result in 
better yields from nucleoids (Figure 5.11c). While the shrinkage of liposomes resulted in more 
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cell-like features – such as the presence of a single bright spot of nucleoid DNA – deGFP 
expression was still absent. Fujiwara et al. observed protein expression from TX-TL using 
bacterial genomes to be quite inefficient34. Hence, it is possible that there is production of 
reporter protein but the expression is quite low and therefore the amount of actively fluorescing 
protein is quite low. Therefore, while we have established the necessary tools to produce 
synthetic systems with cell-like architectures by integrating E. coli components, further 
optimizations are required to engineer a system capable of producing detectable amounts of 
heterologous reporter protein. 
                    
Figure 5.11 (a) Fluorescence and bright-field images of liposomes containing encapsulated nucleoid DNA (red) 
stained used SYTOX orange (white arrows point to liposomes containing nucleoids). Oil drops are in green. (b) 
Fluorescence and bright-field images of liposomes containing encapsulated nucleoid DNA and TX-TL mix. (c) 
Fluorescence and bright-field images of liposomes containing encapsulated nucleoid DNA and TX-TL mix after 
hypertonic shock. Nucleoids are stained used SYTOX orange (shown in red). 
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5.3 CONCLUSION 
Moving forward, we aim to optimise the conditions to achieve protein expression from our 
synthetic cells. Firstly, in our lab we have developed methods to control the area and volume 
of double emulsions55. This allows us to increase the local concentrations of components nearly 
seven-fold thereby allowing the increase of rates of protein production from encapsulated TX-
TL mixtures which will help improve protein expression from nucleoids as well. Secondly, 
using fluorescent proteins is an inefficient choice for readout as their efficiency depends not 
only on production but maturation as well. We plan to replace the fluorescent protein with an 
enzyme – such as β-galactosidase or luciferase – in future works as relatively lower quantities 
of enzymes are enough to convert their respective substrates thereby serving as a better readout 
from TX-TL using nucleoids. To summarize, in this chapter we have described the 
development and integration of tools such as liposomes, TX-TL mix and engineered nucleoids 
which – together with necessary optimisations – can help in the engineering of an artificial cell 
in a controlled bottom-up fashion.  
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5.5 METHODS 
Bacterial strains and cultivation: The bacterial strains used in this project are E. coli DH5α, 
E. coli XL1-Blue, and E. coli BL21(DE3). E. coli DH5α contained the plasmids delivered from 
addgene and was cultured under standard conditions.. Chemically competent E. coli XL1-Blue 
was used for transforming the pTF plasmid for a given target site. It was cultured under 
standard conditions with the addition of spectinomycin (50 μg/ml) or streptomycin (50 μg/ml) 
to the LB agar plates selecting for successful transformants. E. coli BL21(DE3) was used for 
gene editing. Chemically competent E. coli BL21(DE3) was used for transforming pCas, and 
grown at 30°C on kanamycin (50 μg/ml) LB agar plates. Electrocompetent E. coli BL21(DE3) 
pCas was used for co-electroporation with pTF and donor DNA. These were cultured on 
kanamycin (50 μg/ml), spectinomycin (50 μg/ml), and kanamycin + spectinomycin (both 50 
μg/ml) plates at 30°C. 
Plasmids and DNA: The original pCas and pTF plasmids were obtained from addgene, 
reference number #62225 and #62226 respectively. The pTF plasmid was modified using 
standard molecular biological techniques. Briefly, pTF was digested with restriction enzymes 
SpeI (New England Bioscience) and EcoRI (New England Bioscience) at two unique sites, and 
gel purified using a standard kit (QIAgen). The new insert was prepared in the same way. 
Vector and insert were ligated at 37°C for 2 hours by T4 DNA ligase (Thermo Fischer 
Scientific), and transformed into chemically competent E. coli XL1-Blue. Donor DNA 
consisted of a T7 RNA polymerase promoter, the egfp gene, and a T7 RNA polymerase 
terminator, flanked by two ~300 bp homologous arms, obtained from IDT. PT7-deGFP-TT7 was 
obtained from pRSET-deGFP plasmid – a kind gift from David Foschepoth. PT7-Sp2-TT7 was 
ordered from IDT as a gBlock fragment. mRFP-Sp2 sequence was ordered from IDT as a 
gBlock fragment and cloned into pRSET vector using Gibson Assembly. All sequences are 
shown in the appendix. 
Competent Cells: Chemically competent (CC) cells were prepared according to the following 
protocol. E. coli BL21(DE3) cells are grown to an OD600 of 0.4 in a large volume of LB, and 
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chilled in ice-water for 15 minutes. The cells are pelleted at 3500 RPM for 15 minutes at 4°C 
and very gently resuspended in one-fifth of the original volume of transformation buffer I on 
ice (TBFI) (30 mM CH3COONa, 50 mM MnCl2 (Merck), 100 mM KCl (Merck), 10 mM CaCl2 
(Merck), and 15 vol% glycerol). Next, the cells are pelleted at 4500 RPM for 15 minutes at 
4°C and very gently resuspended in about one-fourteenth of their initial volume of 
transformation buffer II on ice (TBFII) (10 mM Na MES buffer at pH 7.0, 75 mM CaCl2, 10 
mM KCL, and 15 vol% glycerol). Aliquots are flash frozen in liquid nitrogen and stored at -
80°C. Electrocompetent (EC) E. coli BL21(DE3) cells were prepared using the following 
procedure. Cells are cultured under the required conditions (antibiotic, inducers, et cetera) in 
LB medium to an OD600 of 0.6, and cooled down in ice-water for 15 minutes. Subsequently, 
cells are spun down at 5000 RPM for 10 minutes at 4°C, the supernatant is discarded, and the 
remaining liquid is aspirated off. The pellet is redissolved in the same volume of ice-cold 10% 
glycerol solution and spun down again. This washing step is repeated once more before the 
cells are resuspended in the liquid that remains after the supernatant is poured off, and either 
flash frozen in liquid nitrogen to store at -80°C, or used immediately.   
Genome editing protocol: The editing procedure used in this project is based on the two-
plasmid system from Jiang et al 48. Briefly, pCas (100 ng) is transformed into chemically 
competent E. coli BL21(DE3). This strain is cultured in the presence of 10 mM L-arabinose to 
induce λ Red expression, and grown to an OD600 of 0.5. At OD600 0.5, 10 ml culture per 
transformation attempt is prepared for electroporation by repeated washing in ice-cold 
sterilised milliQ (see section 2.6, third protocol). Next, pTF (100 ng) and donor DNA (400 ng) 
are co-electroporated into the electrocompetent E. coli BL21(DE3) pCas cells, plated, and 
grown at 30°C overnight. Successful insertion was checked by a genomic colony PCR against 
the new insert, IPTG induction (400 μM) and observation under the SD microscope, and IPTG 
induction (400 μM) in an Infinite M200 Pro plate reader (Tecan).  
Nucleoid Isolation: First, E. coli cells are grown in 250 ml LB medium to an OD600 of 0.7. 
The culture was split in 25 ml batches and centrifuged at 5000 RPM, 4°C, for 10 minutes. The 
supernatant is poured off and cells are resuspended in 1 ml LB, and transferred to a 2-ml tube. 
The cells were centrifuged again at 5000 RPM for 10 minutes, and the supernatant is poured 
off. The remaining liquid is aspirated off and the pellets are stored at -80°C without flash 
freezing. To isolate the nucleoids, a pellet is taken from the -80°C, thawed briefly at room 
temperature, and resuspended thoroughly in 1 ml sucrose buffer (0.58 M sucrose (J.T. Baker), 
100 mM NaCl (Merck), 10 mM Na2HPO4/NaH2PO4 (Merck), with or without 10 mM EDTA). 
After 15 minutes incubation at room temperature, lysozyme is added till a final concentration 
of 1 mg/ml. The suspension is inverted thrice and incubated for 5 minutes at room temperature. 
Next, 1 ml of NaPi buffer (10 mM Na2HPO4/NaH2PO4 at pH 7) is added, the solution is mixed 
well and incubated at room temperature for a few minutes. Finally, the solution is layered onto 
a continuous sucrose gradient made with a gradient-maker using a 12% and 60% filtered 
sucrose solution (12/60 % sucrose, 100 mM NaCl, 10 Na2HPO4/NaH2PO4, with or without 10 
mM EDTA). The gradient plus suspension is centrifuged in a swing-out rotor at 8000 RPM, 
4°C, for 10 minutes. After centrifugation, the bottom of the solution should contain a cloud-
like suspension, while the rest of the solution is clear. Nucleoids can be found in the 3rd ml till 
the 12th ml of gradient counted from the top. Most nucleoids appear to be present in the 6th or 
7th ml. The nucleoids were stained SYTOX Orange (Life Technologies). 
Imaging techniques: Microscopic images were obtained either using a SP8x confocal 
microscope (Leica Microsystems), or with a spinning disk (SD) microscope (Andor IXon3 
laser, Yokogawa CSU X1 spinning disk, Olympus IX81 microscope). Images on the SP8x were 
captured with the accompanying LAS X software. Images on the SD microscope were captured 
with Andor IQ2. Images of double emulsions, of the dewetting process, and of liposomes were 
obtained using a Phantom camera from Vision Research, mounted on an Olympus IX72 
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microscope.  These images were captured either with Vision Research Phantom camera control 
or Phantom PCC software. 
Preparation of Liposomes: A round boro glass capillary (CM Scientific) with an inner 
diameter of 400 µm is pulled apart into two fine-pointed capillaries using a Model PN-31 glass 
capillary puller (Narishige). These two fine-point capillaries are grinded until the inner 
diameters of the orifices are between 40 – 80 and 60 – 120 µm. Subsequently, the two 
capillaries are aligned coaxially under an Olympus CKX41 microscope, with each orifice 
opposite each other in a square boro glass capillary that has been secured to a glass slide (VWR) 
with epoxy glue (Bison). Finally, inlets are constructed out of Fine-ject needles (Henke Sass 
Wolf), which serve as connectors for the tubing feeding in the various solutions needed to 
prepare liposomes. The square capillary is filled with an outer water phase (W2) and an oil 
phase (O), which form an interface between the coaxially aligned fine-point capillaries. The 
inner water phase (W1) flows from the smaller orifice (40 – 80 µm) to the larger one (60 – 120 
µm), merging with the O and W2 phase, thereby forming double emulsions that flow out 
through the latter capillary. The inner phase is a filtered solution of 8 wt% PEG and 2 wt% 
PVA in milliQ. The oil phase is a solution of hexane and chloroform (70:30 v/v), with 5 mg/ml 
L-α-phosphatidylcholine (from chicken egg, Avanti). The outer water phase consists of 10 wt% 
PVA and 1 wt% Pluronic F-68. Next to the components, the flow rates of the various phases 
are crucial and partly dependent on the dimensions of the device. For the devices used in this 
project, double emulsions were formed under at least the following two sets of conditions: W2, 
1300 µl/h; W1, 100 µl/h; O, 300 µl/h – and also – W2, 3000 µl/h; W1, 300 µl/h; O, 400 µl/h. 
The outflow was captured on a glass slide and immediately covered with a coverslip and 
observed under the microscope. To generate the double emulsions, all fluids were pumped into 
the capillary microfluidic devices by using syringe pumps (PHD 2000 series, Harvard 
Apparatus) at desired flow rates. Typical flow rates of the inner, middle and outer phases are 
500, 500, and 2000-5000 μL h-1, respectively. The formation process of emulsion drops were 
monitored by using an inverted optical microscope (IX71, Olympus) equipped with a high 
speed camera (Miroex4, Phantom, Vision Research). The freshly prepared emulsions were 
collected in a semi-enclosed silicone isolation chamber (diameter 9 mm, height 0.12 mm, 
SecureSeal) covered with a glass coverslide for further characterization. The dewetting process 
and resultant labeled liposomes were observed by an optical microscope (IX81, Olympus) and 
a confocal laser scanning microscope (CLSM) (SP8x, Leica). 
Preparation of TX-TL reactions: For transcription–translation systems, the reaction mixtures 
consisted of one-third cell lysate (prepared as described below, ~ 33 mg ml-1) and two-thirds 
reaction buffer. The final reaction mixture contained 50mM Hepes (pH 8.0), 3mM guanosine 
triphosphate, 1mM each of adenosine triphosphate, cytidine triphosphate and uridine 
triphosphate, 0.66 mM spermidine, 0.5 mM cyclic adenosine monophosphate, 0.22 mM 
nicotinamide adenine dinucleotide, 0.17 mM coenzyme A, 20 mM 3-phosphoglyceric acid, 
0.045 mM folinic acid, 0.13 mg ml−1 transfer ribonucleic acid, 0.5 mM of each amino acid, 
9.4mM magnesium glutamate, 11mM potassium glutamate, 2 µM of T7 RNAP and ~11 mg 
ml-1 cell lysate, contributing an additional 0 - 15mM magnesium glutamate (as required) and 
20mM potassium glutamate and fluorescence was measured in a plate reader. Purified T7 
polymerase was added at a concentration of 100 nM. GamS was prepared for TX-TL reactions 
with linear DNA according to previously established protocols56. For In vitro Translation 
(IVTl) reactions, instead of DNA and T7 RNAP, 500 nM of the respective mRNA template 
and was added to the reaction mixture. SUPERase inhibitor (1U/uL of reaction, 
ThermoScientific) was added as an RNase inhibitor. 
Preparation of cell lysate: (protocol for 1L of bacterial culture) : A starter culture of E.coli 
Rosetta2 was prepared in 2xYT broth (16 g tryptone, 10 g yeast extract, 5 g NaCl dissolved in 
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850 mL water and autoclaved) and cultured at 37oC overnight.  To 850 mL of autoclaved 2YT 
broth, 50 mL of starter culture was added along with 100 mL of 10x 2YPTG salt (0.22 M 
NaH2PO4, 0.55 M Na2HPO4, titrated to pH 7.0, autoclaved) and 18.02 g glucose and incubated 
on a shaker (230-250 rpm) at 37oC. OD600 was checked regularly and the culture was harvested 
at OD600 = 1.8. The cells were collected by centrifugation at 5500 rpm for 10 mins at 4
oC in 
three JA-10 vials. The pellets were re-suspended in ice-cold lysis buffer (20% sucrose, 1 mM 
EDTA, 1 mg mL-1 egg white lysozyme, filter-sterilised, 16 mL/ JA-10 vial) and incubated for 
10 mins on ice. The dissolved pellets were pooled and 24 mL of ice-cold MQ water was added. 
They were incubated for 5 more minutes on ice and centrifuged at 7500 rpm for 10 mins at 
4oC. The supernatant was drained and the pellet was weighed. The pellet was resuspended in 
ice-cold milliQ water (0.75x volume) carefully. The cells were lysed by 10 cycles of 10 seconds 
of sonication at 10uM amplitude with 30s breaks on ice between cycles. Once sonicated, the 
cells were centrifuged at 10000 rpm for 10 mins at 4oC. The supernatant was collected, 
incubated at 37oC for 30 minutes and centrifuged again at 15700 rpm at 4oC for 10 mins. The 
supernatant, now lysate, was dialysed against 50% dialysis buffer (5 mM Tris-Cl, 30mM 
potassium glutamate, 3.5-7 mM magnesium glutamate, 0.5 mM DTT, autoclaved) for 45 
minutes followed by 3x45 minutes dialysis against 100% dialysis buffer (10mM Tris-Cl, 60 
mM potassium glutamate, 7-14 mM magnesium glutamate, 1 mM DTT, autoclaved). The 
lysate was aliquoted and flash-frozen in liquid nitrogen and stored at -80°C. Protein 
concentration was determined using a Pierce™ BCA Protein Assay Kit. 
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6.1 CONCLUSIONS 
In this thesis we have demonstrated the utility of cell-free systems as a platform to prototype 
synthetic genetic networks and additionally as a tool to aid in bottom-up synthetic biology. In 
Chapter 2, we have shown DMSO as a tool to identify and remove an important bottleneck in 
TX-TL systems – mRNA dependent secondary structures. In Chapters 3 and 4, we used the 
genetic elements from E. coli cell-free toolbox 2.0 for the bottom-up construction of a genetic 
oscillator in a microfluidic platform that allows long-lived TX-TL reactions to be carried out. 
This oscillator uses bacterial sigma factor – an important component of the E. coli 
transcriptional machinery – as the activator and the viral C1 protein as a repressor. A key 
mechanism leveraged by the used of bacterial sigma factors is their asymmetric competition 
for core RNAP which determines the amount of holoenzyme of each sigma factor available to 
transcribe the genes under their transcriptional control. Furthermore we developed a model, the 
parameters of which were estimated using an Evolutionary Algorithm. The model was able to 
predict trends in network behaviour, in particular amplitude of oscillations, of the genes in the 
oscillator. Finally, we engineered higher-order systems by coupling two different oscillators 
and demonstrated how fundamental mechanisms such as passive transcriptional control 
between sigma factors that arise due to competition for core RNAP control the behaviour of 
such composite systems. In Chapter 5, we demonstrated the utility of cell-free systems in 
conjugation with microfluidic liposome fabrication techniques as a tool for the bottom-up 
construction of artificial cells. While our assembled system failed to express detectable levels 
of reporter protein from a bacterial nucleoid with heterologous deGFP gene, it provides a useful 
platform for further research. 
6.2 OUTLOOK 
Moving forward, I believe TX-TL systems need to harness these qualities – i.e. their utility as 
a platform for prototyping networks and as a tool for bottom-up synthetic biology – so as to 
improve upon current limitations of synthetic biology. For example, in vivo genetic networks 
are implemented using circular plasmid DNA as opposed to linear DNA because the latter is 
degraded by the cell. To incorporate a gene of interest into a plasmid requires significant 
expertise and investment of time. TX-TL systems allow the implementation of genetic 
networks using linear DNA which can be obtained by a simple PCR reaction1,2 . Therefore TX-
TL systems can increase the speed of network prototyping and provides an useful platform to 
rapidly test new genetic elements and expand the repertoire of E. coli cell-free toolbox3. Such 
a library will not only aid in the forward engineering of genetic networks – engineering a 
response for a given network –  but can open up avenues to reverse engineer networks – 
engineering a network design that matches a desired response – as well. Algorithms have been 
developed which can evolve novel network designs to match a desired network output4. 
However the ‘design space’ of possible network designs as predicted by the algorithm is 
usually vast i.e. a number of different networks can be found which match a given phenotype. 
TX-TL systems can serve as a molecular breadboard to rapidly prototype, test and 
experimentally validate all the ‘locally optimal’ designs predicted by such algorithms at a pace 
quicker than that allowed by in vivo synthetic biology.  
In Chapter 5 we have demonstrated the encapsulation of cell-free systems in lipid vesicles to 
serve as platforms to engineer cell-like structures. Encapsulated TX-TL systems have also been 
used to engineer genetic cascades and demonstrate controlled vesicle-fusion5. Such systems 
can also be used to extend the life-time of TX-TL reactions6. Lipid-based vesicles can allow 
the implementation of long-lived TX-TL reactions by the incorporation of membrane-pore 
proteins such as alpha-hemolysin which can facilitate the exchange of nutrients across the 
vesicle membrane. Since such pores have a molecular weight cut-off, it is not possible to 
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replenish biomolecules with a high molecular weight such as RNA Polymerase, but nutrients 
with a relatively lower molecular weight such as NTPs can be exchanged from within and 
outside the vesicle by diffusion thereby serving as a ‘semi-open’ system, as opposed to 
microfluidic platform which allow every component of TX-TL mix to be replenished (‘open’ 
system)3,7–9. Whilst it might be difficult to engineer complex networks such as oscillators in 
compartmentalized TX-TL platforms, they have potential to serve as useful platforms for the 
bottom-up construction of an artificial cell. TX-TL systems have already been shown to 
produce proteins from bacterial genomes10 and generate entire viruses from their respective 
genomes11.  An encapsulated TX-TL platform with membrane pores could be potent enough 
to produce sufficient quantities of the proteins from a bacterial genome to so as to effect the 
division and/or replication of a synthetically-assembled artificial system.  
Genetic networks transformed in microorganisms have oftentimes found applications as 
biosensors and in diagnostic assays12,13. However, such Genetically Modified Organisms 
(GMOs) are subject to extensive regulations. Furthermore, implementations of an in vivo 
synthetic network outside regulated laboratories require the presence of a kill switch which can 
be activated to kill the GMO ‘on-demand’ i.e. in case of contamination14. Such kill switches 
are genetic modules which produce a toxin that can kill the microorganism if required. Since 
cell-free systems are abiotic, they are not subject to the regulations of in vivo synthetic biology 
as they present no risk of contamination. Therefore cell-free systems can contribute to a new 
generation of artificial biosensors i.e. genetic networks encapsulated in vesicles. Furthermore, 
cell-free systems can be freeze-dried on materials such as filter paper which can be shipped 
across the world15,16. Alternative means to preserve and activate cell-free systems need to be 
explored17 such that they can serve as a quicker and safer alternative to implement genetic 
circuits within and outside laboratories.  
To summarize, I believe further research needs to be carried out to engineer genetic networks, 
with diverse functionalities, in cell-free systems which can be implemented across multiple 
platforms – traditional batch TX-TL, long-lived steady-state TX-TL in microfluidic devices or 
liposomes and alternative in vitro freeze-dried platforms in order to bring about an easier, faster 
and safer future for synthetic biology. 
6.3 REFERENCES 
(1)  Marshall, R.; Maxwell, C. S.; Collins, S. P.; Beisel, C. L.; Noireaux, V. Short DNA 
Containing χ Sites Enhances DNA Stability and Gene Expression in E. Coli Cell-Free 
Transcription–translation Systems. Biotechnol. Bioeng. 2017, 114 (9), 2137–2141. 
(2)  Sun, Z. Z.; Yeung, E.; Hayes, C. A.; Noireaux, V.; Murray, R. M. Linear DNA for 
Rapid Prototyping of Synthetic Biological Circuits in an Escherichia Coli Based TX-
TL Cell-Free System. 2013. 
(3)  Niederholtmeyer, H.; Sun, Z. Z.; Hori, Y.; Yeung, E.; Verpoorte, A.; Murray, R. M.; 
Maerkl, S. J. Rapid Cell-Free Forward Engineering of Novel Genetic Ring Oscillators. 
Elife 2015, 4 (OCTOBER2015), 1–18. 
(4)  Smith, R. W.; van Sluijs, B.; Fleck, C. Designing Synthetic Networks in Silico: A 
Generalised Evolutionary Algorithm Approach. BMC Syst. Biol. 2017, 11 (1), 1–19. 
(5)  Adamala, K. P.; Martin-Alarcon, D. A.; Guthrie-Honea, K. R.; Boyden, E. S. 
Engineering Genetic Circuit Interactions within and between Synthetic Minimal Cells. 
Nat. Chem. 2017, 9 (5), 431–439. 
(6)  Noireaux, V.; Bar-Ziv, R.; Libchaber, A. Principles of Cell-Free Genetic Circuit 
 114 
Assembly. Proc. Natl. Acad. Sci. U. S. A. 2003, 100 (22), 12672–12677. 
(7)  Niederholtmeyer, H.; Stepanova, V.; Maerkl, S. J. Implementation of Cell-Free 
Biological Networks at Steady State. Proc. Natl. Acad. Sci. 2013, 110 (40), 15985–
15990. 
(8)  Tayar, A. M.; Karzbrun, E.; Noireaux, V.; Bar-Ziv, R. H. Synchrony and Pattern 
Formation of Coupled Genetic Oscillators on a Chip of Artificial Cells. Proc. Natl. 
Acad. Sci. 2017, 201710620. 
(9)  Karzbrun, E.; Tayar, A. M.; Noireaux, V.; Bar-Ziv, R. H. Programmable On-Chip 
DNA Compartments as Artificial Cells. Science (80-. ). 2014, 345 (6198), 829–832. 
(10)  Fujiwara, K.; Sawamura, T.; Niwa, T.; Deyama, T.; Nomura, S. I. M.; Taguchi, H.; 
Doi, N. In Vitro Transcription-Translation Using Bacterial Genome as a Template to 
Reconstitute Intracellular Profile. Nucleic Acids Res. 2017, 45 (19), 11449–11458. 
(11)  Rustad, M.; Eastlund, A.; Jardine, P.; Noireaux, V. Cell-Free TXTL Synthesis of 
Infectious Bacteriophage T4 in a Single Test Tube Reaction. Synth. Biol. 2018, 3 (1), 
1–7. 
(12)  Shao, J.; Xue, S.; Yu, G.; Yu, Y.; Yang, X.; Bai, Y.; Zhu, S.; Yang, L.; Yin, J.; Wang, 
Y.; et al. Smartphone-Controlled Optogenetically Engineered Cells Enable 
Semiautomatic Glucose Homeostasis in Diabetic Mice. Sci. Transl. Med. 2017, 9 
(387), 1–14. 
(13)  Wang, Q.; Tang, S. Y.; Yang, S. Genetic Biosensors for Small-Molecule Products: 
Design and Applications in High-Throughput Screening. Front. Chem. Sci. Eng. 2017, 
11 (1), 15–26. 
(14)  Stirling, F.; Bitzan, L.; O’Keefe, S.; Redfield, E.; Oliver, J. W. K.; Way, J.; Silver, P. 
A. Rational Design of Evolutionarily Stable Microbial Kill Switches. Mol. Cell 2017, 
68 (4), 686–696. 
(15)  Pardee, K.; Green, A. A.; Ferrante, T.; Cameron, D. E.; DaleyKeyser, A.; Yin, P.; 
Collins, J. J. Paper-Based Synthetic Gene Networks. Cell 2014, 159 (4), 940–954. 
(16)  Pardee, K.; Green, A. A.; Takahashi, M. K.; Braff, D.; Lambert, G.; Lee, J. W.; 
Ferrante, T.; Ma, D.; Donghia, N.; Fan, M.; et al. Rapid, Low-Cost Detection of Zika 
Virus Using Programmable Biomolecular Components. Cell 2016, 165 (5), 1255–
1266. 
(17)  Boothby, T. C.; Tapia, H.; Brozena, A. H.; Pielak, G. J.; Koshland, D.; Boothby, T. C.; 
Tapia, H.; Brozena, A. H.; Piszkiewicz, S.; Smith, A. E.; et al. Tardigrades Use 
Intrinsically Disordered Proteins to Article Tardigrades Use Intrinsically Disordered 
Proteins to Survive Desiccation. Mol. Cell 2017, 65 (6), 975–984.e5. 
 
 
 
 
 115 
 
 
 
 
 
 
 
 
SUMMARY 
 
 
 
 
 
 
 
 
 
 
 116 
Cell-free gene expression (TX-TL) is a field which has added a new dimension for synthetic 
biology applications – from prototyping genetic networks to bottom-up construction of 
artificial cells. TX-TL systems are easy to use, versatile and are compatible with droplet-
based and microfluidic platforms. While a lot of work has been done in optimizing and 
establishing different TX-TL platforms, their full potential is only starting to be realized. The 
work in this thesis is aimed at being a stepping stone toward expanding the repertoire of TX-
TL functionalities and to inspire future works in this field. In Chapter 1, a general 
introduction to the field of synthetic biology is given – from genetic networks in vivo to their 
limitations and the niche that is occupied by cell-free synthetic biology.  
In Chapter 2 we highlight a major bottleneck in protein synthesis in cell-free systems i.e. 
messenger RNA (mRNA) inactivation due to sequence-dependent secondary structures. This 
causes the Ribosome Binding Site (RBS) of the mRNA to be inaccessible by the ribosomes 
and hampers translation and eventual protein yields. Such bottlenecks can lead to inefficient 
protein synthesis and wastage of resources in TX-TL systems. We demonstrate the use of 
DMSO as a chemical tool to remove mRNA secondary structures and improve overall protein 
yield in TX-TL systems and protein expression in distal genes in an operon. 
In Chapter 3 we describe the bottom-up construction of a synthetic genetic oscillator 
implemented in a bacterial cell-free system. While complex genetic systems have been 
constructed in vivo before, there exists a limit as introduction of exogenous networks 
competes with the cell for important resources – such as RNA Polymerase (RNAP) and 
bacterial sigma factors – and hampers cell growth and eventual performance of the genetic 
network. Therefore we implemented a genetic oscillator with an activator repressor motif 
with the sigma factor 28 (σ28) serving as the activator and the viral protein λC1 as the 
repressor. We used a microfluidic nanoreactor to implement a steady-state environment to 
find that the system indeed exhibited oscillations and the properties of the oscillator could be 
tuned by changing the DNA concentrations of the oscillator. We also implemented a 
mathematical model to quantify the behaviour of the oscillator within its oscillating regime. 
In Chapter 4, we use the σ28-oscillator to construct more complex systems. We adopted a 
model-guided approach to modify the properties of our oscillator such as increasing the 
oscillating regime. We implemented this change by replacing the σ28 with a weaker variant - 
sigma factor 19 (σ19) as the activator. Since multiple sigma factors compete for the same 
resource – RNAP – we coupled both oscillators and demonstrated the control of behaviour of 
the coupled system by the passive transcriptional control of one sigma factor over the other. 
In this way we found that the weaker sigma factor can exert control over the RNAP and 
rescue oscillatory behaviours in complex systems. 
In Chapter 5, we outline a pathway for the bottom-up construction of an artificial cell by 
combining the three tenets of a cell – cytoplasm, container and information. We used a 
microfluidics-based device to produce monodisperse liposomes which serve as the container 
into which we encapsulated TX-TL systems (cytoplasm) with tools to visualize proteins and 
mRNA. Finally, in order to mimic features of a bacterial cell, we introduced an nucleoid 
DNA with deGFP protein (information) to verify if the TX-TL system was compatible to 
produce proteins from the nucleoid DNA. Whilst no protein expression was observed, we 
believe the system requires a few optimizations before protein production can be obtained 
from such a reconstituted system.  
In Chapter 6, the findings of this thesis is summarized and we outline how cell-free synthetic 
biology can bring about a better and safer future for synthetic biology. 
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Celvrije genexpressie (cell-free gene expression, ook bekend als TX-TL) heeft nieuwe 
dimensies toegevoegd aan de synthetische biologie – variërend van onderzoek naar 
genetische netwerken tot de constructie van synthetische cellen. Celvrije genexpressie is 
makkelijk in gebruik, veelzijdig, en compatibel met druppel en microfluïdische methoden. 
Ondanks dat er inmiddels een groot aantal expressiesystemen zijn ontwikkeld, moet de 
volledige potentie van celvrije genexpressie nog worden gerealiseerd. Deze scriptie heeft als 
doel de toepassingen van celvrije genexpressie verder uit te breiden en om als inspiratie te 
dienen voor toekomstig werk binnen de celvrije synthetische biologie. Hoofdstuk 1 bestaat 
uit een algemene introductie van de synthetische biologie, met in het bijzonder aandacht voor 
de nadelen van in vivo onderzoek naar genetische netwerken en voor de rol die de celvrije 
synthetische biologie kan spelen in het onderzoek naar deze netwerken.   
 
In Hoofdstuk 2 bespreken we een bottleneck in de eiwitexpressie in celvrije systemen, te 
weten boodschapper RNA (mRNA) inactivatie door sequentie-afhankelijke secundaire 
structuren. Deze secundaire structuren zorgen ervoor dat de ribosomale bindplaats (RBS) van 
het mRNA niet langer toegankelijk is voor de ribosomen, wat een verminderde en inefficiënte 
eiwitexpressie tot gevolg heeft. Wij laten zien dat de toevoeging van DMSO aan celvrije 
reacties deze secundaire structuren oplost, waardoor de opbrengst en efficiëntie van 
eiwitexpressie in celvrije systemen verhoogd kunnen worden.  
 
In Hoofdstuk 3 beschrijven we de constructie van een synthetische genetische oscillator in 
een bacterieel celvrij systeem. Alhoewel complexe genetische systemen al eerder in vivo 
bestudeerd zijn, kennen zij een belangrijk nadeel. Onder in vivo omstandigheden concurreren 
exogene netwerken met de cel om grondstoffen, waardoor zowel de celgroei als de activiteit 
van het exogene netwerk geremd worden. Bovendien, genetische netwerken kunnen geen 
gebruik maken van belangrijke biomoleculen in een cel, zoals RNA polymerase (RNAP) en 
de bacteriële sigma factoren. Daarom hebben we een genetische oscillator met een activator-
repressor motief gebouwd, waarbij sigma factor 28 (σ28) dient als activator en het virale eiwit 
lambda C1 (λC1) als repressor. We hebben gebruikt gemaakt van een microfluïdische 
nanoreactor om een steady state omgeving te realiseren om zo te bevestigen dat het systeem 
inderdaad oscilleert en dat de eigenschappen van de oscillator veranderd kunnen worden door 
de DNA concentraties van de verschillende elementen uit de oscillator te variëren. We 
hebben ook een mathematisch model ontwikkeld om het gedrag van de oscillator te kunnen 
kwantificeren binnen het oscillatoire regime.   
 
In Hoofdstuk 4 gebruiken we de σ28-oscillator om meer complexe genetische netwerken te 
bouwen. We hebben een modelgeleide methode gebruikt om de eigenschappen van de 
oscillator te veranderen, zoals het verbreden van het oscillatoire regime. Dit is mogelijk door 
de sterke activator, σ28, te vervangen met een zwakkere variant, σ19. Aangezien sigma 
factoren concurreren om dezelfde grondstoffen, zoals bijvoorbeeld RNAP, hebben we de σ28 
en σ19 oscillatoren gekoppeld om te onderzoeken hoe zij elkaars gedrag kunnen beïnvloeden. 
Het blijkt dat de σ19 oscillator controle heeft over het gedrag van het gekoppelde systeem 
door middel van passieve transcriptionele controle over RNAP, waardoor het mogelijk is om 
het gekoppelde systeem te laten oscilleren bij de juiste σ19 concentratie. 
 
In Hoofdstuk 5 beschrijven we een route voor de bottom-up constructie van een artificiële 
cel door middel van de combinatie van de drie kernonderdelen van de cel: het cytoplasma, het 
celmembraan, en het DNA. We gebruikten een op microfluidica-gebaseerd apparaat om 
monodisperse liposomen te produceren die dienen als een artificieel celmembraan waarin we 
een artificieel cytoplasma (TX-TL) omvatten. Om de eigenschappen van een bacteriële cel na 
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te bootsen, bevatten de liposomen ook bacteriële chromosomen (nucleoïden) met het 
fluorescente eiwit deGFP om te verifiëren dat het celvrije expressiesysteem instaat is om 
eiwit te produceren vanaf het bacteriële DNA. Aangezien er geen eiwitexpressie is 
geobserveerd zal het systeem verder aangepast moeten worden om dit doel te bereiken.  
 
In Hoofdstuk 6 worden de resultaten uit deze scriptie samengevat en presenteren we ons 
perspectief op hoe de celvrije synthetische biologie bij kan dragen aan een betere, veiligere 
toekomst van synthetisch biologisch onderzoek. 
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APPENDIX : DNA SEQUENCES 
PLASMID MAP AND DNA SEQUENCES USED IN CHAPTER 2 
 
 
Plasmid used for mRNA and protein expression studies. The plasmids for YFP, CFP and eGFP4xBT 
all share the same backbone plasmid, namely the pRSET backbone. The plasmids containing YFP and 
CFP lack the 4xBT gene. 
PT7-RBS-deGFP-4xBT-TT7 
(BT = target for molecular 
beacon) 
taatacgactcactatagggagaccacaacggtttccctctagaaataattttgtttaactttaagaaggagatataccAT
Ggagcttttcactggcgttgttcccatcctggtcgagctggacggcgacgtaaacggccacaagttcagcgtgtccgg
cgagggcgagggcgatgccacctacggcaagctgaccctgaagttcatctgcaccaccggcaagctgcccgtgccc
tggcccaccctcgtgaccaccctgacctacggcgtgcagtgcttcagccgctaccccgaccacatgaagcagcacga
cttcttcaagtccgccatgcccgaaggctacgtccaggagcgcaccatcttcttcaaggacgacggcaactacaagac
ccgcgccgaggtgaagttcgagggcgacaccctggtgaaccgcatcgagctgaagggcatcgacttcaaggagga
cggcaacatcctggggcacaagctggagtacaactacaacagccacaacgtctatatcatggccgacaagcagaaga
acggcatcaaggtgaacttcaagatccgccacaacatcgaggacggcagcgtgcagctcgccgaccactaccagca
gaacacccccatcggcgacggccccgtgctgctgcccgacaaccactacctgagcacccagtccgccctgagcaaa
gaccccaacgagaagcgcgatcacatggtcctgctggagttcgtgaccgccgccgggatctaactcgagtagtagaa
ctctctcaacgtgtacgccatagctagctacaactctctcaacgtaacgtacctaacgcatcgaactctctcaacgttacta
tactaaactacctaactctctcaacgtactactggaaaactacctgaattcgaagcttgatccggctgctaacaaagcccg
aaaggaagctgagttggctgctgccaccgctgagcaataactagcataaccccttggggcctctaaacgggtcttgag
gggttttttgctgaaaggaggaactatatccggat 
wtGFP ATGggtaaaggagaagaacttttcactggagttgtcccaattcttgttgaattagatggtgatgttaatgggcacaaatt
ttctgtcagtggagagggtgaaggtgatgcaacatacggaaaacttacccttaaatttatttgcactactggaaaactacc
tgttccgtggccaacacttgtcactactttctcttatggtgttcaatgcttttcccgttatccggatcatatgaaacggcatga
ctttttcaagagtgccatgcccgaaggttatgtacaggaacgcactatatctttcaaagatgacgggaactacaagacgc
gtgctgaagtcaagtttgaaggtgatacccttgttaatcgtatcgagttaaaaggtattgattttaaagaagatggaaacatt
ctcggacacaaactcgagtacaactataactcacacaatgtatacatcacggcagacaaacaaaagaatggaatcaaa
gctaacttcaaaattcgccacaacattgaagatggatccgttcaactagcagaccattatcaacaaaatactccaattggc
gatggccctgtccttttaccagacaaccattacctgtccacacaatctgccctttcgaaagatcccaacgaaaagagaga
ccacatggtccttcttgagtttgtaacagctgctgggattacacatggcatggatgaactatacaagggtcaccaccatca
ccatcactag 
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CFP ATGgtgagcaagggcgaggagctgttcaccggggtggtgcccatcctggtcgagctggacggcgacgtaaacgg
ccacaggttcagcgtgtccggcgagggcgagggcgatgccacctacggcaagctgaccctgaagttcatctgcacca
ccggcaagctgcccgtgccctggcccaccctcgtgaccaccctgacctggggcgtgcagtgcttcagccgctacccc
gaccacatgaagcagcacgacttcttcaagtccgccatgcccgaaggctacgtccaggagcgtaccatcttcttcaag
gacgacggcaactacaagacccgcgccgaggtgaagttcgagggcgacaccctggtgaaccgcatcgagctgaag
ggcatcgacttcaaggaggacggcaacatcctggggcacaagctggagtacaactacatcagccacaacgtctatatc
accgccgacaagcagaagaacggcatcaaggcccacttcaagatccgccacaacatcgaggacggcagcgtgcag
ctcgccgaccactaccagcagaacacccccatcggcgacggccccgtgctgctgcccgacaaccactacctgagca
cccagtccaagctgagcaaagaccccaacgagaagcgcgatcacatggtcctgctggagttcgtgaccgccgccgg
gatcactcacggcatggacgagctgtacaaggctggtaagcttgcggccgcactcgagcaagaattcgaagcttga 
YFP ATGgtgagcaagggcgaggagctgttcaccggggtggtgcccatcctggtcgagctggacggcgacgtaaacgg
ccacaagttcagcgtgtccggcgagggcgagggcgatgccacctacggcaagctgaccctgaagttcatctgcacca
ccggcaagctgcccgtgccctggcccaccctcgtgaccaccttcggctacggcctgaagtgcttcgcccgctacccc
gaccacatgaagcagcacgacttcttcaagtccgccatgcccgaaggctacgtccaggagcgcaccatcttcttcaag
gacgacggcaactacaagacccgcgccgaggtgaagttcgagggcgacaccctggtgaaccgcatcgagctgaag
ggcatcgacttcaaggaggacggcaacatcctggggcacaagctggagtacaactacaacagccacaacgtctatat
catggccgacaagcagaagaacggcatcaaggtgaacttcaagatccgccacaacatcgaggacggcagcgtgca
gctcgccgaccactaccagcagaacacccccatcggcgacggccccgtgctgctgcccgacaaccactacctgagc
taccagtccaagctgagcaaagaccccaacgagaagcgcgatcacatggtcctgctggagttcgtgaccgccgccg
ggatcactcacggcatggacgagctgtacaaggctggtaagcttgcggccgcactcgagcaagaattcgaagcttga 
PT7-Sp2-TT7 Aggatctcgatcccgcgaaattaatacgactcactatagggagaccacaacggtttccctctagaaataattttgtttaac
tttaagaaggagatataccgcccggatagctcagtcggtagagcagcggccggatgtaactgaatgaaatggtgaag
gacgggtccagtaggctgcttcggcagcctacttgttgagtagagtgtgagctccgtaactagttacatccggccgcgg
gtccagggttcaagtccctgttcgggcgccagaattcgaagcttgatccggctgctaacaaagcccgaaaggaagctg
agttggctgctgccaccgctgagcaataactagcataaccccttggggcctctaaacgggtcttgaggggttttttgctg
aaaggaggaactatatccggatctggcgtaatagcgaagaggcccgcaccgatcgcccttcccaacagttgcgcagc
ctgaatggcgaatgggacgcgccctgtagcggcgcattaagcg 
2 operon PT7 tcgatcccgcgaaattaatacgactcactatagggagaccacaacggtttccctctagaaataattttgtttaactttaaga
aggagatataccAtgaattcactctataccgctgaaggtgtaatggataaacactcgctgtggcagcgttatgtcccgct
ggtgcgtcacgaagcattgcgcctgcaggttcgactgcccgcgagcgtggaacttgacgatctgctacaggcgggcg
gcattgggttacttaatgccgtcgaacgctatgacgccctacaaggaacggcatttacaacttacgcagtgcagcgtatc
cgtggcgctatgctggatgaacttcgcagccgtgactgggtgccgcgcagcgtgcgacgcaacgcgcgtgaagtgg
cacaggcaatagggcaactggagcaggaacttggccgcaacgccacggaaactgaggtagcggaacgtttagggat
cgatattgccgattatcgccaaatgttgctcgacaccaataacagccagctcttctcctacgatgagtggcgcgaagagc
acggcgatagcatcgaactggttactgatgatcatcagcgagaaaacccgctacaacaactactggacagtaatctgc
gccagcgggtgatggaagccatcgaaacgttgccggagcgcgaaaaactggtattaaccctctattaccaggaagag
ctgaatctcaaagagattggcgcggtgctggaggtcggggaatcgcgggtcagtcagttacacagccaggctattaaa
cggttacgcactaaactgggtaagttataatttgtttaactttaagaaggagatataccatggagcttttcactggcgttgttc
ccatcctggtcgagctggacggcgacgtaaacggccacaagttcagcgtgtccggcgagggcgagggcgatgcca
cctacggcaagctgaccctgaagttcatctgcaccaccggcaagctgcccgtgccctggcccaccctcgtgaccacc
ctgacctacggcgtgcagtgcttcagccgctaccccgaccacatgaagcagcacgacttcttcaagtccgccatgccc
gaaggctacgtccaggagcgcaccatcttcttcaaggacgacggcaactacaagacccgcgccgaggtgaagttcg
agggcgacaccctggtgaaccgcatcgagctgaagggcatcgacttcaaggaggacggcaacatcctggggcaca
agctggagtacaactacaacagccacaacgtctatatcatggccgacaagcagaagaacggcatcaaggtgaacttc
aagatccgccacaacatcgaggacggcagcgtgcagctcgccgaccactaccagcagaacacccccatcggcgac
ggccccgtgctgctgcccgacaaccactacctgagcacccagtccgccctgagcaaagaccccaacgagaagcgc
gatcacatggtcctgctggagttcgtgaccgccgccgggatctaagaattcgaagcttgatccggctgctaacaaagcc
cgaaaggaagctgagttggctgctgccaccgctgagcaataactagcataaccccttggggcctctaaacgggtcttg
aggggttttttgctgaaaggaggaactatatccggatctggcgtaatagcgaagaggcccgcaccgatcgcccttccca
acagttgcgcagcctgaatggcgaatgggacgcgccctgtagcggc 
3 operon PT7 tcgatcccgcgaaattaatacgactcactatagggagaccacaacggtttccctctagaaataattttgtttaactttaaga
aggagatataccatgaattcactctataccgctgaaggtgtaatggataaacactcgctgtggcagcgttatgtcccgct
ggtgcgtcacgaagcattgcgcctgcaggttcgactgcccgcgagcgtggaacttgacgatctgctacaggcgggcg
gcattgggttacttaatgccgtcgaacgctatgacgccctacaaggaacggcatttacaacttacgcagtgcagcgtatc
cgtggcgctatgctggatgaacttcgcagccgtgactgggtgccgcgcagcgtgcgacgcaacgcgcgtgaagtgg
cacaggcaatagggcaactggagcaggaacttggccgcaacgccacggaaactgaggtagcggaacgtttagggat
cgatattgccgattatcgccaaatgttgctcgacaccaataacagccagctcttctcctacgatgagtggcgcgaagagc
acggcgatagcatcgaactggttactgatgatcatcagcgagaaaacccgctacaacaactactggacagtaatctgc
gccagcgggtgatggaagccatcgaaacgttgccggagcgcgaaaaactggtattaaccctctattaccaggaagag
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ctgaatctcaaagagattggcgcggtgctggaggtcggggaatcgcgggtcagtcagttacacagccaggctattaaa
cggttacgcactaaactgggtaagttataaaaggagatataccatgtctgaccgcgccactaccacagcttccttaacgtt
cgagtcgctttatggcacacatcacggctggttgaaaagctggctgacgcgcaaactccagtctgcttttgatgcagatg
acattgcccaggacacttttttgcgggtaatggtcagcgaaacgctctcgacgatccgcgatcctcgctccttcctctgca
ctatcgccaaacgcgtgatggtggacctgtttcgccgaaacgcgctggaaaaagcgtatctggagatgctggcgcttat
gccggaggggggagcgccttcacctgaggaacgcgaaagccaactcgagaccctacaactcctcgacagcatgctg
gacgggctaaacggcaaaacacgtgaagcgtttctgctttcgcaactggatggtctgacatacagcgagattgcgcac
aaactcggtgtttccatcagctccgtgaaaaaatacgtggcgaaagccgtcgagcactgcctgctgttccgtctggagta
tgggttataaaaggagatataccatggagcttttcactggcgttgttcccatcctggtcgagctggacggcgacgtaaac
ggccacaagttcagcgtgtccggcgagggcgagggcgatgccacctacggcaagctgaccctgaagttcatctgca
ccaccggcaagctgcccgtgccctggcccaccctcgtgaccaccctgacctacggcgtgcagtgcttcagccgctac
cccgaccacatgaagcagcacgacttcttcaagtccgccatgcccgaaggctacgtccaggagcgcaccatcttcttc
aaggacgacggcaactacaagacccgcgccgaggtgaagttcgagggcgacaccctggtgaaccgcatcgagctg
aagggcatcgacttcaaggaggacggcaacatcctggggcacaagctggagtacaactacaacagccacaacgtct
atatcatggccgacaagcagaagaacggcatcaaggtgaacttcaagatccgccacaacatcgaggacggcagcgt
gcagctcgccgaccactaccagcagaacacccccatcggcgacggccccgtgctgctgcccgacaaccactacctg
agcacccagtccgccctgagcaaagaccccaacgagaagcgcgatcacatggtcctgctggagttcgtgaccgccg
ccgggatctaagaattcgaagcttgatccggctgctaacaaagcccgaaaggaagctgagttggctgctgccaccgct
gagcaataactagcataaccccttggggcctctaaacgggtcttgaggggttttttgctgaaaggaggaactatatccgg
atctggcgtaatagcgaagaggcccgcaccgatcgcccttcccaacagttgcgcagcctgaatggcgaatgggacgc
gccctgtagcggc 
2 operon P70 (deGFP as 
proximal gene) 
ataggggttccgcgcacatttccccgaaaagtgccacctgacgtctaagaaaccattattatcatgacattaacctataaa
aataggcgtatcacgaggccctttcgtcttcaagaattctggcgaatcctctgaccagccagaaaacgacctttctgtggt
gaaaccggatgctgcaattcagagcgccagcaagtgggggacagcagaagacctgaccgccgcagagtggatgttt
gacatggtgaagactatcgcaccatcagccagaaaaccgaattttgctgggtgggctaacgatatccgcctgatgcgtg
aacgtgacggacgtaaccaccgcgacatgtgtgtgctgttccgctgggcatgctgagctaacaccgtgcgtgttgaca
attttacctctggcggtgataatggttgcagctagcaataattttgtttaactttaagaaggagatataccatggagcttttca
ctggcgttgttcccatcctggtcgagctggacggcgacgtaaacggccacaagttcagcgtgtccggcgagggcgag
ggcgatgccacctacggcaagctgaccctgaagttcatctgcaccaccggcaagctgcccgtgccctggcccaccct
cgtgaccaccctgacctacggcgtgcagtgcttcagccgctaccccgaccacatgaagcagcacgacttcttcaagtc
cgccatgcccgaaggctacgtccaggagcgcaccatcttcttcaaggacgacggcaactacaagacccgcgccgag
gtgaagttcgagggcgacaccctggtgaaccgcatcgagctgaagggcatcgacttcaaggaggacggcaacatcc
tggggcacaagctggagtacaactacaacagccacaacgtctatatcatggccgacaagcagaagaacggcatcaa
ggtgaacttcaagatccgccacaacatcgaggacggcagcgtgcagctcgccgaccactaccagcagaacaccccc
atcggcgacggccccgtgctgctgcccgacaaccactacctgagcacccagtccgccctgagcaaagaccccaacg
agaagcgcgatcacatggtcctgctggagttcgtgaccgccgccgggatctaatttgtttaactttaagaaggagatata
ccatgaattcactctataccgctgaaggtgtaatggataaacactcgctgtggcagcgttatgtcccgctggtgcgtcac
gaagcattgcgcctgcaggttcgactgcccgcgagcgtggaacttgacgatctgctacaggcgggcggcattgggtta
cttaatgccgtcgaacgctatgacgccctacaaggaacggcatttacaacttacgcagtgcagcgtatccgtggcgcta
tgctggatgaacttcgcagccgtgactgggtgccgcgcagcgtgcgacgcaacgcgcgtgaagtggcacaggcaat
agggcaactggagcaggaacttggccgcaacgccacggaaactgaggtagcggaacgtttagggatcgatattgcc
gattatcgccaaatgttgctcgacaccaataacagccagctcttctcctacgatgagtggcgcgaagagcacggcgata
gcatcgaactggttactgatgatcatcagcgagaaaacccgctacaacaactactggacagtaatctgcgccagcggg
tgatggaagccatcgaaacgttgccggagcgcgaaaaactggtattaaccctctattaccaggaagagctgaatctcaa
agagattggcgcggtgctggaggtcggggaatcgcgggtcagtcagttacacagccaggctattaaacggttacgca
ctaaactgggtaagttataactcgagcaaagcccgccgaaaggcgggcttttctgtgtcgaccgatgcccttgagagcc
ttcaacccagtcagctccttccggtgggcgcggggcatgactatcgtcgccgcacttatgactgtcttctttatcatgcaa
ctcgtaggacaggtgccggcagcgctcttccgcttcctcgctcactgactcgctgcgctcggtcgttcggctgcggcga
gcggtatcagctcactcaaaggcggtaatacggttatccacagaatcaggggataacgcaggaaagaacatgtgagc
aaaaggccagcaaaaggccaggaaccgtaaaaaggccgcgttgctggcgtttttccataggctccgcc 
2 operon P70 (deGFP as 
distal gene) 
taggggttccgcgcacatttccccgaaaagtgccacctgacgtctaagaaaccattattatcatgacattaacctataaaa
ataggcgtatcacgaggccctttcgtcttcaagaattctggcgaatcctctgaccagccagaaaacgacctttctgtggtg
aaaccggatgctgcaattcagagcgccagcaagtgggggacagcagaagacctgaccgccgcagagtggatgtttg
acatggtgaagactatcgcaccatcagccagaaaaccgaattttgctgggtgggctaacgatatccgcctgatgcgtga
acgtgacggacgtaaccaccgcgacatgtgtgtgctgttccgctgggcatgctgagctaacaccgtgcgtgttgacaat
tttacctctggcggtgataatggttgcagctagcaataattttgtttaactttaagaaggagatataccatgaattcactctat
accgctgaaggtgtaatggataaacactcgctgtggcagcgttatgtcccgctggtgcgtcacgaagcattgcgcctgc
aggttcgactgcccgcgagcgtggaacttgacgatctgctacaggcgggcggcattgggttacttaatgccgtcgaac
gctatgacgccctacaaggaacggcatttacaacttacgcagtgcagcgtatccgtggcgctatgctggatgaacttcg
cagccgtgactgggtgccgcgcagcgtgcgacgcaacgcgcgtgaagtggcacaggcaatagggcaactggagc
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aggaacttggccgcaacgccacggaaactgaggtagcggaacgtttagggatcgatattgccgattatcgccaaatgtt
gctcgacaccaataacagccagctcttctcctacgatgagtggcgcgaagagcacggcgatagcatcgaactggttac
tgatgatcatcagcgagaaaacccgctacaacaactactggacagtaatctgcgccagcgggtgatggaagccatcg
aaacgttgccggagcgcgaaaaactggtattaaccctctattaccaggaagagctgaatctcaaagagattggcgcgg
tgctggaggtcggggaatcgcgggtcagtcagttacacagccaggctattaaacggttacgcactaaactgggtaagtt
ataatttgtttaactttaagaaggagatataccatggagcttttcactggcgttgttcccatcctggtcgagctggacggcg
acgtaaacggccacaagttcagcgtgtccggcgagggcgagggcgatgccacctacggcaagctgaccctgaagtt
catctgcaccaccggcaagctgcccgtgccctggcccaccctcgtgaccaccctgacctacggcgtgcagtgcttcag
ccgctaccccgaccacatgaagcagcacgacttcttcaagtccgccatgcccgaaggctacgtccaggagcgcacca
tcttcttcaaggacgacggcaactacaagacccgcgccgaggtgaagttcgagggcgacaccctggtgaaccgcatc
gagctgaagggcatcgacttcaaggaggacggcaacatcctggggcacaagctggagtacaactacaacagccaca
acgtctatatcatggccgacaagcagaagaacggcatcaaggtgaacttcaagatccgccacaacatcgaggacggc
agcgtgcagctcgccgaccactaccagcagaacacccccatcggcgacggccccgtgctgctgcccgacaaccact
acctgagcacccagtccgccctgagcaaagaccccaacgagaagcgcgatcacatggtcctgctggagttcgtgacc
gccgccgggatctaactcgagcaaagcccgccgaaaggcgggcttttctgtgtcgaccgatgcccttgagagccttca
acccagtcagctccttccggtgggcgcggggcatgactatcgtcgccgcacttatgactgtcttctttatcatgcaactcg
taggacaggtgccggcagcgctcttccgcttcctcgctcactgactcgctgcgctcggtcgttcggctgcggcgagcg
gtatcagctcactcaaa 
 
 
DNA SEQUENCES USED IN CHAPTERS 3 AND 4 
DNA name Sequence 
P70-deGFP ataggggttccgcgcacatttccccgaaaagtgccacctgacgtctaagaaaccattattatcatgacat
taacctataaaaataggcgtatcacgaggccctttcgtcttcaagaattctggcgaatcctctgaccagc
cagaaaacgacctttctgtggtgaaaccggatgctgcaattcagagcgccagcaagtgggggacagc
agaagacctgaccgccgcagagtggatgtttgacatggtgaagactatcgcaccatcagccagaaaa
ccgaattttgctgggtgggctaacgatatccgcctgatgcgtgaacgtgacggacgtaaccaccgcga
catgtgtgtgctgttccgctgggcatgctgagctaacaccgtgcgtgttgacaattttacctctggcggtg
ataatggttgcagctagcaataattttgtttaactttaagaaggagatataccatggagcttttcactggcgt
tgttcccatcctggtcgagctggacggcgacgtaaacggccacaagttcagcgtgtccggcgagggc
gagggcgatgccacctacggcaagctgaccctgaagttcatctgcaccaccggcaagctgcccgtgc
cctggcccaccctcgtgaccaccctgacctacggcgtgcagtgcttcagccgctaccccgaccacatg
aagcagcacgacttcttcaagtccgccatgcccgaaggctacgtccaggagcgcaccatcttcttcaa
ggacgacggcaactacaagacccgcgccgaggtgaagttcgagggcgacaccctggtgaaccgca
tcgagctgaagggcatcgacttcaaggaggacggcaacatcctggggcacaagctggagtacaact
acaacagccacaacgtctatatcatggccgacaagcagaagaacggcatcaaggtgaacttcaagat
ccgccacaacatcgaggacggcagcgtgcagctcgccgaccactaccagcagaacacccccatcg
gcgacggccccgtgctgctgcccgacaaccactacctgagcacccagtccgccctgagcaaagacc
ccaacgagaagcgcgatcacatggtcctgctggagttcgtgaccgccgccgggatctaactcgagca
aagcccgccgaaaggcgggcttttctgtgtcgaccgatgcccttgagagccttcaacccagtcagctc
cttccggtgggcgcggggcatgactatcgtcgccgcacttatgactgtcttctttatcatgcaactcgtag
gacaggtgccggcagcgctcttccgcttcctcgctcactgactcgctgcgctcggtcgttcggctgcgg
cgagcggtatcagctcactcaaaggcggtaatacggttatccacagaatcaggggataacgcaggaa
agaacatgtgagcaaaaggccagcaaaaggccaggaaccgtaaaaaggccgcgttgctggcgttttt
ccataggctccgcccc 
 
P70-σ28 cgaggccctttcgtcttcaagaattctggcgaatcctctgaccagccagaaaacgacctttctgtggtga
aaccggatgctgcaattcagagcgccagcaagtgggggacagcagaagacctgaccgccgcagag
tggatgtttgacatggtgaagactatcgcaccatcagccagaaaaccgaattttgctgggtgggctaac
gatatccgcctgatgcgtgaacgtgacggacgtaaccaccgcgacatgtgtgtgctgttccgctgggc
atgccaggacaacttctggtccggtaacgtgctgagctaacaccgtgcgtgttgacaattttacctctgg
cggtgataatggttgcagctagcaataattttgtttaactttaagaaggaggatccaaatgaattcactcta
taccgctgaaggtgtaatggataaacactcgctgtggcagcgttatgtcccgctggtgcgtcacgaagc
attgcgcctgcaggttcgactgcccgcgagcgtggaacttgacgatctgctacaggcgggcggcattg
ggttacttaatgccgtcgaacgctatgacgccctacaaggaacggcatttacaacttacgcagtgcagc
gtatccgtggcgctatgctggatgaacttcgcagccgtgactgggtgccgcgcagcgtgcgacgcaa
cgcgcgtgaagtggcacaggcaatagggcaactggagcaggaacttggccgcaacgccacggaaa
ctgaggtagcggaacgtttagggatcgatattgccgattatcgccaaatgttgctcgacaccaataaca
gccagctcttctcctacgatgagtggcgcgaagagcacggcgatagcatcgaactggttactgatgat
catcagcgagaaaacccgctacaacaactactggacagtaatctgcgccagcgggtgatggaagcca
tcgaaacgttgccggagcgcgaaaaactggtattaaccctctattaccaggaagagctgaatctcaaag
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agattggcgcggtgctggaggtcggggaatcgcgggtcagtcagttacacagccaggctattaaacg
gttacgcactaaactgggtaagttataatctagaggcgccactcgagagtcgaccaaagcccgccgaa
aggcgggcttttctgtgccggcatgataagctgtcaaacatgagaattgcaacttatatcgtatggggct
gacttcaggtgctacatttgaagagataaattgcactgaaatctagaaatattttatctgattaataagatga
tcttcttgagatcgttttggtctgcgcgtaatctcttgctctgaaaacgaaaaaaccgccttgcagggcgg
tttttcgaaggttctctgagctaccaactcttt 
 
P28-C1-ssra ataggggttccgcgcacatttccccgaaaagtgccacctgacgtctaagaaaccattattatcatgacat
taacctataaaaataggcgtatcacgaggccctttcgtcttcaagaattctggcgaatcctctgaccagc
cagaaaacgacctttctgtggtgaaaccggatgctgcaattcagagcgccagcaagtgggggacagc
agaagacctgaccgccgcagagtggatgtttgacatggtgaagactatcgcaccatcagccagaaaa
ccgaattttgctgggtgggctaacgatatccgcctgatgcgtgaacgtgacggacgtaaccaccgcga
catgtgtgtgctgttccgctgggcatgccaggacaacttctggtccggtaacgtgctgagcccggccaa
gcttcaataaagtttcccccctccttgccgataacgagatcaagctagcaataattttgtttaactttaagaa
ggagatatacatatgagcacaaaaaagaaaccattaacacaagagcagcttgaggacgcacgtcgcc
ttaaagcaatttatgaaaaaaagaaaaatgaacttggcttatcccaggaatctgtcgcagacaagatgg
ggatggggcagtcaggcgttggtgctttatttaatggcatcaatgcattaaatgcttataacgccgcattg
cttgcaaaaattctcaaagttagcgttgaagaatttagcccttcaatcgccagagaaatctacgagatgta
tgaagcggttagtatgcagccgtcacttagaagtgagtatgagtaccctgttttttctcatgttcaggcag
ggatgttctcacctgagcttagaacctttaccaaaggtgatgcggagagatgggtaagcacaaccaaa
aaagccagtgattctgcattctggcttgaggttgaaggtaattccatgaccgcaccaacaggctccaag
ccaagctttcctgacggaatgttaattctcgttgaccctgagcaggctgttgagccaggtgatttctgcat
agccagacttgggggtgatgagtttaccttcaagaaactgatcagggatagcggtcaggtgtttttacaa
ccactaaacccacagtacccaatgatcccatgcaatgagagttgttccgttgtggggaaagttatcgcta
gtcagtggcctgaagagacgtttggctgtgcagcaaacgacgaaaactacgctttagctgcttaagag
ctccgtcgacaagcttgcggccgcactcgagcaaagcccgccgaaaggcgggcttttctgtgtcgac
cgatgcccttgagagccttcaacccagtcagctccttccggtgggcgcggggcatgactatcgtcgcc
gcacttatgactgtcttctttatcatgcaactcgtaggacaggtgccggcagcgctcttccgcttcctcgct
cactgactcgctgcgctcggtcgttcggctgcggcgagcggtatcagctcactcaaaggcggtaatac
ggttatccacagaatcaggggataacgcaggaaagaacatgtgagcaaaaggccagcaaaaggcca
ggaaccgtaaaaaggccgcgttgctggcgtttttccataggctccgcccc 
P70-σ19 cgaggccctttcgtcttcaagaattctggcgaatcctctgaccagccagaaaacgacctttctgtggtga
aaccggatgctgcaattcagagcgccagcaagtgggggacagcagaagacctgaccgccgcagag
tggatgtttgacatggtgaagactatcgcaccatcagccagaaaaccgaattttgctgggtgggctaac
gatatccgcctgatgcgtgaacgtgacggacgtaaccaccgcgacatgtgtgtgctgttccgctgggc
atgccaggacaacttctggtccggtaacgtgctgagctaacaccgtgcgtgttgacaattttacctctgg
cggtgataatggttgcagctagcaataattttgtttaactttaagaaggaggatccaaatgtctgaccgcg
ccactaccacagcttccttaacgttcgagtcgctttatggcacacatcacggctggttgaaaagctggct
gacgcgcaaactccagtctgcttttgatgcagatgacattgcccaggacacttttttgcgggtaatggtca
gcgaaacgctctcgacgatccgcgatcctcgctccttcctctgcactatcgccaaacgcgtgatggtgg
acctgtttcgccgaaacgcgctggaaaaagcgtatctggagatgctggcgcttatgccggagggggg
agcgccttcacctgaggaacgcgaaagccaactcgagaccctacaactcctcgacagcatgctggac
gggctaaacggcaaaacacgtgaagcgtttctgctttcgcaactggatggtctgacatacagcgagatt
gcgcacaaactcggtgtttccatcagctccgtgaaaaaatacgtggcgaaagccgtcgagcactgcct
gctgttccgtctggagtatgggttatgatgtacaagtaactcgaggaattccgactcaattagttcagtca
gtttcaggatattagtcatctctacattgattatgagtattcagaaattccttaaatattctgacaaatgctcttt
ccctaaactccccccataaaaaaacccgccgaagcgggtttttacgttatttgcggattaacgattactcg
ttatcagaaccgcccagacctgcgttcagcagttctgccaggctggcagatgcgtcttccggaattgat
ccgtcgaccaaagcccgccgaaaggcgggcttttctgtgccggcatgataagctgtcaaacatgaga
attgcaacttatatcgtatggggctgacttcaggtgctacatttgaagagataaattgcactgaaatctaga
aatattttatctgattaataagatgatcttcttgagatcgttttggtctgcgcgtaatctcttgctctgaaaacg
aaaaaaccgccttgcagggcggtttttcgaaggttctctgagctaccaactcttt 
P19-C1-ssra cgaggccctttcgtcttcaagaattctggcgaatcctctgaccagccagaaaacgacctttctgtggtga
aaccggatgctgcaattcagagcgccagcaagtgggggacagcagaagacctgaccgccgcagag
tggatgtttgacatggtgaagactatcgcaccatcagccagaaaaccgaattttgctgggtgggctaac
gatatccgcctgatgcgtgaacgtgacggacgtaaccaccgcgacatgtgtgtgctgttccgctgggc
atgccaggacaacttctggtccggtaacgtgctgagcccggccaagcttactgtaaggaaaataattctt
atttcgattgtcctttttacccttctcgttcgactcatagctgctagcaataattttgtttaactttaagaagga
ggatccaaatgagcacaaaaaagaaaccattaacacaagagcagcttgaggacgcacgtcgccttaa
agcaatttatgaaaaaaagaaaaatgaacttggcttatcccaggaatctgtcgcagacaagatggggat
ggggcagtcaggcgttggtgctttatttaatggcatcaatgcattaaatgcttataacgccgcattgcttgc
aaaaattctcaaagttagcgttgaagaatttagcccttcaatcgccagagaaatctacgagatgtatgaa
gcggttagtatgcagccgtcacttagaagtgagtatgagtaccctgttttttctcatgttcaggcagggat
gttctcacctgagcttagaacctttaccaaaggtgatgcggagagatgggtaagcacaaccaaaaaag
ccagtgattctgcattctggcttgaggttgaaggtaattccatgaccgcaccaacaggctccaagccaa
gctttcctgacggaatgttaattctcgttgaccctgagcaggctgttgagccaggtgatttctgcatagcc
agacttgggggtgatgagtttaccttcaagaaactgatcagggatagcggtcaggtgtttttacaaccac
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taaacccacagtacccaatgatcccatgcaatgagagttgttccgttgtggggaaagttatcgctagtca
gtggcctgaagagacgtttggctgtgcagcaaacgacgaaaactacgctttagctgcttaatctagagg
cgccactcgagagtcgaccaaagcccgccgaaaggcgggcttttctgtgccggcatgataagctgtc
aaacatgagaattgcaacttatatcgtatggggctgacttcaggtgctacatttgaagagataaattgcac
tgaaatctagaaatattttatctgattaataagatgatcttcttgagatcgttttggtctgcgcgtaatctcttg
ctctgaaaacgaaaaaaccgccttgcagggcggtttttcgaaggttctctgagctaccaactcttt 
P70-deGFP-ssra ataggggttccgcgcacatttccccgaaaagtgccacctgacgtctaagaaaccattattatcatgacat
taacctataaaaataggcgtatcacgaggccctttcgtcttcaagaattctggcgaatcctctgaccagc
cagaaaacgacctttctgtggtgaaaccggatgctgcaattcagagcgccagcaagtgggggacagc
agaagacctgaccgccgcagagtggatgtttgacatggtgaagactatcgcaccatcagccagaaaa
ccgaattttgctgggtgggctaacgatatccgcctgatgcgtgaacgtgacggacgtaaccaccgcga
catgtgtgtgctgttccgctgggcatgctgagctaacaccgtgcgtgttgacaattttacctctggcggtg
ataatggttgcagctagcaataattttgtttaactttaagaaggagatataccatggagcttttcactggcgt
tgttcccatcctggtcgagctggacggcgacgtaaacggccacaagttcagcgtgtccggcgagggc
gagggcgatgccacctacggcaagctgaccctgaagttcatctgcaccaccggcaagctgcccgtgc
cctggcccaccctcgtgaccaccctgacctacggcgtgcagtgcttcagccgctaccccgaccacatg
aagcagcacgacttcttcaagtccgccatgcccgaaggctacgtccaggagcgcaccatcttcttcaa
ggacgacggcaactacaagacccgcgccgaggtgaagttcgagggcgacaccctggtgaaccgca
tcgagctgaagggcatcgacttcaaggaggacggcaacatcctggggcacaagctggagtacaact
acaacagccacaacgtctatatcatggccgacaagcagaagaacggcatcaaggtgaacttcaagat
ccgccacaacatcgaggacggcagcgtgcagctcgccgaccactaccagcagaacacccccatcg
gcgacggccccgtgctgctgcccgacaaccactacctgagcacccagtccgccctgagcaaagacc
ccaacgagaagcgcgatcacatggtcctgctggagttcgtgaccgccgccgggatcgcagcaaacg
acgaaaactacgctttagctgcttaactcgagcaaagcccgccgaaaggcgggcttttctgtgtcgacc
gatgcccttgagagccttcaacccagtcagctccttccggtgggcgcggggcatgactatcgtcgccg
cacttatgactgtcttctttatcatgcaactcgtaggacaggtgccggcagcgctcttccgcttcctcgctc
actgactcgctgcgctcggtcgttcggctgcggcgagcggtatcagctcactcaaaggcggtaatacg
gttatccacagaatcaggggataacgcaggaaagaacatgtgagcaaaaggccagcaaaaggccag
gaaccgtaaaaaggccgcgttgctggcgtttttccataggctccgcccc 
 
P28-deGFP ataggggttccgcgcacatttccccgaaaagtgccacctgacgtctaagaaaccattattatcatgacat
taacctataaaaataggcgtatcacgaggccctttcgtcttcaagaattctggcgaatcctctgaccagc
cagaaaacgacctttctgtggtgaaaccggatgctgcaattcagagcgccagcaagtgggggacagc
agaagacctgaccgccgcagagtggatgtttgacatggtgaagactatcgcaccatcagccagaaaa
ccgaattttgctgggtgggctaacgatatccgcctgatgcgtgaacgtgacggacgtaaccaccgcga
catgtgtgtgctgttccgctgggcatgccaggacaacttctggtccggtaacgtgctgagcccggccaa
gcttcaataaagtttcccccctccttgccgataacgagatcaagctagcaataattttgtttaactttaagaa
ggagatataccatggagcttttcactggcgttgttcccatcctggtcgagctggacggcgacgtaaacg
gccacaagttcagcgtgtccggcgagggcgagggcgatgccacctacggcaagctgaccctgaagt
tcatctgcaccaccggcaagctgcccgtgccctggcccaccctcgtgaccaccctgacctacggcgt
gcagtgcttcagccgctaccccgaccacatgaagcagcacgacttcttcaagtccgccatgcccgaag
gctacgtccaggagcgcaccatcttcttcaaggacgacggcaactacaagacccgcgccgaggtga
agttcgagggcgacaccctggtgaaccgcatcgagctgaagggcatcgacttcaaggaggacggca
acatcctggggcacaagctggagtacaactacaacagccacaacgtctatatcatggccgacaagca
gaagaacggcatcaaggtgaacttcaagatccgccacaacatcgaggacggcagcgtgcagctcgc
cgaccactaccagcagaacacccccatcggcgacggccccgtgctgctgcccgacaaccactacct
gagcacccagtccgccctgagcaaagaccccaacgagaagcgcgatcacatggtcctgctggagtt
cgtgaccgccgccgggatctaactcgagcaaagcccgccgaaaggcgggcttttctgtgtcgaccga
tgcccttgagagccttcaacccagtcagctccttccggtgggcgcggggcatgactatcgtcgccgca
cttatgactgtcttctttatcatgcaactcgtaggacaggtgccggcagcgctcttccgcttcctcgctcac
tgactcgctgcgctcggtcgttcggctgcggcgagcggtatcagctcactcaaaggcggtaatacggt
tatccacagaatcaggggataacgcaggaaagaacatgtgagcaaaaggccagcaaaaggccagg
aaccgtaaaaaggccgcgttgctggcgtttttccataggctccgcccc 
P19-deGFP ataggggttccgcgcacatttccccgaaaagtgccacctgacgtctaagaaaccattattatcatgacat
taacctataaaaataggcgtatcacgaggccctttcgtcttcaagaattctggcgaatcctctgaccagc
cagaaaacgacctttctgtggtgaaaccggatgctgcaattcagagcgccagcaagtgggggacagc
agaagacctgaccgccgcagagtggatgtttgacatggtgaagactatcgcaccatcagccagaaaa
ccgaattttgctgggtgggctaacgatatccgcctgatgcgtgaacgtgacggacgtaaccaccgcga
catgtgtgtgctgttccgctgggcatgccaggacaacttctggtccggtaacgtgctgagcccggccaa
gcttactgtaaggaaaataattcttatttcgattgtcctttttacccttctcgttcgactcatagctgctagcaa
taattttgtttaactttaagaaggagatataccatggagcttttcactggcgttgttcccatcctggtcgagc
tggacggcgacgtaaacggccacaagttcagcgtgtccggcgagggcgagggcgatgccacctac
ggcaagctgaccctgaagttcatctgcaccaccggcaagctgcccgtgccctggcccaccctcgtga
ccaccctgacctacggcgtgcagtgcttcagccgctaccccgaccacatgaagcagcacgacttcttc
aagtccgccatgcccgaaggctacgtccaggagcgcaccatcttcttcaaggacgacggcaactaca
agacccgcgccgaggtgaagttcgagggcgacaccctggtgaaccgcatcgagctgaagggcatc
gacttcaaggaggacggcaacatcctggggcacaagctggagtacaactacaacagccacaacgtct
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atatcatggccgacaagcagaagaacggcatcaaggtgaacttcaagatccgccacaacatcgagga
cggcagcgtgcagctcgccgaccactaccagcagaacacccccatcggcgacggccccgtgctgct
gcccgacaaccactacctgagcacccagtccgccctgagcaaagaccccaacgagaagcgcgatc
acatggtcctgctggagttcgtgaccgccgccgggatctaactcgagcaaagcccgccgaaaggcg
ggcttttctgtgtcgaccgatgcccttgagagccttcaacccagtcagctccttccggtgggcgcgggg
catgactatcgtcgccgcacttatgactgtcttctttatcatgcaactcgtaggacaggtgccggcagcg
ctcttccgcttcctcgctcactgactcgctgcgctcggtcgttcggctgcggcgagcggtatcagctcac
tcaaaggcggtaatacggttatccacagaatcaggggataacgcaggaaagaacatgtgagcaaaag
gccagcaaaaggccaggaaccgtaaaaaggccgcgttgctggcgtttttccataggctccgcccc 
P19-deCFP ataggggttccgcgcacatttccccgaaaagtgccacctgacgtctaagaaaccattattatcatgacat
taacctataaaaataggcgtatcacgaggccctttcgtcttcaagaattctggcgaatcctctgaccagc
cagaaaacgacctttctgtggtgaaaccggatgctgcaattcagagcgccagcaagtgggggacagc
agaagacctgaccgccgcagagtggatgtttgacatggtgaagactatcgcaccatcagccagaaaa
ccgaattttgctgggtgggctaacgatatccgcctgatgcgtgaacgtgacggacgtaaccaccgcga
catgtgtgtgctgttccgctgggcatgccaggacaacttctggtccggtaacgtgctgagcccggccaa
gcttactgtaaggaaaataattcttatttcgattgtcctttttacccttctcgttcgactcatagctgctagcaa
taattttgtttaactttaagaaggagatataccatggagcttttcactggcgttgttcccatcctggtcgagc
tggacggcgacgtaaacggccacaagttcagcgtgtccggcgagggcgagggcgatgccacctac
ggcaagctgaccctgaagttcatctgcaccaccggcaagctgcccgtgccctggcccaccctcgtga
ccaccctgacctggggcgtgcagtgcttcagccgctaccccgaccacatgaagcagcacgacttcttc
aagtccgccatgcccgaaggctacgtccaggagcgcaccatcttcttcaaggacgacggcaactaca
agacccgcgccgaggtgaagttcgagggcgacaccctggtgaaccgcatcgagctgaagggcatc
gacttcaaggaggacggcaacatcctggggcacaagctggagtacaactacatcagccacaacgtct
atatcaccgccgacaagcagaagaacggcatcaaggccaacttcaagatccgccacaacatcgagg
acggcagcgtgcagctcgccgaccactaccagcagaacacccccatcggcgacggccccgtgctg
ctgcccgacaaccactacctgagcacccagtccgccctgagcaaagaccccaacgagaagcgcgat
cacatggtcctgctggagttcgtgaccgccgccgggatctaactcgagcaaagcccgccgaaaggc
gggcttttctgtgtcgaccgatgcccttgagagccttcaacccagtcagctccttccggtgggcgcggg
gcatgactatcgtcgccgcacttatgactgtcttctttatcatgcaactcgtaggacaggtgccggcagc
gctcttccgcttcctcgctcactgactcgctgcgctcggtcgttcggctgcggcgagcggtatcagctca
ctcaaaggcggtaatacggttatccacagaatcaggggataacgcaggaaagaacatgtgagcaaaa
ggccagcaaaaggccaggaaccgtaaaaaggccgcgttgctggcgtttttccataggctccgcccc 
P28-deYFP ataggggttccgcgcacatttccccgaaaagtgccacctgacgtctaagaaaccattattatcatgacat
taacctataaaaataggcgtatcacgaggccctttcgtcttcaagaattctggcgaatcctctgaccagc
cagaaaacgacctttctgtggtgaaaccggatgctgcaattcagagcgccagcaagtgggggacagc
agaagacctgaccgccgcagagtggatgtttgacatggtgaagactatcgcaccatcagccagaaaa
ccgaattttgctgggtgggctaacgatatccgcctgatgcgtgaacgtgacggacgtaaccaccgcga
catgtgtgtgctgttccgctgggcatgccaggacaacttctggtccggtaacgtgctgagcccggccaa
gcttcaataaagtttcccccctccttgccgataacgagatcaagctagcaataattttgtttaactttaagaa
ggagatataccatggagcttttcactggcgttgttcccatcctggtcgagctggacggcgacgtaaacg
gccacaagttcagcgtgtccggcgagggcgagggcgatgccacctacggcaagctgaccctgaagt
tcatctgcaccaccggcaagctgcccgtgccctggcccaccctcgtgaccaccttcggctacggcctg
cagtgcttcgcccgctaccccgaccacatgaagcagcacgacttcttcaagtccgccatgcccgaagg
ctacgtccaggagcgcaccatcttcttcaaggacgacggcaactacaagacccgcgccgaggtgaa
gttcgagggcgacaccctggtgaaccgcatcgagctgaagggcatcgacttcaaggaggacggcaa
catcctggggcacaagctggagtacaactacaacagccacaacgtctatatcatggccgacaagcag
aagaacggcatcaaggtgaacttcaagatccgccacaacatcgaggacggcagcgtgcagctcgcc
gaccactaccagcagaacacccccatcggcgacggccccgtgctgctgcccgacaaccactacctg
agctaccagtccgccctgagcaaagaccccaacgagaagcgcgatcacatggtcctgctggagttcg
tgaccgccgccgggatctaactcgagcaaagcccgccgaaaggcgggcttttctgtgtcgaccgatg
cccttgagagccttcaacccagtcagctccttccggtgggcgcggggcatgactatcgtcgccgcactt
atgactgtcttctttatcatgcaactcgtaggacaggtgccggcagcgctcttccgcttcctcgctcactg
actcgctgcgctcggtcgttcggctgcggcgagcggtatcagctcactcaaaggcggtaatacggttat
ccacagaatcaggggataacgcaggaaagaacatgtgagcaaaaggccagcaaaaggccaggaa
ccgtaaaaaggccgcgttgctggcgtttttccataggctccgcccc 
 
PLASMID MAP AND DNA SEQUENCES USED IN CHAPTER 5 
pCas plasmid: addgene reference number #62225 
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This plasmid contains the lambda red recombination system (used to promote HDR and consists of: 
araBAD promoter; Gam; Beta; Exo; λ tL3 termination), araC (regulator of the arabinose operon), Cas9 
(exonuclease), KanR (confers kanamycin resistance), pSC101 ori (the origin of replication), Rep101 
(temperature-sensitive gene encoding RepA protein needed for plasmid replication), lacIq promoter 
(promotes activity of the lac operator), lacI (repressor of the lac operator unless lactose or IPTG is 
present), lac operator, and sgRNA (an IPTG-inducible feature guiding Cas9 to the pMB1 replicon on 
pTF to induce a DSB there, meaning that pCas can be used to remove pTF). 
pTF plasmid: addgene reference number #62226 
                             
 
This plasmid contains an ori (the pMB1 origin of replication), SmR (confers spectinomycin and 
streptomycin resistance), J23119(SpeI) promoter (bacterial promoter modified with a SpeI restriction 
site at the end), and the sgRNA (the actual single guide RNA that targets Cas9 to the correct site in the 
genome). In this figure, only the single guide RNA scaffold (gRNA) is displayed. The N20 comes right 
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in front of this scaffold (so at the 5’ end, between the white and blue arrows), together forming the 
sgRNA.  
 
 
DNA name Sequence 
TS2 donor DNA 
 
tttatgatccgacggtacagtttgagttctggttctcggaaaagcggattgcggatatcaggcaggttga
aaccacagcacgctatcttggcacggcgctgtactggatagccgccagtatcaatatcaaaccgggcc
atgattattatttttacatccgcagtgtgaacaccgttggcaaatcggcattcgtggaggctgttggccag
ccgagtgatgatgcatccggctatctgaattttttcaaaggagagatagggaaaacccatctggctcag
gagttgtggacgcagattgataacggtcagcttgcgcctgacccccaatacgcaaaccgcctctcccc
gcgcgttggccgattcattaatgcaggatctcgatcccgcgaaattaatacgactcactatagggagac
cacaacggtttccctctagaaataattttgtttaactttaagaaggagatataccatggagcttttcactggc
gttgttcccatcctggtcgagctggacggcgacgtaaacggccacaagttcagcgtgtccggcgagg
gcgagggcgatgccacctacggcaagctgaccctgaagttcatctgcaccaccggcaagctgcccgt
gccctggcccaccctcgtgaccaccctgacctacggcgtgcagtgcttcagccgctaccccgaccac
atgaagcagcacgacttcttcaagtccgccatgcccgaaggctacgtccaggagcgcaccatcttcttc
aaggacgacggcaactacaagacccgcgccgaggtgaagttcgagggcgacaccctggtgaaccg
catcgagctgaagggcatcgacttcaaggaggacggcaacatcctggggcacaagctggagtacaa
ctacaacagccacaacgtctatatcatggccgacaagcagaagaacggcatcaaggtgaacttcaag
atccgccacaacatcgaggacggcagcgtgcagctcgccgaccactaccagcagaacacccccatc
ggcgacggccccgtgctgctgcccgacaaccactacctgagcacccagtccgccctgagcaaagac
cccaacgagaagcgcgatcacatggtcctgctggagttcgtgaccgccgccgggatctaactcgaga
attcgaagcttgatccggctgctaacaaagcccgaaaggaagctgagttggctgctgccaccgctgag
caataactagcataaccccttggggcctctaaacgggtcttgaggggttttttgctgaaaggaggaacta
tatccggatctggcgtaatagcgaagaggcccgcaccgatcgcccttcccaacagttgcgcagcctga
atggcgaatgggactggcggaaatcagaacgtccatcacggatgtcagtaatgaaatcacgcagacc
gtcaataagaaactggaagaccagagtgcggcaatccagcagatacagaaggttcaggttgatacaa
ataataacctgaacagcatgtgggctgtgaagctgcagcagatgcaggacggacgcctttatatcgcg
ggtattggtgccggtattgagaatacccctgacggtatgcagagtcaggtgctgctggcggcggacag
gattgcgatgattaatcctgcgaatggcaacacaaagccgatgtttgttggtc 
 
TS7 donor DNA 
 
ctgaagtggtgtgcatgcgctgttgtccggcacatgtttttctgccgaatgttctttattgtctaataacgcta
tttttttataccaagactgacaagaagatctgtactcaggcatgggatgagttcagcgttattatcatctgc
aataaaagtaatatcccgactagtcataaattcgtcgttcaaataaatgtcgacccgatatgtaccaggtg
gtgcctcgcgtcccttagtaaaggcggataaatcgacagattcagcaagatcattgcttaaaaaccgtg
gattaaaataatactctgcgtcaacgggaaataccgcagttgctaagccaagggcccaatacgcaaac
cgcctctccccgcgcgttggccgattcattaatgcaggatctcgatcccgcgaaattaatacgactcact
atagggagaccacaacggtttccctctagaaataattttgtttaactttaagaaggagatataccatggag
cttttcactggcgttgttcccatcctggtcgagctggacggcgacgtaaacggccacaagttcagcgtgt
ccggcgagggcgagggcgatgccacctacggcaagctgaccctgaagttcatctgcaccaccggca
agctgcccgtgccctggcccaccctcgtgaccaccctgacctacggcgtgcagtgcttcagccgctac
cccgaccacatgaagcagcacgacttcttcaagtccgccatgcccgaaggctacgtccaggagcgca
ccatcttcttcaaggacgacggcaactacaagacccgcgccgaggtgaagttcgagggcgacaccct
ggtgaaccgcatcgagctgaagggcatcgacttcaaggaggacggcaacatcctggggcacaagct
ggagtacaactacaacagccacaacgtctatatcatggccgacaagcagaagaacggcatcaaggtg
aacttcaagatccgccacaacatcgaggacggcagcgtgcagctcgccgaccactaccagcagaac
acccccatcggcgacggccccgtgctgctgcccgacaaccactacctgagcacccagtccgccctg
agcaaagaccccaacgagaagcgcgatcacatggtcctgctggagttcgtgaccgccgccgggatct
aactcgagaattcgaagcttgatccggctgctaacaaagcccgaaaggaagctgagttggctgctgcc
accgctgagcaataactagcataaccccttggggcctctaaacgggtcttgaggggttttttgctgaaag
gaggaactatatccggatctggcgtaatagcgaagaggcccgcaccgatcgcccttcccaacagttgc
gcagcctgaatggcgaatgggaccaatggtaagccgtgcaaagcgaggcattattaacacctgatgc
atacgatatgccttaaatgcggcacgaaaggctgtcattattaattccgattgagtttattattaattaggtc
actggcttactgcatggttgccttaatacgcggagttaatgcaccgtaatcattgatcgtctgaaaactgat
atccccggttgcagcatgcgtgatatccaccgatacttcaccttttggcggcaccatggtgtttgggaga
ttgctatttcctgctttcatatttgttacggtaatgaaatagggcgttggattaataagcgtgagtttgctacc
gctgcga 
 
TS16 donor DNA 
 
aggagttaaggctgtcacacggatttggatgagaacccatcatgtgcaggaaaattatcttcggagagg
atgtatccgccagcgcacgttctgtttcctgtaacaacagtttgtcatctgttttacgggaagcgaagctg
cctttcttgaggaaagtggcatgctccgcatcagaagcaataacagagatgcgtgtgtcatgctccccc
agttttccttcccaatacgcaaaccgcctctccccgcgcgttggccgattcattaatgcaggatctcgatc
ccgcgaaattaatacgactcactatagggagaccacaacggtttccctctagaaataattttgtttaacttt
aagaaggagatataccatggagcttttcactggcgttgttcccatcctggtcgagctggacggcgacgt
aaacggccacaagttcagcgtgtccggcgagggcgagggcgatgccacctacggcaagctgaccct
gaagttcatctgcaccaccggcaagctgcccgtgccctggcccaccctcgtgaccaccctgacctacg
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gcgtgcagtgcttcagccgctaccccgaccacatgaagcagcacgacttcttcaagtccgccatgccc
gaaggctacgtccaggagcgcaccatcttcttcaaggacgacggcaactacaagacccgcgccgag
gtgaagttcgagggcgacaccctggtgaaccgcatcgagctgaagggcatcgacttcaaggaggac
ggcaacatcctggggcacaagctggagtacaactacaacagccacaacgtctatatcatggccgaca
agcagaagaacggcatcaaggtgaacttcaagatccgccacaacatcgaggacggcagcgtgcagc
tcgccgaccactaccagcagaacacccccatcggcgacggccccgtgctgctgcccgacaaccact
acctgagcacccagtccgccctgagcaaagaccccaacgagaagcgcgatcacatggtcctgctgg
agttcgtgaccgccgccgggatctaactcgagaattcgaagcttgatccggctgctaacaaagcccga
aaggaagctgagttggctgctgccaccgctgagcaataactagcataaccccttggggcctctaaacg
ggtcttgaggggttttttgctgaaaggaggaactatatccggatctggcgtaatagcgaagaggcccgc
accgatcgcccttcccaacagttgcgcagcctgaatggcgaatgggacgattggatatccaccatgtg
ctgtatcctgcttttgctgccagcgccaccacattgttgccggaatcagggttctgctcatagtcataaatc
agtgtccggctcagggaagacactgtactggaggctgtcgaggtataatcgtcaataaataaaccggg
tgccgtattcagccacggtgtggttggtacgggatagtcatacactgacatataatccctgcgc 
 
PT7-Sp2-TT7 caggatctcgatcccgcgaaattaatacgactcactatagggagaccacaacggtttccctctagaaat
aattttgtttaactttaagaaggagatataccgcccggatagctcagtcggtagagcagcggccggatgt
aactgaatgaaatggtgaaggacgggtccagtaggctgcttcggcagcctacttgttgagtagagtgtg
agctccgtaactagttacatccggccgcgggtccagggttcaagtccctgttcgggcgccagaattcg
aagcttgatccggctgctaacaaagcccgaaaggaagctgagttggctgctgccaccgctgagcaat
aactagcataaccccttggggcctctaaacgggtcttgaggggttttttgctgaaaggaggaactatatc
cggatctggcgtaatagcgaagaggcccgcaccgatcgcccttcccaacagttgcgcagcctgaatg
gcgaatgggacgcgccctgtagcggcgcattaagcg 
PT7-mRFP-TT7 cccgcgaaattaatacgactcactatagggagaccacaacggtttccctctagaaataattttgtttaactt
taagaaggagatataccatggcttcctccgaagacgttatcaaagagttcatgcgtttcaaagttcgtatg
gaaggttccgttaacggtcacgagttcgaaatcgaaggtgaaggtgaaggtcgtccgtacgaaggtac
ccagaccgctaaactgaaagttaccaaaggtggtccgctgccgttcgcttgggacatcctgtccccgc
agttccagtacggttccaaagcttacgttaaacacccggctgacatcccggactacctgaaactgtcctt
cccggaaggtttcaaatgggaacgtgttatgaacttcgaagacggtggtgttgttaccgttacccagga
ctcctccctgcaagacggtgagttcatctacaaagttaaactgcgtggtaccaacttcccgtccgacggt
ccggttatgcagaaaaaaaccatgggttgggaagcttccaccgaacgtatgtacccggaagacggtg
ctctgaaaggtgaaatcaaaatgcgtctgaaactgaaagacggtggtcactacgacgctgaagttaaa
accacctacatggctaaaaaaccggttcagctgccgggtgcttacaaaaccgacatcaaactggacat
cacctcccacaacgaagactacaccatcgttgaacagtacgaacgtgctgaaggtcgtcactccaccg
gtgcttaagcccggatagctcagtcggtagagcagcggccggatgtaactgaatgaaatggtgaagg
acgggtccagtaggctgcttcggcagcctacttgttgagtagagtgtgagctccgtaactagttacatcc
ggccgcgggtccagggttcaagtccctgttcgggcgccagaattcgaagcttgatccggctgctaaca
aagcccgaaaggaagctgagttggctgctgccaccgctgagcaataactagcataaccccttggggc
ctctaaacgggtcttgaggggttttttgctgaaaggaggaactatatccggatctggcgtaatagcgaag
aggcccgcaccgatcgcccttcccaacagttgcgcagcctgaatggcgaatgggacgcgccctgtag
cggcgcattaagcgcggcgggtgtggtggttacgcgcagcgtgaccgctacacttgccagcgcccta
gcgcccgctcctttcgctttcttcccttcctttctcgccacgttcgccggctttccccgtcaagctctaaatc
gggggctccctttagggttccgatttagtgctttacggcacctcgaccccaaaaaacttgattagggtga
tggttcacgtagtgggccatcgccctgatagacggtttttcgccctttgacgttggagtccacgttctttaa
tagtggactcttgttccaaactggaacaacactcaaccctatctcggtctattcttttgatttataagggattt
tgccgatttcggcctattggttaaaaaatgagctgatttaacaaaaatttaacgcgaattttaacaaaatatt
aacgcttacaatttaggtggcacttttcggggaaatgtgcgcggaacccctatttgtttatttttctaaatac
attcaaatatgtatccgctcatgagacaataaccctgataaatgcttcaataatattgaaaaaggaagagt
atgagtattcaacatttccgtgtcgcccttattcccttttttgcggcattttgccttcctgtttttgctcacccag
aaacgctggtgaaagtaaaagatgctgaagatcagttgggtgcacgagtgggttacatcgaactggat
ctcaacagcggtaagatccttgagagttttcgccccgaagaacgttttccaatgatgagcacttttaaagt
tctgctatgtggcgcggtattatcccgtattgacgccgggcaagagcaactcggtcgccgcatacacta
ttctcagaatgacttggttgagtactcaccagtcacagaaaagcatcttacggatggcatgacagtaaga
gaattatgcagtgctgccataaccatgagtgataacactgcggccaacttacttctgacaacgatcgga
ggaccgaaggagctaaccgcttttttgcacaacatgggggatcatgtaactcgccttgatcgttgggaa
ccggagctgaatgaagccataccaaacgacgagcgtgacaccacgatgcctgtagcaatggcaaca
acgttgcgcaaactattaactggcgaactacttactctagcttcccggcaacaattaatagactggatgg
aggcggataaagttgcaggaccacttctgcgctcggcccttccggctggctggtttattgctgataaatc
tggagccggtgagcgtgggtctcgcggtatcattgcagcactggggccagatggtaagccctcccgt
atcgtagttatctacacgacggggagtcaggcaactatggatgaacgaaatagacagatcgctgagat
aggtgcctcactgattaagcattggtaactgtcagaccaagtttactcatatatactttagattgatttaaaa
cttcatttttaatttaaaaggatctaggtgaagatcctttttgataatctcatgaccaaaatcccttaacgtga
gttttcgttccactgagcgtcagaccccgtagaaaagatcaaaggatcttcttgagatcctttttttctgcg
cgtaatctgctgcttgcaaacaaaaaaaccaccgctaccagcggtggtttgtttgccggatcaagagct
accaactctttttccgaaggtaactggcttcagcagagcgcagataccaaatactgtccttctagtgtagc
cgtagttaggccaccacttcaagaactctgtagcaccgcctacatacctcgctctgctaatcctgttacca
gtggctgctgccagtggcgataagtcgtgtcttaccgggttggactcaagacgatagttaccggataag
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gcgcagcggtcgggctgaacggggggttcgtgcacacagcccagcttggagcgaacgacctacac
cgaactgagatacctacagcgtgagctatgagaaagcgccacgcttcccgaagggagaaaggcgga
caggtatccggtaagcggcagggtcggaacaggagagcgcacgagggagcttccagggggaaac
gcctggtatctttatagtcctgtcgggtttcgccacctctgacttgagcgtcgatttttgtgatgctcgtcag
gggggcggagcctatggaaaaacgccagcaacgcggcctttttacggttcctggccttttgctggcctt
ttgctcacatgttctttcctgcgttatcccctgattctgtggataaccgtattaccgcctttgagtgagctgat
accgctcgccgcagccgaacgaccgagcgcagcgagtcagtgagcgaggaagcggaagagcgc
ccaatacgcaaaccgcctctccccgcgcgttggccgattcattaatgcaggatctcga 
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